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Cashew allergy  
Cashew allergy is a severe allergy [1-4] of which the prevalence appears to be increasing [6]. 
As information is scarce on prevalence, allergen characteristics, and cross-reactivity, the 
IDEAL project was initiated: Improvement of Diagnostic mEthods for ALlergy assessment of 
cashew allergy in children. In this project the clinical side of cashew allergy was combined 
with molecular studies in order to get a broad picture of cashew nut allergy and its 
responsible allergens. This was realised by involving three tertiary care centres for food 
allergy (Erasmus MC Rotterdam, University Medical Centre Groningen, and Reinier de Graaf 
Gasthuis) to perform Double Blind Placebo Controlled Food Challenges (DBPCFC) in children 
with suspected cashew allergy.  
This thesis research was performed as part of this IDEAL project and focussed on the 
molecular biological studies. This thesis describes the study of cashew nut (Anacardium 
occidentale) proteins, focussed on its known allergens: Ana o 1, Ana o 2 and Ana o 3. These 
proteins are studied with regards to purification, effects of heat treatments, cross-reactivity, 
and IgE binding.  
 
Allergy  
The self-reported prevalence of food allergy in Europe is approximately 6%. However, the 
prevalence of food challenge-confirmed food allergy is below 1% [7]. Type I hypersensitivity, 
or IgE-mediated allergy, can be divided into three phases: the sensitization, stimulation, and 
effector phase [8], see Figure 1.1. During the sensitization phase an allergen (protein) enters 
the body, for example via ingestion, and this allergen is taken up and processed by an 
Antigen Presenting Cell (APC). The APC presents the allergen to CD4+-T cells through their 
MHCII molecule and T Cell Receptor (TCR). Once these cells differentiate into Th2 cells, they 
can activate B cells by a combination of cytokines (IL4, IL13) and co-stimulatory receptor 
binding (CD40-CD40Ligand, MHCII-B-cell receptor). The activated B cells start to produce and 
release IgE, which binds to mast cells and basophils due to the presence of high affinity IgE 
receptors (FcɛRI) expressed on these cells [8, 9]. During the second phase, the allergen again 
enters the body and binds and crosslinks two receptor-bound IgE molecules, thereby 
inducing the third phase. In this third phase, allergic mediators such as histamine and other 
inflammatory mediators are released from the mast cells and basophils, inducing the 
symptoms typical for an allergic reaction (e.g. itchiness, bronchial spasm, etc.) [10]. 
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Figure 1.2 Cashew apple and cashew 
 nut, based on [5]. 
 
 
Figure 1.1 Food allergy: sensitization, stimulation and effector phase. Based on [9].  
 
As explained above, in order to develop an allergy, a protein or peptide must come into 
contact with an antigen presenting cell. For food allergy the most obvious contact between 
food proteins and cells is through the digestive system. Proteins can be transported over the 
gut by several methods: for example paracellular transport [12], or endocytosis via M-cells 
[12] or enterocytes [13] could explain the ability of food proteins/peptides to reach immune 
cells and initiating the sensitization or stimulation phase. The 2S albumins of brazil nut and 
sesame seed, digested and undigested, can pass the 
epithelial cell layer intact as shown in a Caco-2 setup, 
indicating both the resistance to digestion and the 
capability of intestinal transport of these 2S albumins 
[14]. Also peanut protein was shown to be transported 
across the intestinal epithelial layer in an in vivo mouse 
model [15].  
 
Cashew nut  
Cashew (Anacardium occidentale) originates from Brazil 
and has been distributed to Mozambique and India by 
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Figure 1.3 Overview of the steps of 
cashew nut processing, based on [5]. 
the Portuguese in the 16th century, after which these nuts were further spread by nature 
[16]. Cashew trees are easily cultivated, yielding 7 to 11 kilos of cashew nuts per year. The 
cashew tree is often cultivated by smallholder farms, and cross-pollination occurs freely 
between trees, leading to high variability 
between trees with little characterisation 
regarding to cashew tree varieties [5].  
 
The cashew nut is a kidney-shaped seed 
which forms below a cashew apple, also 
named the false fruit of the cashew tree, see 
Figure 1.2. The edible cashew nut kernel is 
protected by a peel (testa) and is sheltered 
inside a shell containing a corrosive liquid 
named cashew nut shell liquid [5]. In recent 
years the global production of cashew nuts 
has been rising with a production of 4.7 
million tonnes of raw cashew in 2011 with 
Vietnam as largest producer [16]. This 
production is mostly focussed on the cashew 
nut, but value-added side-products can be 
obtained from the cashew apple (alcoholic 
beverages, juice, candy, chutney, jam), testa (poultry feed), and cashew nut shell liquid 
(ingredient for paint, varnish) [17].  
As explained by Azam-Ali and Judge [5], cashew nuts require many processing steps to be 
prepared for consumption. Picked or fallen cashew nuts are soaked to increase the moisture 
content of the kernel to 9% in order to avoid blackening during the subsequent heating step. 
This heating step, where the nut is roasted or fried, makes the shell brittle and simplifies 
taking out the cashew kernel. The shell is most often manually removed, yielding more of 
the highly desired whole cashew kernels compared to machine cutting of the shell. The 
removed kernel at this point is still covered by the testa, which is removed after a heating 
step of 6hr at 70˚C. After subsequent sorting of the cashews based on size, the moisture 
content is adjusted to 5% by humidification, after which the cashews are shipped and 
processed (e.g. roasted, fried) for consumption [5], see Figure 1.3.  
  
Clinical aspects  
As mentioned by van der Valk et al. [18]; allergy to cashew has gained increasing attention in 
recent years, and is often categorized as a severe allergy compared to other (tree-) nut 
allergies [1-4]. A retrospective study in a hospital in Sweden showed an increasing number of 
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cashew-allergic reactions over a period of 10 years (2001-2010) [6]. Another study in Sweden 
mentioned that in children over 3 years of age, allergic reactions to peanut and tree nuts 
were the most common food allergies resulting in emergency hospital visits. In total 5% of 
these food allergic reactions were due to a cashew allergy [19]. In children, most (74%, 58 
out of 78) cashew allergic reactions occur below 6 years of age [3].  
The prevalence of cashew allergy itself has not been clearly described in literature. 
Prevalence of tree nut allergy as a group was determined at 1.3% based on self-reported 
lifetime allergy and 0.5% based on oral food challenges [20]. Within this group of tree nut 
allergy the percentage of cashew allergic individuals lies somewhere between 5% [21] and 
55% [22] (see Table 1.1). The prevalence of tree nut allergy as a group seems to be 
increasing in children as based on self-reported allergies [23].  
  
Table 1.1 Cashew allergy prevalence as calculated from several studies. 
Year Region Population % cashew 
allergic of tree 
nut allergic 
Methods Source 
1995-
1997 
USA Children with acute reactions to 
peanut and or tree nuts 
55% (11/20) Questionnaire upon 
hospital allergy 
treatment 
[22] 
1997 USA Members of the Food Allergy and 
Anaphylaxis Network, patients of 
allergists (89% <18 year old) 
20% Questionnaire [24] 
1997 USA General US population 7% (8/118) Telephone survey [25] 
2002 USA General US population 44% (36/82) Telephone survey [26] 
2003-
2006 
The 
Netherlands 
Adults with suspected food 
allergy 
20%  Questionnaire upon 
suspected food 
allergy 
[27] 
2005 USA 3-21 years old with tree nut 
allergy 
30% (34/115) Diagnosed by history, 
skin prick test or IgE 
levels 
[4] 
2005 France Schoolchildren 5% (1/19) Questionnaire [21] 
2005 UK 7-10 year old children 19% (8/43) Skin prick test [28] 
2008 USA General US population 35% (29/84) Telephone survey [29] 
2016 Europe 0- <18 year old children 30% (78/256) Medical history [3] 
 
Considering the symptoms upon an allergic reaction to cashew, certain dissimilarities were 
found between multiple studies. A study on 42 cashew-allergic children in France showed 
that most suffered from cutaneous symptoms (56%), 25% displayed respiratory reactions 
and 7% displayed asthmatic reactions [30]. Hourihane et al. showed that 14 out of 29 (48%) 
cashew allergic patients experienced wheezing and 11 out of 29 (38%) experienced collapse 
or feeling faint [31]. Maloney et al. show 84% of cashew allergic reactions result in 
cutaneous symptoms, 70% in respiratory symptoms and about 65% in gastrointestinal 
symptoms [32]. On the other hand in the UK, from 47 cashew-allergic children 98% showed 
cutaneous symptoms, 32% gastrointestinal and 40% suffered from wheezing [2]. These data 
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show high variability in the perceived symptoms. An explanation for these differences might 
be found in a difference in study population or different methods of observation.  
Despite the difference in symptoms observed between different studies, all studies agree on 
the severity of this allergy. The severity of cashew allergy can be explained by two factors: 
the high risk of a severe allergic reaction and the low amount of cashew required in order to 
develop this reaction. The high risk associated with cashew allergy has been revealed by 
Davoren et al. In a retrospective study in Australia it was shown that although peanut allergy 
was more prevalent, incidence of anaphylaxis upon cashew ingestion (20 out of 27 cashew 
allergic reactions developed into anaphylaxis, 74%) was higher than peanut induced 
anaphylaxis (54 out of 177, 31%) [1]. In another study, cashew-allergic children were 
matched and compared to peanut-allergic children. This comparison showed that cashew 
allergy resulted more often in severe reactions, such as lower airway narrowing, than peanut 
allergy. Next to this, upon emergency treatment, adrenalin was more often administered to 
cashew allergic than peanut allergic children [2].  
The low threshold required for an allergic reaction was described by Hourihane et al. stating 
that 14 out of 29 (48%) cashew-allergic patients experienced an allergic reaction after 
exposure to cashew via smelling/touching or tasting but not eating [31]. 
 
Known allergens in cashew: Ana o 1, Ana o 2 and Ana o 3  
The majority of a cashew nut is composed of lipids (44%), but the second largest component 
in cashew is protein (19%) [33]. In this protein fraction the three known allergens from 
cashew are present: Ana o 1, Ana o 2 and Ana o 3. The nucleotide and amino acid sequences 
of these three major allergens are depicted in Figure 1.4. 
 
Ana o 1  
Ana o 1 is a 7S globulin of 50kDa. The cDNA coding sequence of Ana o 1 has been described 
by Wang et al. after preparing a cDNA library from cashew in late maturation, subsequent 
expression in E. coli and screening by serum from cashew allergic patients. For Ana o 1, two 
cDNA sequences were identified: Ana o1.0101 and Ana o1.0102, which differ by a single 
nucleotide [34]. As a 7S globulin, Ana o 1 is a seed storage protein that is part of the cupin 
protein family. Based on other cupins, Ana o 1 is expected to contain a double stranded α-
helix [10] and, like other 7S globulins, is expected to form a trimer of 150kDa in native state 
[38].  
Ana o 1 has been noted as a major allergen when recombinantly produced Ana o 1 bound 
50% of patient sera (10/20). Upon subsequent epitope studies, 11 linear epitopes [34] and 
one conformational epitope [39] were observed.  
 
General introduction 
9 
Ana o 2  
Ana o 2, also named anacardein or cashew major protein, is an 11S globulin that also 
belongs to the cupin protein family [10]. In general, 11S globulins are the most prevalent 
proteins in many seeds [38] and when examining cashew protein extracts this also seems the 
case for cashew [40]. 11S globulins are commonly hexameric proteins composed of 60kDa 
subunits. These subunits each contain an acidic large subunit of about 40kDa and a basic 
small subunit of about 20kDa linked together by a single disulphide bond [41]. In Ana o 2, 
these size descriptions are correct as the large subunit has been determined at 33kDa [35] 
and the small subunit at 20kDa [42, 43]. On denaturing SDS-PAGE also a minor band of 
53kDa was tentatively identified as Ana o 2 [35].  
 
Ana o 1: Ana o 1.0101, vicilin-like protein [Anacardium occidentale] GenBank: 
AAM73730.2 [34] 
1  mgpptkfsfs lflvsvlvlc lgfalakidp elkqckhqck vqrqydeqqk eqcvkeceky 
61  ykekkgrere heeeeeewgt ggvdepsthe paekhlsqcm rqcerqeggq qkqlcrfrcq 
121  erykkergqh nykreddede dedeaeeede npyvfededf ttkvkteqgk vvllpkftqk 
181  skllhaleky rlavlvanpq afvvpshmda dsiffvswgr gtitkilenk resinvrqgd 
241  ivsissgtpf yianndenek lylvqflrpv nlpghfevfh gpggenpesf yrafsweile 
301  aalktskdtl eklfekqdqg timkaskeqi ramsrrgegp kiwpfteest gsfklfkkdp 
361  sqsnkygqlf eaeridyppl ekldmvvsya nitkggmsvp fynsratkia ivvsgegcve 
421  iacphlsssk sshpsykklr arirkdtvfi vpaghpfatv asgnenleiv cfevnaegni 
481  rytlagkkni ikvmekeake lafkmegeev dkvfgkqdee fffqgpewrk ekegrade 
 
Ana o 1: Ana o 1.0102, vicilin-like protein, partial [Anacardium occidentale] GenBank: 
AAM73729.1 [34] 
1  pptkfsfslf lvsvlvlclg falakidpel kqckhqckvq rqydeqqkeq cvkecekyyk 
61 ekkgrerehe eeeeewgtgg vdepsthepa ekhlsqcmrq cerqeggqqk qlcrfrcqer 
121  ykkergqhny kreddedede deaeeedenp yvfededftt kvkteqgkvv llpkftqksk 
181  llhalekyrl avlvanpqaf vvpshmdads iffvswgrgt itkilenkre sinvrqgdiv 
241  sissgtpfyi anndenekly lvqflrpvnl pghfevfhgp ggenpesfyr afsweileaa 
301  lktskdtlek lfekqdqgti mkaskeqvra msrrgegpki wpfteestgs fklfkkdpsq 
361  snkygqlfea eridypplek ldmvvsyani tkggmsvpfy nsratkiaiv vsgegcveia 
421  cphlssskss hpsykklrar irkdtvfivp aghpfatvas gnenleivcf evnaegniry 
481  tlagkkniik vmekeakela fkmegeevdk vfgkqdeeff fqgpewrkek egrade 
 
Ana o 2: Ana o 2, partial [Anacardium occidentale] GenBank: AAN76862.1 [35] 
1  lsvcflilfh gclasrqewq qqdecqidrl dalepdnrve yeagtveawd pnheqfrcag 
61  valvrhtiqp nglllpqysn apqliyvvqg egmtgisypg cpetyqapqq grqqgqsgrf 
121  qdrhqkirrf rrgdiiaipa gvahwcyneg nspvvtvtll dvsnsqnqld rtprkfhlag 
181  npkdvfqqqq qhqsrgrnlf sgfdtellae afqvderlik qlksednrgg ivkvkddelr 
241  virpsrsqse rgseseeese dekrrwgqrd ngieetictm rlkenindpa radiytpevg 
301  rlttlnslnl pilkwlqlsv ekgvlyknal vlphwnlnsh siiygckgkg qvqvvdnfgn 
361  rvfdgevreg qmlvvpqnfa vvkrareerf ewisfktndr amtsplagrt svlggmpeev 
421  lanafqisre darkikfnnq qttltsgess hhmrdda 
 
Ana o 3: 2s albumin [Anacardium occidentale] GenBank: AAL91665.1 [36] 
1  makfllllsa favlllvana siyraiveve edsgreqscq rqfeeqqrfr ncqryvkqev 
61  qrggrynqrq eslreccqel qevdrrcrcq nleqmvrqlq qqeqikgeev relyetasel 
121  pricsispsq gcqfqssy 
 
Figure 1.4 Protein sequence of Ana o 1, Ana o 2 and Ana o 3 with the difference between Ana o 
1.0101 and Ana o 1 1.0102 indicated in bold and italic, IgE-binding epitopes [34, 35, 37] underlined. 
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To the recombinant version of Ana o 2, 13 out of 21 (62%) cashew-allergic patient IgE could 
bind, indicating Ana o 2 to be a major allergen. Ana o 2 contains at least 22 linear epitopes 
which are spread out over the entire protein [35]. When these linear epitopes were 
compared to linear epitopes on other 11S globulin proteins, four “hot spots” were identified, 
IgE binding epitopes at overlapping positions in aligned protein sequences. One of these 
hotspots in Ana o 2 was identified to be shielded within the monomeric subunits of Ana o 2, 
requiring denaturation of the protein before exposure of this epitope [44]. Next to these 
linear epitopes at least one conformational epitope on Ana o 2 has been discovered [43, 45]. 
This conformational epitope was studied using a monoclonal mouse antibody that has been 
shown to inhibit human IgE binding to a conformational epitope on Ana o 2. This 
conformational epitope consists of a protein segment of 24 amino acids containing β-strands 
and a short helical segment on the large subunit of Ana o 2, which connects to the small 
subunit of Ana o 2 [43, 45]. 
 
Ana o 3  
Ana o 3 belongs, as a 2S albumin, to the prolamin superfamily of proteins. These proteins are 
mostly seed storage proteins and are commonly small (7-16kDa) with multiple inter-chain 
disulphide bonds and four α-helices [10]. Also the cDNA sequence of Ana o 3 has been 
determined by Robotham et al. and the recombinant Ana o 3 has been used to produce goat 
anti-Ana o 3 antibodies that can be used to purify native Ana o 3. This showed native Ana o 3 
to be a 12.598kDa 2S albumin which probably undergoes posttranslational modification as 
the protein size based on the cDNA sequence was predicted to be 16.335kDa [37]. Based on 
literature this protein is most probably proteolytically cleaved at the C-terminus into a small 
and a large subunit that stay associated by four disulphide bonds [41, 46]. The large subunit 
of this protein is present in three isoforms of 6, 8 and 10kDa [37]. The small subunit is not 
mentioned in experimental studies, perhaps because it is too small to be observed on SDS-
PAGE or simply because it was never looked for. On western blot 21 out of 26 (81%) patient 
sera bound to rAna o 3, confirming Ana o 3 to be a major allergen. In Ana o 3, 8 linear 
epitopes have been identified, of which some show high similarity with Jug r 1 from walnut 
and sesame seed 2S albumin [37].  
 
Purified and recombinantly produced cashew allergens  
The cashew nut allergens Ana o 1, 2 and 3 have been recombinantly produced in E. coli by 
Wang and Robotham et al. [34, 35, 37]. Cashew-derived Ana o 1, 2, and 3 have been 
identified using these recombinant allergens by inhibition blotting. Inhibition blotting was 
done by pre-incubating serum from a cashew-allergic person with e.g. recombinant Ana o 1, 
and observing on western blot which protein bands from cashew are no longer bound by IgE, 
thereby identifying native Ana o 1. E. coli derived recombinant Ana o 1 is a protein of 55 and 
General introduction 
11 
65kDa (two clones, different in start site, differing 73 amino acids) [34], rAna o 2 is 52kDa 
and also forms a dimer of 120kDa [35], rAna o 3 is a 14kDa protein [37].  
 
Of the three allergens, only Ana o 3 has been purified from the cashew nut [42]. In this 
protocol Mattison et al. used a sodium phosphate gradient on a ceramic hydroxyapatite 
column after defatting of the cashews and precipitation of the protein extract. In this article 
neither the yield nor the purity of the purified Ana o 3 allergen was mentioned. For Ana o 2 a 
purification protocol has been described [47], however, as mentioned by Teuber et al. this 
fraction is not immunologically pure [48]. No protocol for the purification of Ana o 1 has 
been described in literature.  
 
Allergen protein purification starting from the food source or after generating recombinant 
proteins, warrants a discussion on subsequent application. The recombinant production of 
proteins is, in general, easier to standardise, often yields higher amounts of pure protein 
(depending on the expression system used), and contamination of one allergen with the 
other is much less likely to occur compared to protein purification from the food source. 
Purification from the food source directly, on the other hand, results in a native protein with 
correct post-translational modifications like protein folding, disulphide bridges, 
glycosylation, etc. When multiple isoforms of a single protein are present in the food source 
purification might extract multiple (but not necessarily all) isoforms, while recombinant 
protein expression only produces one isoform unless multiple colonies of the different 
protein isoforms are prepared. Also some technical specifications can prompt different 
choices as protein purification and recombinant expression both require different specialist 
equipment, and besides, for recombinant protein expression the protein/cDNA sequence of 
the protein of interest should be known, otherwise first a cDNA library should be prepared. 
Lastly the effect of the food matrix when studying heat treatment effects, protein digestion 
or protein transport characteristics is missed for recombinantly produces proteins.  
 
Heat treatments and in vitro digestion  
Cashews are eaten in processed form: most commonly the raw nuts are heated for 20-35min 
at 150°C in order to remove the shell, afterwards they can be roasted or fried. Roasted 
cashews (120°C or 160°C for 20min) are most often eaten in the US while in the Netherlands 
mostly fried cashews (93°C increased to 135°C in 35-40min or 150°C -160°C for 1-3min) are 
consumed [49]. Because cashews are always heat-treated before consumption, and as this 
might affect the structure and function of the proteins, several studies have examined the 
effect of processing on cashew proteins. Most of these studies have been performed using 
SDS-PAGE and western blotting techniques, using either patient IgE or polyclonal anti-
cashew antibodies, thereby mostly focussing on (linear) epitopes.  
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Studies focussing on roasted cashew show varying results fluctuating from no difference in 
antibody binding [50], to decreased [51] or even increased [52] antibody binding (patient IgE 
[50, 51] or polyclonal IgG [51, 52]) upon roasting of cashew nuts. The discrepancies between 
these studies can to some extent be caused by the increased solubility of Ana o 3 in roasted 
cashew [51]. When the antibodies used, bind specifically to Ana o 3, this binding will be 
increased in extracts from roasted cashew nuts simply due to the higher amount of Ana o 3 
present in the roasted cashew sample. 
 
Besides roasting, also more harsh heat treatments like γ-irradiation and autoclaving have 
been applied to cashew. γ-Irradiation followed by frying or blanching did not affect binding 
of a polyclonal antibody, while γ-irradiation followed by autoclaving or roasting did reduce 
binding of anti-cashew IgG as observed on western blot [53]. The required dose of γ-
irradiation will, however, lead to inedible cashews [54].  
A study by Venkatachalam et al. showed a thorough comparison of cashew subjected to 
many different heat treatments by using rabbit, goat and mouse antibodies. For Ana o 1, a 
decrease in antibody binding after roasting, blanching, microwaving and autoclaving was 
observed but not after γ-irradiation, indicating the probable loss of a conformational epitope 
within Ana o 1 upon heating. Another antibody showed only decreased binding to Ana o 1 
after prolonged autoclaving of the cashew nuts [55]. Ana o 2 remained immunologically 
stable despite microwaving, roasting, blanching or γ-irradiation. Only autoclaving for 20min 
could decrease antibody binding slightly [55]. The immunoreactivity of Ana o 2 towards two 
monoclonal mouse antibodies could chemically be reduced by SDS but not by guanidinium 
HCl or urea despite that the protein conformation of Ana o 2 was changed by all three 
chemicals [56]. Ana o 3 appeared more sensitive to processing steps such as roasting, 
autoclaving and blanching [55]. However, for Ana o 3 this was assessed using a monoclonal 
antibody that potentially binds a conformational epitope [55], while for Ana o 2 the 
antibodies used in the various studies probably target linear epitopes [56], making it difficult 
to compare the stability of these two allergens. It is expected that Ana o 3, like other 2S 
albumins, is highly resistant to heat processing [46]. Considering pH stability, all three 
allergens were stable in the middle-pH range but were unstable at the extreme pH of 1 and 
13 [55]. 
 
Lastly, the effect of sulphite, a chemical that has been shown to disrupt disulphide bonds, 
has been tested on cashew extracts [52]. On both western blot and dot blot, a decrease in 
patient-IgE binding was observed after sulphite treatment of both raw and roasted cashew 
[52]. However, such a treatment cannot be applied to whole cashews, and, as already 
mentioned by the authors, sodium sulphite itself can cause allergic reactions.  
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Besides the effect of heat and processing treatments on cashew nut proteins, also the in 
vitro digestibility of these proteins has been studied. This in vitro digestion showed Ana o 1 
and the 30kDa subunit of Ana o 2 to be partially susceptible to both pepsin and trypsin 
digestion. However, Ana o 3 and the 20kDa subunit of Ana o 2 were not completely digested 
by either pepsin (0.8U 2hr) or trypsin (20U 2hr) alone, nor by pepsin (0.8U 30min) followed 
by trypsin (2U 30min). Ana o 3 pre-treated with DTT to break disulphide bonds was more 
susceptible to pepsin digestion, as based on reduced visibility on SDS-PAGE and reduced (but 
not completely obstructed) IgE binding in inhibition ELISA testing [42]. The effect of in vitro 
digested cashew on the in vivo allergic response has also been studied. Mice sensitized to 
native cashew showed reduced allergic reactions upon intraperitoneal injected pepsin-
digested cashew compared to exposure to non-digested cashew protein. Next to this, 
immunotherapy using a pepsin-digested cashew protein extract could reduce the allergic 
reaction upon cashew challenges in mice, indicating a possible role for pepsin-digested 
cashew in immunotherapy [57].  
 
To summarise, as could be expected from 7S globulins, 11S globulins, and 2S albumins [10] 
Ana o 1, Ana o 2 and Ana o 3 are highly resistant to heat treatments and quite resistant to in 
vitro digestion. The IgE-immunoreactivity of Ana o 2 and 3 can be decreased by sulphite 
treatments and intense γ-irradiation. However, applying these treatments in the cashew nut 
industry is not feasible as sodium sulphite itself might cause allergic reactions and cannot be 
applied to whole cashew nuts, and as the use of high γ-irradiation would result in non-edible 
cashews [54]. 
 
Cross-allergenicity with other Anacardiaceae and other tree nuts  
Cashew is a tree nut belonging to the family of Anacardiaceae together with other edible 
plants and trees like sumac, mango, pistachio, and pink pepper [58]. Cross-allergenicity 
between cashew and other Anacardiaceae and tree nuts has been studied to some extent. 
Especially the possibility of cross reactivity between cashew and pistachio has been 
presented by several groups [59-63] and part of this cross reactivity might be explained by 
cross reactivity between Pis v 3 and Ana o 1 [62], and sequence homology between Pis v 2 
and Ana o 2 and between Pis v 1 and Ana o 3 [63]. Cashew allergen Ana o 3 even showed a 
higher specificity in correctly identifying pistachio allergy by serum IgE, compared to using a 
pistachio extract [64]. Also in vivo cross-reactivity between cashew and pistachio has been 
noted. In this study, cashew-immunotherapy in cashew-sensitized mice resulted in 
decreased allergic reaction towards both cashew and pistachio [65]. Also the role of walnut, 
a tree nut but not a member of the Anacardiaceae, was studied here. Mice sensitized to 
both cashew and walnut showed a diminished allergic reaction towards cashew after 
receiving walnut immunotherapy [65]. The other way around, when walnut was introduced 
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into the diet of cashew-sensitized mice, the mice showed elevated walnut-specific IgE levels 
and developed an allergic reaction towards walnut [66].  
Besides walnut and pistachio, also studies with mango have been performed. Mango as 
member of the Anacardiaceae is suspected to cross-react with both cashew and pistachio as 
based on inhibition RAST results [67-69].  
Studies on the possibility of cross reactivity between cashew and peanut are not unexpected 
as 20-30% of peanut allergic individuals are also allergic to one or more tree nuts [23]. 
However, studies using cashew and peanut inhibition ELISAs [50, 70], basophil activation test 
(BAT) [70], and studies on epitope homology of Ana o 1 and Ara h 1 [34] did not substantiate 
a claim of cross allergenicity between peanut and cashew. No cross-reacivity was found by 
inhibition ELISA and inhibition western blot between roasted cashew and rAra h 2 [71]. 
Epitope homology between the 11S globulins Ara h 3 (peanut), Cor a 9 (hazelnut), Jug r 4 
(walnut) and Ana o 2, however, has been suggested [72]. Overall, cross reactivity between 
cashew and peanut is not confirmed, which is not unexpected as peanut is neither a tree nut 
nor part of the Anacardiaceae family. This notion is further substantiated by the finding that 
in vivo it has been shown that peanut-allergic persons, who are also tree nut allergic, are less 
likely to be allergic to cashew than peanut-tolerant persons who are tree nut allergic [32].  
 
Cashew apple and cashew pollen  
Besides allergens in the cashew itself and cross-reactive allergens in related plants, also 
some research has been performed on allergenic proteins in other parts of the cashew tree: 
the cashew apple, pollen and the shell. Despite the limited exposure to these products 
outside cashew cultivation areas, it is still worth mentioning.  
Presence of allergens in the cashew apple similar to the allergens present in cashew nuts has 
been described by Comstock et al. In this study cashew-allergic patients’ sera showed IgE 
binding to proteins from cashew apple juice concentrate on western blot, a reaction that 
could be inhibited (7.5, 20, 25, 50, 60kDa bands) for some sera when pre-incubated with 
cashew nut extract [73]. Upon western blotting with anti-Ana o 1 and anti-Ana o 2 
monoclonal antibodies, several proteins from cashew apple juice could be detected (45kDa 
anti-Ana o 1; 37 and 46kDa anti-Ana o 2) [73]. Besides cashew apple allergy, one can also be 
allergic to cashew tree pollen. In India, a country with many cashew-plantations, 65 patients 
with allergic bronchial asthma were tested for cashew-pollen sensitisation by a bronchial 
provocation test and a skin prick test. Of these 65, patients 20 were found to be allergic to 
pollen of the Anacardium occidentale tree by both tests [74]. The last study deals with the 
shell around the cashew kernel. A defatted protein extract was made from cashew nut shell, 
showing presence of multiple proteins of 14–97kDa as visualised by SDS-PAGE [75]. In 
addition, the oil present in this shell can cause contact dermatitis [76]. 
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Detection by immunoassay  
As for now, cashew allergy cannot be cured, cashew allergic patients should avoid cashews, 
even trace amounts. Several methods for the detection of cashew nut allergens in food 
products have been developed, e.g. ELISA, immunoblotting, (RT-)PCR, dipstick, and mass 
spectrometry [77]. As described by van Hengel [77] each of these methods has it’s pro’s and 
con’s. For example, PCR analysis detects DNA or RNA sensitively, serving as an indicator but 
does not directly detect the proteins. The dipstick method is a fast method to detect 
proteins but is not quantitative, and mass spectrometry is very specific but requires highly 
specialised equipment and trained personnel [77].  
 
Specifically for the detection of cashew nut in food products, methods have been developed. 
First of all an ELISA assay has been developed for the detection of the so-called “cashew 
major protein” which mainly exists of Ana o 2. The assay is able to detect levels of 0.02ppm 
cashew major protein, and is suitable for use in most food matrixes (e.g. wheat flour, rice 
cereal, chocolate cookies) and compatible with several spices (e.g. salt, brown sugar, 
cardamom). The assay did show diminished sensitivity when combined with milk chocolate, 
raisin bran cereal, cinnamon and nutmeg. Upon heat-processing of cashew the detection 
was diminished as well, especially roasting of the cashew at 170°C for 20min diminished the 
sensitivity of this ELISA assay [78]. Gaskin and Taylor also developed a cashew specific ELISA 
with high sensitivity (1μg cashew/g of product) but with significant cross reactivity towards 
pistachio and, to a certain degree, also towards hazelnut [79]. Secondly, a mass 
spectrometry method has been developed, detecting Ana o 2 and Ana o 3 in the sub-ppm 
range, thereby being declared as more sensitive than ELISA assays [80]. Lastly, also PCR 
assays detecting DNA, have been developed targeting Ana o 3, detecting 2mg/kg [81] and 
0.005% of the total food weight [82].  
 
Aim and outline of the thesis  
Diagnostic procedures in allergy are partly based on the detection of serum-IgE for the 
offending allergen. Very important drawbacks of this type of testing, are the often limited 
clinical relevance of its outcomes with often high numbers of false-positive or false-negative 
test results. The aim of this thesis is a better chemical identification and functional 
characterisation of the major cashew nut allergens Ana o 1, 2 and 3. This characterisation 
will contribute to the development of more sensitive and reliable diagnostic procedures for 
the early detection of cashew allergy in young children. This will allow improved disease 
monitoring and future therapy for this ’vulnerable’ group. 
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In the second chapter of this thesis a review is provided on intestinal protein transport, 
focussing on the difference between sensitised versus non-sensitised persons. This 
difference in intestinal protein transport between sensitised and non-sensitised persons 
could indicate a possible mechanism of how allergens could come into contact with immune 
cells and cause the deveopment of a food allergy. The experimental chapters of this thesis 
are focussed on cashew nut allergy, studying the cashew nut allergens Ana o 1, Ana o 2 and 
Ana o 3. In chapter 3, a purification method is described for Ana o 1, Ana o 2 and Ana o 3 
from blanched cashew nuts, and their protein characteristics such as IgE-binding and 
glycosylation are described. For Ana o 3 epitope mapping experiments have been 
performed, and mass spectrometry was done to study the N- and C-termini of Ana o 3. Next, 
in chapter 4, a comparison was made between cashews of different origins which have been 
subjected to different heat treatments. This was done as all cashew studies described in 
literature have been performed using store-bought cashews, from unknown origin and with 
doubtfull information on pre-treatments (e.g. heating steps applied in order to remove the 
shell) while being sold and used as “ raw” cashew. Therefore, in chapter 4, 8 different origins 
of cashew were compared for their protein composition. This allowed us to assess whether 
or not data from literature can be universally used in cashew protein research or whether it 
is specific to a cashew of a particular origin. Furthermore, the difference between different 
origins and the influence of heat treamtens on the cashews’ protein composition, protein 
glycation/glycosylation, digestibility, and IgE binding was studied. In Chapter 5, the 
recombinant production of Ana o 1, 2 and 3 from Pichia pastoris is described. This was done 
as recombinantly expressed proteins are usually more easily purified in greater quantity and 
with no chance of allergen contamination between the purified Ana o 1, Ana o 2 and Ana o 
3. The cloning and purification of these three allergens, as well as characterization on 1D and 
2D electrophoresis, western blot, and inhibition blot, is described in this chapter.  
The results of these 5 chapters are discussed in chapter 6. The newly obtained knowledge on 
Ana o 1, 2 and 3 is summarized. Also, extra information regarding the importance of cross-
reactivity with other nuts and Anacardiaceae family members is provided, and the relevance 
of these results for the clinical field is discussed. 
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Abstract 
In view of the imminent deficiency of protein sources for human consumption in the near 
future, new protein sources need to be identified. However, safety issues such as the risk of 
allergenicity are often a bottleneck, due to the absence of predictive, validated and accepted 
methods for risk assessment. The current strategy to assess the allergenic potential of 
proteins focuses mainly on homology, stability and cross-reactivity, although other factors 
such as intestinal transport might be of added value too. In this review, we present an 
overview of the knowledge of protein transport across the intestinal wall and the methods 
currently being used to measure this. A literature study reveals that protein transport in 
sensitised persons occurs para-cellularly with the involvement of mast cells, and trans-
cellularly via enterocytes, while in non-sensitised persons micro-fold cells and enterocytes 
are considered most important. However, there is a lack of comparable systematic studies 
on transport of allergenic proteins. Knowledge of the multiple protein transport pathways 
and which model system can be useful to study these processes may be of added value in 
the risk assessment of food allergenicity. 
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Introduction 
In the near future, a shortage of protein sources for human consumption is foreseen and, 
therefore, alternative and sustainable protein sources (e.g. insects and algae) are now being 
explored for the production of food and feed. However, safety issues, such as the risk of 
allergenicity of novel proteins are often a bottleneck in bringing these products to the food 
market due to the absence of predictive, validated and accepted methods for risk 
assessment. New proteins or genetically modified foods are currently assessed for their 
allergenic potential using an allergenicity assessment strategy advised by the Food and 
agriculture Organization and the WorldHealth Organization. This strategy is based on a 
weight of evidence approach that recognises that no single endpoint can be used to predict 
human allergenic potential [1, 2] and focuses on characterising the protein/gene source, 
amino acid sequence homology to known allergens, in vitro cross-reactivity with known 
allergens and protein stability in a static pepsin digestion model [3]. However, these 
methods are mostly subjective and no guidance on procedures and interpretation of the 
outcome is available as yet. For example, several reviews and studies have indicated that in 
vitro digestion using the simulated gastric fluid method, protein digestion by pepsin in acidic 
conditions, is not always a good predictor of allergenicity [4,5]. A comparative study by Fu et 
al. found no correlation between simulated gastric and intestinal fluid stability of allergenic 
and non-allergenic protein and between major and minor allergens [6]. Furthermore, it was 
shown (own experience) in a dynamic digestion model (TNO’s intestinal model for the 
gastrointestinal tract) that even less stable proteins might reach the intestinal tract in an 
intact, at least immunogenic, form. We hypothesised that transport of food proteins and 
peptides across the gastrointestinal barrier is needed to induce sensitisation or to elicit an 
allergic reaction, making it an important parameter in allergy research, next to digestion of 
these proteins. Therefore, we collected information on how proteins are transported in both 
sensitised persons and non-sensitised persons. This information can be used to estimate 
whether intestinal passage of protein or immune-reactive protein fragments can be 
incorporated into a new method for risk assessment of allergenicity of a protein. For this 
reason a comprehensive literature study was performed using the open-access databases 
NCBI-PubMed, Scopus and Web of Science to review the current knowledge on the 
mechanisms of protein transport across the small intestine and which methods are currently 
being used to study the intestinal absorbance of proteins. 
 
Transport of allergens across the intestinal tract 
The gastrointestinal barrier has different functions to fulfil, e.g. absorb nutrients and exclude 
“unwanted” compounds, such as bacteria and allergens. The intestinal tract is composed of 
different layers, glycocalyx, luminal mucosa, which are composed of a monolayer of 
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epithelial cells, lamina propria, which is connective tissue scaffold containing the blood and 
lymphatic vessels, and the muscularis mucosa (muscle layer) [7]. The lamina propria is highly 
folded to form villi, increasing the intestinal surface. This surface is covered by a 
heterogeneous population of epithelial cells, including absorptive intestinal epithelial cells 
(enterocytes), enteroendocrine cells (L-cells), mucin-secreting goblet cells and microfold cells 
(M cells) [8].  
The secretive and absorptive cells have a highly folded apical membrane, forming uniform 
micro-villi, express brush border enzymes and membrane-embedded transporter proteins. 
The epithelial cells are joined at their apical side by tight junctions and other integral 
membrane proteins (e.g. claudins and occludins) that prevent the passage of 
macromolecular compounds larger than 600Da [9, 10]. In addition, secretory Ig A (IgA) and 
mucus (secreted by goblet cells) also restrict the absorption of dietary antigens [11]. Mucus, 
a mixture consisting mainly of water, glycoproteins (e.g. mucin), lipids and proteins, forms a 
protective layer of 50–450μm on top of the intestinal epithelial cell layer [12]. Although no 
reports on the relation between protein absorption and intestinal mucus were found, 
thickness of the mucus layer can influence the absorption rate of drug compounds [12], 
making it acceptable to reason that also food protein absorption can be limited or facilitated 
by the mucus.  
Intestinal micro-biota is pivotal to health homeostasis. Although a clear relation between gut 
micro-biota and allergy has been established many times, the mechanism behind this is not 
clear yet. As summarised by Gigante et al., a difference in gut micro-biota can be seen 
between atopic (prone to develop allergies) and healthy persons. Furthermore, the gut 
micro-biota plays a crucial role in oral tolerance induction as germ-free mice do not develop 
tolerance [13]. Moreover, lack of intestinal bacteria in germ-free mice leads to a decreased 
intestinal surface, decreased intestinal cell renewal, and a thinner mucus layer [14]. 
However, no evidence was found on the role of micro-biota in protein transport, but due to 
the date present, it can be envisioned that micro-biota will play a relevant role. 
 
Para-cellular and trans-cellular transport routes of proteins 
Transport of proteins across the intestinal tract depends on size, polarity, shape, aggregation 
status and 3D structure of the protein and may occur either via the para-cellular route or via 
trans-cellular routes (Figure 2.1). Para-cellular transport refers to the transfer of compounds 
through the inter-cellular space between the cells and is regulated by the integrity of tight 
junctions [19,20]. Para-cellular transport is only considered to occur for small hydrophilic 
compounds (up to 600Da [9, 10]), but Pauletti et al. and Rubas et al. described that the 
maximal radius of a protein, which could pass the intestinal barrier via the para-cellular 
mechanism was estimated at 15A° (± 3.5kDa) [19, 21]. Proteins transported via the para-
cellular route are not exposed to lysosomes in the enterocyte and are therefore not 
Protein transport across the small intestine in food allergy 
27 
degraded [15]. In healthy adults, however, paracellular protein/antigen transport is not 
considered of much importance [22–25]. This is in contrast to already sensitised persons, 
where the integrity of the tight junctions is decreased due to the presence of mast cells, 
enhancing the amount of non-degraded protein entering the human body [26] as will be 
more extensively explained in the section concerning mast cells. 
 
 
Figure 2.1 Different passage routes across the intestines. 
 
The trans-cellular transport route comprises the absorption of compounds via passive 
diffusion, carrier-mediated transport, or endocytosis (Figure 2.1). As proteins are mostly 
hydrophilic macro-molecules, passive diffusion across the lipid bi-layer of the cell membrane 
is considered minimal and will therefore not be discussed in this review. Carrier-mediated 
transport routes are present in the human intestine for amino-acids [27] and di- and tri-
peptides [22], but literature on protein carrier-mediated transport was not found. The main 
route of trans-cellular protein transport is endocytosis, which is known to occur in different 
cell types and will be described in the following sections. 
 
Enterocytes 
Enterocytes or absorptive intestinal cells are epithelial cells and are the most abundant cells 
in the intestinal barrier. Due to the formation of tight junctions between two adjacent 
enterocytes, they are involved in para-cellular transport, but additionally they are also 
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involved in protein and peptide absorption via the trans-cellular route. According to So et al. 
[28], soluble particles such as proteins can be endocytosed by enterocytes, after which they 
are transported in small vesicles or larger phagosomes and are either digested in lysosomes 
or left intact (trans-cytosis) [29], but the fragments as well as the intact proteins may still be 
allergenic, as was shown by Terpend et al. In this study, HT29–9A cells (an enterocytic cell 
line) were incubated with HRP; 1% HRP was endocytosed by the cells, of which 90% was 
subsequently hydrolysed intra-cellularly. However, the authors showed that 40% of the 
hydrolysed protein had a molecular mass of at least 1100Da, which is still large enough to 
bind MHC-II molecules [30]. In another study, it was estimated that 2% of intact proteins can 
reach the intestinal lymph and portal circulation under physiological conditions [31]. 
Belut et al. described another trans-cellular pathway of antigen uptake by enterocytic cells, 
which is facilitated by IgE and only occurs in sensitised persons, when luminal antigen-
specific IgE is present [32]. This IgE forms a complex with the antigen and binds to the CD23 
receptor, which is over-expressed on the apical membrane of enterocytes in sensitised 
persons. The CD23 receptor transports the IgE-antigen complex trans-cellularly without 
lysosomal degradation across the intestinal membrane [9, 33]. The importance of CD23 in 
this transport system was shown by Bevilacqua et al. who exposed the intestine of HRP 
sensitised and non-sensitised mice to HRP. The HRP sensitised mice showed increased 
transport of intact HRP, which was eliminated after the addition of anti-CD23 antibodies, 
whereas the transport of partly degraded HRP was not changed [33]. The involvement of IgE 
was further demonstrated by Yu et al. who passively immunised naive mice by injecting 
immune serum from a mouse that had been actively sensitised to HRP. IgE depletion of this 
serum eliminated the induced increase in intestinal trans-epithelial antigen transport [34]. 
O’Brien et al. showed that after antigen uptake with or without subsequent lysosomal 
degradation, antigens with a size of at least 18–20 amino acids long can be presented on 
enterocytic MHC-II molecules [35], or secreted into exosomes. Thereafter, the antigen can 
be presented to T cells by MHCII molecules on the enterocyte, but this rarely happens [36]. It 
is more likely that antigen-containing exosomes or tolerosomes will present the antigens on 
their MHC-II molecules to T cells [9, 36, 37], possibly reaching them via pores in the intestinal 
basement membrane or via the blood circulation. Inflammatory conditions in the intestine 
may increase exosome secretion from intestinal epithelial cells as was shown in vitro when 
intestinal epithelial cells increased secretion of exosomes after the addition of the pro-
inflammatory cytokine IFN-γ [36]. Exosomes are thought to induce tolerance toward the 
antigen it contains. However, not all studies confirm this effect [38]. It has been suggested 
that intestinal epithelial derived MHC-II containing exosomes are tolerogenic in the absence 
of co-stimulatory molecules, but can activate T cells in presence of co-stimulatory molecules 
[25]. 
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Besides IgE, also IgA and IgG are involved in enterocytic protein transport. Polymeric IgA and 
IgG reach the intestinal lumen trans-cellularly via, respectively, the polymeric IgA receptor 
and the neonatal Fc receptor on enterocytes [39, 40]. However, in contrast to IgE, binding of 
luminal antigens to IgA prevents their uptake, and binding of IgA to antigens that have 
already crossed the intestinal tract leads to secretion back into the intestinal lumen. 
Therefore, antigen-specific IgA is considered to be protective against sensitisation and 
allergic reactions. Transport of IgG–antigen complexes across the intestines in the neonate 
seems to be tolerogenic, but in adults this role is less clear [40]. 
 
M cells 
M cells are specialised epithelial cells that are part of the Peyer’s patches in the intestinal 
tract (Figure 2.2), but they can also be found in the gut independently of these patches [42]. 
Since M cells contain fewer lysosomes, have a thinner glycocalyx layer compared to 
enterocytes and do not present membrane-associated enzymes, the chance of compounds 
to be degraded during trans-cellular transport is low. M cells have been shown to transport 
proteins, bacteria, viruses and other particles of up to 1μm [43], either via phagocytosis [44], 
endocytosis [45] or pinocytosis [43]. For example, HRP has been shown to be absorbed by 
rabbit and piglet tonsil and intestinal Peyer’s patch cells [45, 46]. Another study showed that 
in vivo exposure of murine intestine to IgA and IgG against mouse mammary tumour virus 
revealed binding and internalisation of both Igs by M cells [47]. 
 
The mechanism by which M cells transport proteins and/or antigens has been suggested to 
occur via a basal pocket, such as invagination in M cells creating “M cell pockets” where B 
and T cells, macrophages and dendritic cells (DC) appear to be present [48, 49]. The exact 
function of these pockets is unknown but it is thought that these pockets may shorten the 
intra-cellular distance for antigens to travel before being displayed to antigen-presenting 
cells, which then migrate to antigen-specific lymphocytes in underlying lymphoid follicles 
inducing T-cell proliferation. This process results in the development of IgA-producing B cells, 
some of which move into the vasculature and then back to the mucosal surfaces, efficiently 
seeding specific mucosal immunity [43, 50, 51]. Considering antigen transport, most 
research has been focused on the uptake of antigens by either M cells or enterocytes. The 
current perception is that particulate or aggregated antigens are taken up by M cells, 
inducing a local or systemic immune response towards that antigen and inducing the 
production of IgA. Soluble antigens, on the other hand, are thought to be predominantly 
absorbed by epithelial cells, leading to suppression of the immune system, induction of 
tolerance, towards this antigen [11, 52]. A comparison between soluble and aggregated milk 
proteins (α-lactalbumin and β-lactoglobulin) revealed both in vitro and in vivo an uptake of 
aggregated milk proteins by Peyer’s patches, containing mostly M cells, inducing a stronger 
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immune reaction than the soluble milk proteins that were predominantly transported into 
intestinal epithelial cells. However severity of orally induced anaphylactic reactions were 
greatly impaired by aggregation of the milk proteins, implying that aggregated antigens can 
induce sensitisation, while allergic reactions following this sensitisation are mainly caused by 
soluble antigens [53]. However, M cells have been proven to transport not only insoluble, 
but also soluble peptides and the onset of tolerance versus sensitisation also seems to be 
influenced by particle size [54, 55]. 
 
 
Figure 2.2 The intestine at a cellular level, based on Spahn and Kucharzik [41]. 
 
Mast cells 
Shea-Donohue et al. estimated that about 2% of resident intestinal cells are mast cells and 
during immune responses this amount increases [56]. Mast cells are involved in eliciting 
symptoms during allergic reactions, but they are also indirectly involved in the transport of 
allergens. In this respect, food hypersensitivity reactions are known to occur in two phases. 
The first phase is mast cell independent and antigen-specific with antigen uptake occurring 
via trans-cytosis by intestinal epithelial cells, which is increased by sensitisation to the 
allergen. The next phase is mast cell-dependent, increased after sensitisation, and during 
this phase intestinal permeability to non-specific bystander proteins is also increased [26]. 
Using colonocytes this increased intestinal permeability was shown to be triggered by IgE-
induced tryptase release by mast cells, which activates the protease-activated receptor 2 on 
colonic epithelial cells, causing redistribution of several tight junction proteins and inducing 
increased para-cellular permeability to macromolecules [57]. As small intestinal enterocytes 
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also contain this protease-activated receptor [58], we expect a similar interaction between 
activated mast cell components and enterocytes in the small intestine. 
 
DCs 
DCs constitute a major cellular component of the intestinal lamina propria, and play a pivotal 
role in the balance between tolerance and sensitisation in the intestine. DCs are antigen-
presenting cells and are able to intercalate between intestinal epithelial cells, by virtue of 
extended dendrites without disrupting the epithelial barrier by opening tight junctions and 
forming new tight junctional complexes with adjacent epithelial cells, a process that is up-
regulated in inflammatory conditions [59]. In this way DCs are able to take up soluble 
compounds from the lumen, although protein up-take by dendrites is controversial [60] and 
no literature data of direct protein or peptide sampling by DCs from the intestinal lumen was 
found. 
In addition, Chambers et al. showed that intestinal (Peyer’s patch) DCs obtained from 
sensitised and subsequently challenged mice can induce allergen-specific IgE in naive mice in 
the absence of an allergen challenge [61]. However, in general, intestinal DCs are thought to 
be more tolerogenic compared to DCs from other organs (e.g. the spleen) as they activate 
relatively more regulatory T cells [62]. Both the level of DC maturation and the type of DC 
could be of influence in this “tolerogenic” role; immature DCs are more likely to induce 
tolerance [36] and plasmacytoid DCs have been shown to decrease sensitisation [63]. 
 
Macro-phages 
Besides DCs, macro-phages have been shown capable of transporting antigens across the 
intestinal tract using pseudopodia [64]. After antigen uptake, the antigen-containing macro-
phages enter the systemic circulation, leading to systemic reactions towards this antigen. 
Whether or not Peyer’s patch macro-phages transport compounds out of Peyer’s patches 
depends on the compound size; (latex) particles with a diameter <5μm can be transported 
via macro-phages, while particles with a diameter of 5–10μm mostly remain inside the 
Peyer’s patches, eliciting local mucosal effects [18, 65]. Similar to intestinal DCs, intestinal 
lamina propria macro-phages display a non-inflammatory phenotype compared to macro-
phages from other tissues, e.g. blood monocytes, from which they stem. Unlike other macro-
phages, intestinal macro-phages do not express receptors for, among others, LPS, IgG and IL-
2, and express low levels of all major pro-inflammatory cytokines, even after phagocytosis, 
an action which they perform avidly [66]. On top of this non-inflammatory phenotype of 
intestinal macro-phages, these cells have also been described as critical actors in intestinal 
tolerance induction to food protein antigens [67]. 
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Goblet cells 
The last epithelial cell type that must be discussed is the goblet cell, whose main function is 
the production of mucin. Recently McDole et al. showed in vivo, in healthy persons, that 
goblet cells transported 10kDa peptides from the intestinal lumen to underlying lamina 
propria DCs. However, this transport is probably size limited as it was shown that large 
particles (0.02–1μm) cannot enter via this pathway [68]. 
 
From such literature data it can be concluded that protein transport in non-sensitised 
persons occurs via the M cells and enterocytes, while in sensitised persons the para-cellular 
route with involvement of mast cells, and trans-cellular route via enterocytes are considered 
the most important. 
 
Measurement of allergen transport across the intestinal tract 
Food proteins need to cross the gastrointestinal tract in order to induce sensitisation or elicit 
an allergic reaction. Therefore, we assume that the assessment of allergen or protein 
transport across the intestinal barrier might be a relevant, additional parameter in 
allergenicity risk assessment. The different techniques to assess intestinal protein transport 
will be discussed in the following sections. An overview of reviewed transport studies and 
allergens used is given in Table 2.1. 
 
In vitro assays 
Several in vitro methods have been used to study intestinal protein absorption, and an 
overview is presented in Table 2.1. Various cell lines (e.g. Caco-2 and HT-29) can be used to 
study the epithelial transport of proteins in vitro. These cell lines are from different origins 
and species and all have their advantages and disadvantages. The Caco-2 cells, a cell line of 
human colonic origin, exhibit many properties of small intestinal epithelium as they form a 
polarised monolayer of well-differentiated columnar absorptive cells expressing a brush 
border on their apical surface with typical small intestinal enzymes and transporters. The 
cells form very dense tight junctions, whose tightness resembles more the colonic than small 
intestinal tissue [8]. HT-29 cells stem from a human colon adenocarcinoma cell line that 
contains both absorptive and mucus secretive cells [30]. Compared to the Caco-2 cell line or 
the human intestine, the HT-29 expresses few carriers and is mostly used to study the effect 
of mucin on transport [80]. One of the major advantages of using cell lines to study the 
intestinal transport of proteins is the relatively high throughput at which different proteins 
can be studied. On the other hand, due to the lack of a physiologically relevant environment 
(e.g. interactions with other cell-types, intestinal fluid composition and mucus presence) 
[81], prediction of human oral exposure to allergens on the basis of in vitro studies with cell 
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lines might be prone to errors. Other in vitro methods for measuring intestinal transport of 
proteins include the Ussing chamber technique and the everted sac technique [75–79, 82].  
 
Table 2.1 In vitro absorption studies using different techniques, proteins and analysis methods. For 
each study the transport of intact protein is presented. FITC; Fluorescein isothiocyanate. 
 
Technique  Species Protein Food-
related 
Intact  
protein 
Analysis Reference 
Caco-2, 
everted sac  
 
 
Human, 
Wistar 
rat  
γ-Conglutin Lupin Yes Immunoblotting [69] 
Caco-2, HT-29   Human FITC-tetanus 
toxoid, FITC-
ovalbumin 
No Assumed Laser scanning 
confocal microscopy 
for fluorescence 
intensities 
[28] 
HT-29   Human FITC-tetanus 
toxoid 
No Assumed Fluorescence 
microscopy 
[70] 
Caco-2   Human Ber e 1, Ses i 1 Brazil nut 
Sesame 
seed 
Yes HPLC, ELISA [98] 
Caco-2   Human β-Lactoglobulin, 
albumin 
Milk Assumed 
125
I-radioactive 
labeling 
[72] 
HT29-19A   Human Horseradish 
peroxidise 
No Yes HPLC, 
3
H-labeling [30] 
Caco-2   Human β-Lactoglobulin, 
α-lactalbumin 
Milk Yes HPLC, 
14
C-labeling [73] 
Ussing 
chamber 
 Rabbit β-Lactoglobulin Milk Yes Elisa, HPLC, SDS-PAGE, 
14
C-labeling 
[74] 
Ussing 
chamber 
 Rabbit Horseradish 
peroxidise 
No Yes Enzymatic activity, 
3
H-
radioactive labeling 
[75] 
Ussing 
chamber 
 Rabbit  Bovine Serum 
Albumin 
No Yes Immunoblotting, 
ELISA, 
125
I-radioactive 
labeling 
[76] 
Ussing 
chamber 
 Human  Horseradish 
peroxidise 
No Yes Enzymatic activity, 
3
H-
radioactive labeling 
[77] 
Ussing 
chamber 
 Pig Horseradish 
peroxidise 
No Yes Enzymatic activity [78] 
Ussing 
chamber 
 Wistar  
rat pups 
Horseradish 
peroxidise 
No Yes 
125
I-radioactive 
labeling combined 
with HPLC gel filtration 
[79] 
Ussing 
chamber 
 Human Horseradish 
peroxidise 
No Yes Enzymatic activity, 
125
I-
radioactive labeling 
[77] 
Introduction of 
material into 
the 
gut lumen 
(ileal loop) 
 
 
 
BALB/c 
mouse 
Ara h 1, Ara h 2, 
Ara h 3 
Peanut Unknown Transmission electron 
microscopy, 
fluorescence 
microscopy, detection 
of protein bodies  
[54] 
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Both techniques have a higher resemblance to the in vivo situation as they require small 
sections of ex vivo intestinal tissue rather than cell mono-layers. In both the Ussing chamber 
technique and everted sac technique, a section of the gut is used. In the everted sac method, 
the intestinal section is everted and both ends are tied after filling the sac with buffer. The 
‘sausage’ is placed into buffer with the compound of interest. With the Ussing chamber 
technique, the intestinal segment is mounted in an Ussing chamber where one side will be 
exposed to buffer with the compound of interest (apical or lumen side) and the other side to 
buffer without the compound of interest (basolateral or mucosal side). 
Heyman et al. and Majamaa et al. both used the Ussing technique with jejunal biopsies from 
children to study the transport of HRP [77, 82]. However, due to the limited availability of 
healthy human tissue, intestinal tissue from rabbit [75], piglets [78] or rats [79] is often used. 
No literature could be found on intestinal protein absorption using the everted sac 
technique with human tissue. However, the everted sac technique has been applied for 
investigating the absorption of human γ-globulin and ovalbumin across the ileum of rabbits 
and guinea pigs [83], as well as γ-conglutin absorption in rats [69]. A disadvantage of everted 
sac method against the Ussing chamber technique is that with everted sac the muscle layer 
is still present and this may lead to the underestimation of the protein transport value. A 
major disadvantage of using ex vivo human tissue is its relatively limited viability and low 
throughput. Normally, ex vivo tissue is used within 2–3 h, because intestinal oedema and 
disruption of the villi will occur when tissue is incubated in vitro [84]. The disadvantage of 
using animal tissue may be the inter-species differences in anatomy, physiology, 
metabolism, diet and micro-biota, which complicates the extrapolation of data to humans 
[80, 85]. But an advantage of using animal ex vivo tissue is the possibility to investigate the 
effect of sensitisation on the intestinal absorption of proteins by immunising the tissue in 
vivo prior to the in vitro studies [29]. Pigs share more physiological and immunological 
similarities to humans than rodents, and the use of (mini)pigs is becoming increasingly 
common in nutritional research [86]. Therefore, we recently developed InTESTineTM, a 
medium throughput alternative for the Ussing chamber technique using intestinal waste 
tissue from pigs, incubated on a rocker platform in a high oxygen incubator. In this system, 
viability of tissue could be retained for 2h and the para-cellular absorption transport 
resembles that of human intestinal tissue in Ussing chambers (Wortelboer et al., 
unpublished results) and transport of macro-molecular proteins was studied using 
radioactive labelled proteins (Verhoeckx et al., unpublished results). 
 
In vivo assays 
The most physiologically relevant way to study intestinal protein absorption is by oral 
exposure to the protein in vivo, as all types of intestinal cells, blood circulation and mucus 
are present. Preferably, to elucidate the protein absorption in human, in vivo experiments 
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are performed in humans, as this is the target species. However, the majority of 
experimental studies on protein absorption described in literature have been performed in 
animals (Table 2.2).Consequently, the interpretation of the findings could be difficult due to 
inter-species differences. Also, the possibility of separating variables that influence protein 
absorption is limited in in vivo studies [81]. 
 
Table 2.2 In vivo absorption studies using different techniques, proteins and analysis methods. For 
each studie the transport of intact protein is presented. 
Technique Species Protein Food-
related 
Intact 
protein 
Analysis Ref-
erence 
Oral exposure  Pig IgG, β-
lactoglobulin, 
albumin, trypsin 
Colostrum Yes Immunoblotting [87] 
Oral exposure Human  α-Lactalbumin Milk Assumed 
125
I-radioactive 
labeling 
[88] 
Oral exposure Human β-Lactoglobulin Milk Assumed Radioimmunoassay [89] 
Oral exposure  Human  Ovalbumin Egg Yes Gel permeation 
chromatography, 
ELISA 
[16] 
Oral exposure Brown Norway 
rat 
β-Lactoglobulin Milk Assumed ELISA [90] 
Oral exposure BALB/c mouse human serum 
albumin 
No No 
125
I-radioactive 
labeling 
[91] 
Oral exposure ddY mouse ovalbumin Egg Yes ELISA, 
Immunoblotting 
[71] 
Oral exposure, 
everted sac  
Guinea pig, 
hamster, rabbit  
albumin, γ-
globulin, β2- γ-
globulin 
Egg/milk Assumed Fluorescence 
microscopy 
[83] 
Oral exposure 
BALB/c mouse, 
CD rat rabbit 
IgA No Assumed 
Colloidal gold-
conjugation 
electron 
microscopy 
[47] 
Oral exposure ddY mouse 
14-16kDa rice 
allergen 
Rice  Yes 
ELISA, 
Immunoblotting 
[92] 
 
The number of in vivo studies of intestinal protein absorption in humans is limited, though 
we were able to find some examples. Paganelli and Levinsky measured β-lactoglobulin by 
RIA in the serum of healthy human subjects, indicating that β-lactoglobulin was present in 
the blood after 0.5 – 3h of milk consumption [89]. Husby and colleagues investigated the 
absorption of ovalbumin and β-lactoglobulin into the blood of healthy adults by HPLC 
combined with ELISA. The study revealed that intact ovalbumin was absorbed by seven of 
eight individuals, whereas β-lactoglobulin was not detected in any of the subjects [93]. 
Jakobsson et al. measured α-lactalbumin from human milk in the serum of breast fed infants 
by RIA [88]. In the same project, these researchers discovered that the absorption of α-
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lactalbumin decreased as age increased, indicating that the intestinal wall becomes less 
permeable, also mentioned as closure of the gut. A comparable observation was made by 
Roberton et al., who measured the absorption of cows’ milk protein β-lactoglobulin into the 
blood of preterm and term neonates by RIA [94]. This observation appears to be applicable 
to all species, although the rate at which the decrease in protein absorption occurs is 
different between species [95]. 
It is clear that in in vivo protein transport studies many different animal species are used, 
e.g. rats, mice, guinea pigs, dogs, pigs, calves, cows, steers and sheep [22, 96]. In the absence 
of a so-called golden standard in predicting or identifying food allergens by use of intestinal 
transport studies, the use of larger animals, particularly pigs, might be better comparable to 
the human situation [96]. 
 
Protein analysis 
A crucial step in protein transport studies is the analytical method to be used to detect the 
intact protein. In protein transport studies, proteins are often labelled radioactively [30, 72, 
75, 76, 79, 91, 97] or fluorescently [28, 70, 83] for relatively easy detection. However, the 
detection of fluorescent or radioactive labelled proteins in plasma does not necessarily 
indicate that the protein is absorbed intact [91, 97]. The same is true for using transmission 
electron microscopy [46, 47, 61, 83], fluorescence microscopy [28, 61, 70, 83], light 
microscopy [46, 54], ELISA [16, 71, 76, 90, 92, 97, 98] and/or a RIA [88, 89]. A positive result 
in an ELISA or RIA could be caused by only a specific part of the protein, so even if the 
protein is degraded intra-cellularly it may still be recognised by the antibody used in these 
assays. Immunoblotting [69, 71, 87, 92] and high-performance liquid (gel permeation) 
chromatography [16, 30, 79, 99] are good alternatives, since these techniques separate the 
proteins by their molecular weight, thus proving the presence of intact protein. Another 
appropriate method, but unfortunately not always possible, is measuring the functional 
activity of the protein. For example, Heyman et al. used an HRP enzyme activity assay to 
measure intact HRP, since only intact HRP shows enzyme activity [100]. A more quantitative 
method, however not applied in the screened literature, is the use of LC coupled to MS. 
However, the use of these techniques requires special skills and equipment, fragments and 
intact proteins cannot always be measured simultaneously and the concentration of 
transported proteins and fragments is often at the lower LOD. Furthermore, the MS spectra 
of intact proteins are very complex and are difficult to recognise in biological samples 
containing more than one protein. 
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Figure 2.3 Different mechanisms and cells involved in intestinal protein transport. Boxes indicate they 
have no (dashed lines), or a possible (no filling) role in intestinal protein transport in sensitised (light 
grey) or non-sensitised (dark grey) persons. 
 
Conclusion and discussion 
New proteins or genetically modified foods are currently assessed for their allergenic 
potential using an allergenicity assessment strategy advised by the Food and Agriculture 
Organization and World Health Organization. This strategy is based on a weight of evidence 
approach that recognises that no single endpoint can be used to predict human allergenic 
potential [1, 2]. 
The goal of this review was to study how protein and immune-reactive protein fragments 
are transported across the intestinal wall, and whether it can be advised to develop a new 
model for allergenicity risk assessment based on this protein transport. 
Proteins are transported across the intestinal barrier via many different routes and these 
routes appear to depend on the health status of the individual. The different routes and cells 
involved are summarised in Figure 2.3. The data indicate that in non-sensitised persons, 
absorption of proteins via M cells and trans-cellular transport via enterocytes are considered 
very important, whereas in sensitised persons, proteins can also be transported via the para-
cellular transport route with involvement of mast cells, and trans-cellular via IgE-mediated 
transport via the CD23 receptor on enterocytes. The current perception is that particulate or 
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aggregated antigens are taken up by M cells, inducing a local or systemic immune response 
towards that antigen and inducing the production of IgA. Soluble antigens on the other hand 
are thought to be predominantly absorbed by epithelial cells, leading to suppression of the 
immune system, induction of tolerance, towards this antigen [11, 52]. For this reason, 
transport route (M cells or epithelial cells) and/or transported protein size (intact or 
fragmented) could be possible parameters to predict the allergenic potential of proteins. 
However, at the moment more research is needed since no comparative study on proteins 
with different allergenicity was found in the literature and the studies performed on 
individual allergens cannot be compared due to inter-laboratory differences, differences in 
transport methods and the analytical methods used. 
Enough evidence was found that intact protein can cross the intestinal wall, which indicates 
that there is a potential risk of immunological sensitisation. This urges the need to develop a 
good protocol to determine the route of transport. In our opinion, the use of ex vivo 
intestinal segments or in vivo experiments is crucial next to a reliable instrumental analytical 
method (e.g. LC-MS) to analyse intact and fragmented proteins preferably simultaneously. 
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Abstract 
In this study a fast and simple purification procedure for the three known allergens from 
cashew (7S globulin Ana o 1, 11S globulin Ana o 2, and 2S albumin Ana o 3) is described. The 
purified allergens are characterized by sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE), Western blot, glycoprotein stain, and protein identification. The 
purified proteins still bind IgE, and this IgE binding varied between different pools of patient 
serum. Ana o 1 was found to be a glycoprotein. Ana o 3 has been studied more in detail to 
identify both the small and large subunits, both displaying micro-heterogeneity, and epitope 
mapping of Ana o 3 has been performed. 
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Introduction 
The prevalence of allergy to tree nuts in Europe is 0.5% (based on oral food challenges) to 
1.3% (based on self-reported allergy) [1]. Within this group, the percentage of cashew 
(Anacardium occidentale) allergy is between 7% [2] and 55% [3]. Individuals suffering from 
cashew allergy can experience cutaneous, respiratory, and gastrointestinal symptoms and, in 
the most severe case, anaphylactic shock [4−6]. Administration of adrenaline is required 
more often [7], and the risk of developing an anaphylactic reaction seems higher than in 
peanut allergic patients [4]. 
Currently, three major cashew allergens are known: Ana o 1, Ana o 2, and Ana o 3 [8]. Ana o 
1 is a 7S vicilin seed storage protein of 50kDa that is expected to form a trimer in the native 
state [9-10]. The 11S globulin in cashew, Ana o 2, consists of a 33kDa large subunit and a 
20kDa small subunit, bound together by disulfide bonds, forming a 53kDa protein [11-12]. In 
native conditions 11S globulins form hexameric structures of ~360kDa [10]. In literature Ana 
o 2 is also referred to as anacardein and cashew major protein [13-14]. The third major 
cashew allergen is Ana o 3, a 2S albumin of 12.6kDa [15]. On the basis of similarity to other 
2S albumins, this protein is most probably proteolytically cleaved into an N-terminal small 
subunit and a C-terminal large subunit that remain associated by four disulfide bonds [10, 
16]. Robotham et al. reported denatured and reduced Ana o 3 to contain three isoforms of 
6, 8, and 10kDa. Each isoform had an N-terminal sequence that corresponded to the large 
subunit, but no small subunit was described [15].  
Reports on isolation and characterization of the cashew allergens are scarce. Ana o 3 has 
been purified before [17, 18], but neither purity nor yield were mentioned. Occasionally, 
references to isolated forms of Ana o 2 (anacardein) are made [19, 20]; however, as already 
indicated by the authors themselves, these fractions are not “immunochemically pure” [20]. 
When this protocol was repeated in 2010, a purity of >90% was stated, but no protein 
characterization data like SDS-PAGE or Western blot were shown [13].  
In this article we describe a fast and simple method to obtain Ana o 1, Ana o 2, and Ana o 3 
with high purity. While purification of Ana o 1 has never been described, the purification of 
Ana o 2 has never been fully described or characterized. We describe a simple method that 
allows simultaneous purification of Ana o 1 and Ana o 3. Biochemical and immunochemical 
analysis of the isolated proteins revealed that the proteins retain their IgE-binding capacity 
and showed Ana o 1, but not Ana o 2 or Ana o 3, to be a glycoprotein. Ana o 3 has been 
examined further to identify the large subunit, as well as the so-far unidentified small 
subunit. Both the small and large subunits display micro-heterogeneity.  
 
 
 
Chapter 3 
48 
Materials and methods 
 
Materials and reagents 
Blanched cashews (Anacardium occidentale) from Brazil were kindly provided by Intersnack 
(Doetinchem, The Netherlands). Acetone, ammonium sulfate, and glycine were purchased 
from Merck (Darmstadt, Germany). Filter paper (595 1/2) was purchased from Whatman 
(Dassel, Germany). Ammonium bicarbonate, NaCl, NaH2PO4, β-mercaptoethanol, sodium 
dodecyl sulfate (SDS), Tween-20, bovine serum albumin (BSA), alkaline-phosphatase 
conjugated goat antirabbit antibody, Sigmafast 5-bromo-4- chloro-3-indolyl phosphate/nitro 
blue tetrazolium (BCIP/NBT), and dithiothreitol (DTT) were purchased from Sigma-Aldrich 
(St. Louis, MO). Amicon centrifugal filters were purchased from Merck Millipore (Tullagreen, 
Ireland). Minisart syringe filters (0.45μm) were purchased from Sartorius Stedim 
(Goettingen, Germany). Ethylenediaminetetraacetic acid (EDTA), Halt protease inhibitor 
cocktail (no. 78438), Pierce Coomassie (Bradford) Protein Assay Kit, and Pierce Glycoprotein 
Staining Kit were purchased from Thermo Scientific (Rockford, IL). NuPAGE lithium dodecyl 
sulfate (LDS) sample buffer, NuPAGE 1 mm 10% Bis-Tris mini gels, NuPAGE 2-(N-orpholino) 
ethanesulfonic acid (MES) SDS running buffer, and SimplyBlue SafeStain were purchased 
from Invitrogen (Carlsbad, CA). Protein molecular weight marker and nitrocellulose 
membrane were purchased from Bio-Rad (Hercules, CA). Tris was purchased from USB 
(Cleveland, OH). Methanol was purchased from Actu-All (Randmeer, The Netherlands). 
Rabbit antihuman IgE was purchased from Dako (Glostrup, Denmark). Eight serum samples 
were purchased from Plasmalab International (Everett, WA). Ana o 3 peptides for epitope 
mapping were purchased from Synpeptide (Shanghai, China). The polyester backbone was 
purchased from GL Precision (San Jose, CA). IgE was purchased from Enzo (Farmingdale, NY). 
Trypsin was purchased from Promega (Madison, WI). 
  
Obtaining defatted cashew and extraction of total soluble protein  
Blanched cashews were ground by mortar and pestle. Ground cashews were defatted twice 
with acetone, 1:5w/v for 2h at 4°C while stirring, followed by filtration using filter paper and 
drying for 2h (first defatting step) or overnight (second defatting step). Defatted cashew was 
suspended in an ammonium bicarbonate buffer, pH7.9 (0.1M ammonium bicarbonate, 0.5M 
NaCl), 1:5w/v and stirred overnight at 4°C. Subsequently, the samples were centrifuged for 
90min at 4000g at 4°C, and the obtained supernatant was used for the purification of Ana o 
1 and Ana o 3. 
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Protein precipitation 
Proteins were precipitated in a stepwise fashion. In the first step, 15% w/v ammonium 
sulfate was added and mixed by stirring for 1h at 4°C; subsequently this was centrifuged for 
1h at 4°C in a swinging bucket centrifuge. The process was repeated three more times to 
yield final ammonium sulfate concentrations of 30%, 45%, and 52.5%w/v. The final 
supernatant, obtained after the last step of precipitation (52.5%), was diluted four times in 
Milli-Q water (MQ).  
  
Purification of Ana o 1 using ultrafiltration  
Four times 4mL of the diluted final supernatant of ammonium sulfate precipitation was 
passed through a 30kDa Amicon centrifugal filter by centrifugation, followed by two times 
5mL of MQ. Subsequently again four times 4mL of the diluted final supernatant was passed 
through the same filter. Five mL of MQ was added to the retentate; this retentate was 
passed through a new 30kDa Amicon centrifugal filter and purified in this filter by 10 times 
5min shaking in 5mL of MQ followed by centrifugation. All centrifugation steps were 
performed for 5min at 4000g at 20°C. The final retentate containing Ana o 1 was suspended 
in a final volume of 3 mL of MQ, concentrated using a 0.5mL 3Da Amicon centrifugal filter, 
and stored at −20°C. 
   
Purification of Ana o 3 using ultrafiltration  
The filtrate from Ana o 1 purification was concentrated using a 50mL 3kDa Amicon 
centrifugal filter and stored at −20°C. 
 
 Purification of Ana o 2 using gel filtration chromatography 
Ground blanched cashew was stirred in ammonium bicarbonate buffer (1:5w/v) overnight at 
4°C and centrifuged for 30min at 4000g at 20°C. From the supernatant the top white layer 
and lipid layer were removed and the remaining supernatant was filtered (0.45μm). Of this 
filtered supernatant, 300μL was loaded onto a Superdex 200 column (10/300GL, bed volume 
24mL) on an Akta purifier (both Amersham Pharmacia Biotech (Uppsala, Sweden)). The 
proteins were eluted from the column using 15mL elution buffer (50mM NaH2PO4, 0.15M 
NaCl, pH7) at 0.5mL/min; 0.5mL fractions were collected. The fractions were concentrated 
using a 0.5mL 3kDa Amicon centrifugal filter and stored at −20°C. 
 
Purification of Ana o 3 in the presence of protease inhibitors  
Ground blanched cashew was stirred in ammonium bicarbonate buffer (1:5w/v) with added 
protease inhibitor cocktail and 5mM EDTA for 1h at 4°C and centrifuged for 90min at 4000g 
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at 4°C. Protein precipitation and purification of Ana o 3 was performed as described above 
with the adaptation of performing all steps at 4°C.  
 
Protein concentration  
Protein concentration was determined using a Coomassie protein assay according to the 
manufacturer’s instructions. 
 
SDS-PAGE  
On the basis of a Coomassie protein assay, 20μg of denatured and reduced samples (10% β-
mercaptoethanol in NuPAGE LDS sample buffer, 5min, 100°C) were loaded onto NuPAGE 
1mm 10% Bis-Tris mini gels, alongside a molecular weight marker (Precision Plus Protein 
Dual Xtra Standard). Electrophoresis was performed at 160V for 55min in NuPAGE MES SDS 
running buffer. For SDS-PAGE, the gels were stained with SimplyBlue SafeStain. Imaging and 
analysis were performed using a Universal Hood III and Image Lab 4.1 software (both Bio-
Rad). Nonreducing denaturing SDS-PAGE was performed as described above, but during the 
sample preparation no β-mercaptoethanol was added. 
 
Western blotting 
Transfer of proteins from reducing denaturing SDS-PAGE gel to a nitrocellulose membrane 
(0.2μm) was performed using a Criterion blotter (Bio-Rad) in a cold tris-glycine buffer (25mM 
tris, 190mM glycine, 0.1% SDS, 20% methanol) for 36min at 70V. Membranes were washed 
with TBST (50mM tris, 150mM NaCl, 0.1% Tween-20, pH7.4) and blocked with 3% BSA in TBS 
(TBST without Tween-20) for 1h at 4°C. After washing with TBST and TBS, the blots were 
incubated overnight with a pool (to ascertain sufficient coverage of epitopes) of patient 
serum (group 1) or plasma (group 2) 1:5 diluted in TBS. Subsequently, the blots were washed 
with TBST and TBS and incubated with rabbit antihuman IgE diluted 1:15.000 in TBS. Again, 
the blots were washed with TBST and TBS, incubated with alkaline phosphatase conjugated 
goat anti-rabbit diluted 1:20.000 in TBS, followed by washing with TBST and TBS. Blots were 
stained with Sigmafast BCIP/NBT for 10min (group 1 and antibody control blot) or 2.5min 
(group 2). Imaging and analysis were performed using a Universal Hood III and Image Lab 4.1 
software. The antibody control blot was performed as described earlier, but instead of 
serum/plasma the membrane was incubated overnight with TBS. Inhibition Western blotting 
was performed as described earlier with the exception that the plasma was incubated with 
either 1mg/mL purified Ana o 1 or Ana o 3 for 4h at room temperature. 
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Table 3.1 Clinical characteristics of cashew and tree-nut allergic subjects: self-reported allergies and 
cashew IgE levels as measured by Immulite. a positive DBPCFC to cashew as described in van der Valk 
et al., submitted manuscript. b sample 1-4 as used in Ana o 3 epitope mapping experiments. 
 c measured by ImmunoCAP by Plasmalab International. 
Patient 
# 
serum 
pool 1 
Self-reported 
allergies patients 
serum pool 1 (blot 
D1) 
Dutch children 
IgE level 
cashew 
(kU/l) 
Patient # 
plasma 
pool 2 
Self-reported allergies patients 
plasma pool 2 (blot D2) 
American adults 
IgE level 
cashew 
(kU/l) 
1 Cashew
a
, pistachio 23.7 1
b 
Cashew, walnut, peanut, tree 
pollen, cat, dog, horse 
100.0 
2 Cashew
a
 21.8 2
 b
 Tree nuts, banana, eggplant, dust 56.9 
3 Cashew
a
, pistachio 10.9 3
 b
 Nuts, avocado, corn, raw 
vegetables, dog, horse, cow 
100.0 
4 Cashew
a
, chicken egg 11.1 4
 b
 Tree nuts, pecan, hazelnut, dust, 
grass, insect venom, alcohol 
19.2 
5 Cashew
a
, kiwi, 
shrimp 
13.0 5 Cashew, brazil nut, almond, 
hazelnut, peanut, dust 
13.2 
6 Cashew
a
, peanut, 
hazelnut 
38.6 6 Cashew, pistachio, pecan, walnut, 
almond, hazelnut, macadamia, 
peanut, coconut, cat, dog, dust   
59.6 
7 Cashew
a
, peanut, 
hazelnut 
27.0 7 Tree nuts, hazelnut, dust 35.5
c 
8 Cashew
a
, pistachio, 
citrus fruit 
44.7 8 Cashew, walnut, peanut, shellfish, 
fish, scotch bloom 
26.2 
9 Cashew
a
 47.4  
10 Cashew
a
, kiwi 51.9 
11 Cashew
a
, pistachio, 
walnut, almond 
10.8 
12 Cashew
a
, almond, 
chicken egg, milk 
12.7 
13 Cashew
a
, cows’ milk, 
chicken egg, pear, 
peas 
48.7 
 
Serum and plasma 
Serum of Western blot group 1 was obtained from 13 cashew-allergic (double-blind placebo-
controlled food challenge (DBPCFC) diagnosed) individuals out of the multicentre 
prospective study “Improvement of diagnostic methods for allergy assessment” with cashew 
allergy in children as a showcase (trial number NTR3572, medical ethical approval number 
2012-125, Erasmus Medical Centre Rotterdam). Plasma of group 2 was obtained from 
PlasmaLab International. Eight patients with self-reported history of cashew or tree nut 
allergy were selected based on high cashew-IgE titres. Clinical characteristics of the subjects 
are described in Table 3.1: self-reported allergies and cashew-IgE levels as determined by 
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Immulite 2000, F202. Glycoprotein staining. Glycosylation of proteins was checked using a 
Glycoprotein Staining kit. Samples were run on SDS-PAGE as described above alongside a 
positive control (horseradish peroxidase, kit content) and a negative control (soybean trypsin 
inhibitor, kit content). Staining was performed according to the manufacturer’s instructions. 
Imaging and analysis were performed using a Universal Hood III and Image Lab 4.1 software. 
 
Protein identification 
Protein identification by MALDIMS/MS was performed by Alphalyse Denmark. Protein 
samples for protein identification were excised from denaturing reducing Coomassie-stained 
SDS-PAGE gels. Trypsin-digested protein bands were analysed on a Bruker Autoflex Speed 
MALDI TOF/TOF. The MS data were blasted against the NCBI and UniProt database. 
Additional protein identification analysis of the 10kDa protein band of Ana o 3 was 
performed by LC-MS/MS analysis. On the basis of the results of Shevchenko et al. [21], bands 
cut from SDS-PAGE gel were washed in 0.2M NH4HCO3 in acetonitrile (1:1) followed by 
addition of 10mM DTT in 0.1M NH4HCO3 at 56°C for 45min. The gel pieces were incubated 
in 55mM iodoacetamide (IAA) in 0.1M NH4HCO3 and washed in 0.1M NH4HCO3 in 
acetonitrile (1:1), and after drying in a SpeedVac, the gel pieces were digested overnight at 
37°C in 0.1M NH4HCO3 with sequencing grade modified porcine trypsin (Promega). Gel 
pieces were incubated with 25mM NH4HCO3 for 15min at 37°C. After addition of 
acetonitrile the samples were dried and dissolved in 0.1% formic acid. Trypsin-digested 
peptides were separated on a Thermo Scientific EASY column (3μm bead-packed 10cm C18 
column) connected to an Easy-nLC 1000 ultrahigh-pressure system (Thermo Scientific). 
Peptides were loaded in solvent A (0.1% formic acid in MQ) onto a pre-column (5μm bead-
packed 2cm C18 column) prior to separation on the analytical column using a 40min 5−50% 
linear gradient of solvent B (100% acetonitrile (ACN) in 0.1% formic acid) at a flow rate of 
300nL/min. During the gradient, online MS analysis of peptides was performed with a 
QExactive Plus (Thermo Scientific) mass spectrometer using a nanoelectrospray source. 
Ionization (2.4kV) was performed using a stainless steel emitter and a heated capillary 
temperature of 250°C. Full MS scans were acquired over the m/z range 400−1.500 with a 
mass resolution of 70.000 (at m/z 200). Full scan target was set at 1 × 106 with a maximum 
fill time of 100ms. The five most intense peaks with charge states 1−4 were fragmented in 
the higher-energy collisional dissociation (HCD) collision cell with a normalized collision 
energy of 30%. The mass range was set to 200−2000 with a mass resolution of 17.500 (at 
m/z 200). The target value for fragment scans was set at 1 × 105, the intensity threshold was 
kept at 4 × 104, and the maximum allowed accumulation times were 50ms. The peptide 
match was set to preferred, isolation width was set at 4 and isotope exclusion was on, and 
the dynamic exclusion was set to 30s. LC-MS/MS data acquired by the Q-Exactive were 
processed using ProteomeDiscoverer software 1.4 (Thermo Scientific). The fragmentation 
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spectra were searched against an Anacardiaceae database downloaded from Uniprot using 
Sequest HT with precursor mass tolerance of 10ppm and fragment mass tolerance of 
20mDa. Minimum peptide length was 6 amino acids, and maximum of miscleavages was set 
to 2. Carbamidomethylation of cysteine was set as fixed modification, and oxidation of 
methionine was set as variable modification. The percolator was used for false-discovery 
rate (FDR) estimation using reversed decoy database filtering on q-value below 1% for strict 
and 5% for relaxed stringency. 
 
Analysis of Ana o 3 by UPLC/PDA/ESI-MS 
Identification of the heterogeneity of the N- and C-termini was executed by ultra-
performance liquid chromatography UPLC)/photodiode array (PDA)/electrospray ion source 
(ESI)-MS. Purified native Ana o 3, denatured and reduced Ana o 3 (10mM DTT, 1% SDS, 5min 
at 100°C), and proteins eluted from de-stained SDS-PAGE (50mM Tris, 0.1mM EDTA, 0.15M 
NaCl, 0.1% SDS, 1mM DTT, 4h) were filtered over a 0.5 mL 3kDa Amicon centrifugal filter and 
suspended in 200μL of eluent A (0.1% trifluoroacetyl (TFA) and 1% ACN in water). The 
solution was analyzed by LC/PDA/ESI-MS by injecting 2μL in an Acquity UPLC separation 
module equipped with a BEH C4 300Å column (1.7μm, 2.1 × 100mm), interfaced with an 
Acquity PDA detector and a Synapt G2-Si HD mass spectrometer. Gradient elution was 
performed between eluent A and B. Eluent A was 1% ACN and 0.1% TFA in water; eluent B 
was 0.1% TFA in ACN. The gradient ramp was 0−2min isocratic 90% A, 2−12min linear 
gradient from 90% A to 25% A, 12−15min linear gradient from 25% A to 0.1% A, 15−20min 
isocratic 0.1% A, plus reconditioning. The flow rate was 0.35 mL/min. PDA detection was 
performed in the range 200−400nm, with a resolution of 1.2nm and a sampling rate of 40 
points/s. MS detection was performed in the full scan mode with the following parameters: 
positive ion mode, capillary voltage 3kV, source temperature 150°C, cone voltage 40V, 
desolvation temperature 500°C, cone gas flow (N2) 200L/h, desolvation gas flow (N2) 
800L/h, aquisition range 150−4000m/z, scan time 0.3s, and interscan time 0.015s. The UV 
chromatogram was obtained by extracting the trace measured at 214nm from the PDA full 
scan trace. 
  
Analysis of Ana o 3 tryptic peptides by UPLC/PDA/ESI-MS 
Purified Ana o 3 was denatured and reduced (1% SDS, 10mM DTT, 5min at 100°C) and 
digested with trypsin for 1h at 37°C. Samples were analysed by LC/PDA/ESI-MS by injecting 
2μL in an Acquity UPLC separation module equipped with a Peptide BEH C18 column, 300Å 
(1.7μm, 2.1mm × 150), interfaced with an Acquity PDA detector and a Synapt G2-Si HD mass 
spectrometer. Gradient elution was performed between eluent A and B. Eluent A was 1% 
ACN and 0.1% TFA in water; eluent B was 0.1% TFA in ACN. The gradient ramp was 0−2min 
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isocratic 97% A, 2−10min linear gradient from 97% A to 78% A, 12−16min linear gradient 
from 78% A to 70% A, 16−19 min from 70% A to 0.1% A, 19−24min isocratic 0.1% A, plus 
reconditioning. The flow rate was 0.35mL/min. PDA detection was performed in the range 
200−400nm, with a resolution of 1.2nm and a sampling rate of 40 points/s. MS detection 
was performed in the full scan mode with the following parameters: positive ion mode, 
capillary voltage 3kV, source temperature 150°C, cone voltage 30V, desolvation temperature 
500°C, cone gas flow (N2) 200L/h, desolvation gas flow (N2) 800L/h, acquisition range 100−
3000m/z, scan time 0.3s, and interscan time 0.015s. Survey MSe mode was applied with the 
following parameters: acquisition range 100−3000m/z, ramp high energy from 20.0 to 30.0, 
TIC threshold 5.0, survey scan time 0.3s. Lock spray mass correction was applied by 
continuously perfusing Angiotensin II as calibrant into the source during the scan. The data 
were analysed using BioPharmaLynx 1.3.3 software. Identified peptides were cross-checked 
manually.  
 
Epitope mapping of Ana o 3 
Forty-two peptides of 15 amino acids, with an offset of 3 amino acids, were synthesized by 
Synpeptide, covering the entire length of Ana o 3 (amino acids 1−138). Peptides were 
dissolved, and 5μmol was spotted in duplicate on nitrocellulose (0.2μm, placed on a 
polyester backbone) alongside two positive controls (0.6μg total protein extract and 5μg IgE) 
and a negative solvent control. The same procedure was followed as explained above for 
Western blotting with the only difference being that the blots were incubated with plasma 
from individual patients (group 2) and one blot was incubated with serum from a non-
allergic person. The four plasma samples were chosen based on the highest Ana o 3 binding 
capacity out of the eight plasma samples, as determined by Western blotting (data not 
shown), for clinical characteristics see Table 3.1. Staining was performed for 30min. After 
washing in TBS, the average pixel intensity of each duplicate spot was calculated using the 
Image Lab 4.1 software, and the values for the negative serum were deducted per duplicate 
spot. Strong binding epitopes were defined as the 30% strongest IgE-binding epitopes.  
 
Results 
 
Protein purification  
Purification of Ana o 1 and Ana o 3 was achieved by protein extraction from defatted cashew 
followed by stepwise ammonium sulfate precipitation. The final supernatant, after 52.5% 
ammonium sulfate precipitation, was used to purify Ana o 1 and Ana o 3. Ana o 2 was 
purified by gel filtration chromatography of a non-defatted cashew extract. A flow sheet for 
the purification of Ana o 1, Ana o 2, and Ana o 3 is shown in Figure 3.1.  
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Figure 3.1 Flow sheet for the purification of Ana o 1, Ana o 2, and Ana o 3. AHC, ammonium 
bicarbonate buffer; o/n, overnight 16h; rt, room temperature; final sup, final supernatant. 
 
In Figure 3.2A, various fractions collected during the purification process of cashew allergens 
are shown on denaturing and reducing SDS-PAGE gel. The two total protein extracts 
(defatted and non-defatted) contain several proteins next to Ana o 1, Ana o 2, and Ana o 3, 
with the 11S globulin Ana o 2 as the most prominent protein. Upon stepwise addition of 
ammonium sulfate to the total protein extract (defatted), to a final concentration of 15, 30, 
and 45%, generally Ana o 2 together with various high molecular weight proteins 
precipitated; see Supplementary Information, Figure 3.S1. After the last step of precipitation 
(52.5%), the final supernatant contains only Ana o 1 and Ana o 3 (Figure 3.2A, lane 3); this 
last fraction was used to purify these two proteins. Omitting the stepwise precipitation steps 
by directly adding 52.5% ammonium sulfate resulted in a supernatant containing more 
impurities (data not shown). 
The gel filtration chromatogram from the purification of Ana o 2 showed three peaks (Figure 
3.3): peak 1 contains a mixture of several proteins (among others, Ana o 1, Ana o 2, and Ana 
o 3), peak 2 contains Ana o 1 and Ana o 2, and peak 3 contains the purified Ana o 2 fraction 
as shown in Figure 3.2A (lane 6).  
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Protein identification 
As specified in Figure 3.2A and Figure 3.S2, on the basis of MALDI-MS/MS, Ana o 1 was 
confirmed in the 100kDa band (b) and the 50kDa band (c). For Ana o 2 the 53kDa (a), 30kDa 
(d), and 21kDa bands (f) were confirmed as the complete protein, large subunit, and small 
subunit, respectively. The 22kDa band (e) was identified as an 11S globulin from pistachio; 
however, we interpret this to be Ana o 2 from cashew, as 11S from pistachio and Ana o 2 
display 49% sequence identity and 65% sequence similarity (EMBOSS Needle, EMBL-EBI). 
The three bands in lane 7 (10, 8, 6kDa; bands g, h, i, respectively) were identified as Ana o 3. 
 
Purity and yield of the proteins 
Purities of the Ana o 1, Ana o 2, and Ana o 3 fractions were determined by applying 
increased protein concentrations (20, 30, and 40μg) on SDSPAGE (data not shown). Purity of 
these fractions was calculated as the relative percentage of the desired protein bands versus 
visible impurities on SDS-PAGE. Purity of Ana o 1 was 95.6% ± 3.3%, purity of Ana o 2 was 
92.6% ± 4.6%, and purity of Ana o 3 was 98.5% ± 1.3%. Protein yield of the purified fractions 
was calculated based on the Coomassie protein assay and SDS-PAGE analysis of several 
purified fractions. Overall yield is 1% for Ana o 1 (0.33mg per run), 34% for Ana o 2 (1.99mg 
per run), and 3% for Ana o 3 (5.52 mg per run).  
  
Western blot  
In Figure 3.2D, two Western blots performed with two different pools of patient 
serum/plasma are shown; blot D1 was performed using 13 sera from cashew-allergic 
children as determined by DBPCFC, while blot D2 was performed using 8 plasma samples 
from cashew- or tree-nut allergic adults. Less strong IgE-binding to cashew allergens is 
observed using serum from group 1 (blot D1), compared to plasma from group 2 (blot D2). 
Blot D1 shows binding of IgE to Ana o 2 (lane 4; 30, 22, and 21kDa), Ana o 3 (lane 5; 10 and 
8kDa, not 6kDa), and slightly to Ana o 1 (lane 3; 50kDa). In the total protein extract, the 
same proteins as well as additional proteins of 80, 70, 53 (full length Ana o 2), 40, and 16kDa 
appear IgE-reactive. In blot D2 binding of IgE to Ana o 1 (lane 3; 100 and 50kDa), Ana o 2 
(lane 4; 30, 22, and 21kDa), and Ana o 3 (lane 5; 10 and 8kDa, not 6kDa) is visible. In the total 
protein extract, the same proteins as well as additional proteins of 80, 65, 53kDa (Ana o 2), 
40, 16, and 12kDa bind IgE. In blot D2, lane 3, a small impurity of 30kDa (Ana o 2) can be 
observed in the purified Ana o 1 extract. In the third blot, D3, the antibody control blot is 
shown, demonstrating marginal non-specific binding of the antibodies to the 22−21kDa 
subunits of Ana o 2. These Western blots indicate that all three purified protein fractions are 
able to bind IgE.  
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Figure 3.2 All lanes: mwm, molecular weight marker; Total protein, total protein extract from 
defatted cashew used for purification of Ana o 1 and Ana o 3; Final sup, final supernatant after 52.5% 
ammonium sulfate precipitation; Total protein nd, total protein extract from non-defatted cashew 
used for purification of Ana o 2; neg. control, negative control glycoprotein stain (soybean trypsin 
inhibitor); pos. control, positive control glycoprotein stain (horseradish peroxidase). (A) Reducing 
denaturing SDS-PAGE of purified cashew extracts. Letters a−i indicate bands cut for protein 
identification: (a) 53kDa Ana o 2, (b) 100kDa Ana o 1, (c) 50kDa Ana o 1, (d) 30kDa Ana o 2, (e) 22kDa 
11S globulin, (f) 21kDa Ana o 2, (g) 10kDa Ana o 3, (h) 8kDa Ana o 3, (i) 6kDa Ana o 3. (B) Non-
reducing denaturing SDS-PAGE of purified cashew extracts, no β-mercaptoethanol added. (C) 
Glycoprotein stain of purified cashew extracts. (D) Western blots of purified cashew extracts. Blot D1 
has been incubated with the serum pool of group 1, blot D2 has been incubated with a plasma pool 
from group 2, and blot D3 is the antibody control blot that has not been incubated with patient 
plasma or serum. 
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Inhibition blotting, presented in Figure 3.S3, shows that purified Ana o 1 completely 
inhibited binding to Ana o 1, and Ana o 3 completely inhibited binding to Ana o 3 in the total 
protein extract. Besides inhibition of binding to Ana o 1, purified Ana o 1 also diminished IgE 
binding to Ana o 2 and Ana o 3.  
 
 
Figure 3.3 Gel filtration chromatogram of total protein extract of non-defatted cashew used for the 
purification of Ana o 2. 
 
Non-reducing denaturing SDS-PAGE 
To check the presence of disulfide bridges in the purified allergen fractions, a non-reducing 
denaturing SDS-PAGE, in the absence of β-mercaptoethanol, was performed. In the Ana o 1 
fraction (Figure 3.2B, lane 3) protein bands of 160, 100, and 50kDa can be observed. In lane 
4, containing Ana o 2, diffuse bands of 53, 42, 39, 30, 20, and 10kDa are present. Ana o 3 
(lane 5) shows an abundant protein band of 12kDa and minor bands of 20 and 5kDa.  
 
Glycosylation of cashew proteins 
On the basis of prediction models (NetNGlyc 1.0, Denmark, http://www.cbs.dtu.dk/ 
services/NetNGlyc/), the amino acid sequences of Ana o 1 (amino acid 391, asparagine) and 
Ana o 3 (amino acid 19, asparagine), but not that of Ana o 2, contain putative N-glycosylation 
motifs. The predicted glycosylation of Ana o 1 was confirmed by glycoprotein staining (see 
Figure 3.2C). Both Ana o 2 and Ana o 3 do not seem to be glycosylated, neither in the 
purified nor in the total protein fraction. In addition an unknown protein of 3kDa, present in 
the full protein extract, also seems to be glycosylated.  
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Analysis of Ana o 3 
Protein characterization and protein identification of Ana o 3 revealed some discrepancies 
with data from literature. It was previously reported that all three denatured protein bands 
from SDS-PAGE represented the large subunit of Ana o 3.15 However, our results identify 
one of the bands as the small subunit from Ana o 3. Besides, the IgE binding on Western blot 
to two out of three bands of denatured Ana o 3 indicated the possibility of one of these 
bands possibly being the small subunit of Ana o 3. To analyse this possibility, both denatured 
reduced and native Ana o 3 samples were analysed for peptide mass, purity, and annotation 
of protein sequences using UPLC/PDA/ESI-MS.  
 
Table 3.2 Molecular masses of denatured Ana o 3 derived from UPLC/PDA/ESI-MS analysis and their 
tentative sequence identification. aAccording to Moreno and Clemente [16], bAccording to our data. 
 Tentative sequence annotation 
within the range 0.5 Da from the 
theoretical calculated mass 
Experimental 
molecular 
mass (Da) 
Leader 
peptide 
b
 
Small 
subunit 
b
 
Large 
subunit 
b
 
Leader peptide 1-20
a
 1-20/28
 b
      
Small subunit 21-65
a
 29-65
 b
      
Large subunit 66-138
a
 69-137
b
     
Chromatographic Peak 
1 (Rt = 5.61) 
34-62 / 35-63 3742.7  X  
34-63 / 35-64 / 36-65 3799.7  X  
33-63  3886.8  X  
33-65 4099.9  X  
Chromatographic Peak 
2 (Rt = 5.82) 
37-64  3514.6  X  
37-65 3670.7  X  
22-53 3959.8  X  
39-69 4016.8  X X 
33-66  4263.1  X  
31-66 4507.1  X  
Chromatographic Peak 
3 (Rt = 7.60) 
2-70 or 56-122 or unknown 
isoform 
8161.7 X X X 
1-71 or unknown isoform 8421.8 X X X 
Chromatographic Peak 
4 (Rt= 7.91) 
69-136 8084.7   X 
69-137 8171.7   X 
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Denatured and reduced Ana o 3 shows four peaks (Figure 3.4A). Peaks 1 and 2, 
corresponding to the 6kDa protein band on SDS-PAGE, were compatible with the small 
subunit of Ana o 3 with molecular weights of 3.7−4.5kDa. Peak 3 (10kDa band) and peak 4 
(8kDa band) were both compatible with the large subunit of Ana o 3 with molecular weights 
of 8.1−8.4kDa. Using both trypsin-digested and nondigested denatured reduced Ana o 3, the 
peptide sequences from the four peaks were annotated (see Table 3.2). The range of protein 
molecular weights in the four peaks was found to originate from N- and C-terminal micro-
heterogeneity, also called N- or C-terminal clipping (see Table 3.3 and Figure 3.5). Tryptic 
peptides clearly showed that the small subunit displayed both N- and C-terminal micro-
heterogeneity, with its N-terminus starting at amino acid 29−36 and its C-terminus 
terminating at amino acid 63−65. The large subunit displayed only minimal C-terminal micro-
heterogeneity, starting at amino acid 69 and ending at amino acid 136−137. When Ana o 3 
was purified using protease inhibitors, the same degree of micro-heterogeneity was 
obtained (data not shown). 
Native Ana o 3 eluted as one major peak of 11.8−12.8kDa (Figure 3.4C and D) with a purity of 
88% (Figure 3.4B, purity calculated by UV trace at 214nm). The observed masses fitted with 
the molecular masses of the small subunit (peaks 1 and 2) linked to the large subunit (peak 
4) by two disulfide bridges. Together with the two other predicted disulfide bridges within 
the large subunit,16 a total of 4 disulfide bridges can be found within native Ana o 3. Besides 
demonstrating micro-heterogeneity in Ana o 3, the obtained data also indicate the presence 
of isoforms of the large subunit.  
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Table 3.3 Sequence annotation of Ana o 3 tryptic peptides including termini based on molecular mass 
(<10 ppm error) and fragment identification. 
 
 
 
Figure 3.5 Amino acid sequence (coding region) of Ana o 3, with the small and large subunits 
indicated as based on UPLC/PDA/ESI-MS analysis. The leader peptide is underlined, the black bars 
indicate the constant regions, and the light gray bars indicate regions of micro-heterogeneity. A 
dotted box is placed around the small subunit (first box) and the large subunit (second box) of Ana o 
3. 
 
Epitope mapping of Ana o 3 
Using 42 overlapping linear peptides, 12 IgE-binding peptides were detected in Ana o 3 (see 
Table 3.4). Two IgE-binding peptide regions were identified, with the first consisting of 
amino acids 10−30 and the second, more strongly IgE-bound region consisting of amino acids 
85−108. Besides 4 mildly binding epitopes described in Table 3.4, 2 strongly binding peptides 
were identified at amino acids 55−69 and 121−135. All strongly binding epitopes were 
detected in the peptides of the large subunit or containing part of the large subunit.  
 
  
Peptide m/z 
(charge state) 
Identified peptide sequence 
565.9 (3+) 36-48 N-termini small subunit until trypsin cleavage site (amino acid 48) 
618.0 (3+) 35-48 
637.0 (3+) 34-48 
666.0 (3+) 33-48 
704.3 (3+) 32-48 
747.3 (3+) 31-48 
790.3 (3+) 30-48 
823.4 (3+) 29-48 
660.4 (2+) 55-65 Trypsin cleavage site (amino acid 55) until  
C-termini small subunit 582.3 (2+) 55-64 
553.8 (2+) 55-63 
759.7 (3+) 69-86 N-terminus large subunit until trypsin cleavage site (amino acid 86) 
786.4 (2+) 123-137 Trypsin cleavage site (amino acid 123) until  
C-termini large subunit 742.8 (2+) 123-136 
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Table 3.4 Linear epitope mapping of Ana o 3 using plasma of four individuals (no. 1−4) from group 2; 
bold peptide numbers indicate a strong IgE-binding epitope, bold amino acid numbers indicate an IgE-
binding peptide region; underlined amino acid sequences indicate the small subunit of Ana o 3 (amino 
acids 29−65), between the leader sequence (1−20) and the large subunit (69−137) of Ana o 3. 
 
 IgE-binding intensity 
Peptide Amino acid # Amino acid sequence 1 2 3 4 
1 1-15 MAKFLLLLSAFAVLL     
2 4-18 FLLLLSAFAVLLLVA     
3 7-21 LLSAFAVLLLVANAS     
4 10-24 AFAVLLLVANASIYR + + + ++ 
5 13-27 VLLLVANASIYRAIV + +  + 
6 16-30 LVANASIYRAIVEVE + +  + 
7 19-33 NASIYRAIVEVEEDS     
8 22-36 IYRAIVEVEEDSGRE     
9 25-39 AIVEVEEDSGREQSC     
10 28-42 EVEEDSGREQSCQRQ     
11 31-45 EDSGREQSCQRQFEE     
12 34-48 GREQSCQRQFEEQQR     
13 37-51 QSCQRQFEEQQRFRN     
14 40-54 QRQFEEQQRFRNCQR ++    
15 43-57 FEEQQRFRNCQRYVK     
16 46-60 QQRFRNCQRYVKQEV     
17 49-63 FRNCQRYVKQEVQRG + ++   
18 52-66 CQRYVKQEVQRGGRY     
19 55-69 YVKQEVQRGGRYNQR ++ +++  + 
20 58-72 QEVQRGGRYNQRQES     
21 61-75 QRGGRYNQRQESLRE     
22 64-78 GRYNQRQESLRECCQ     
23 67-81 NQRQESLRECCQELQ     
24 70-84 QESLRECCQELQEVD     
25 73-87 LRECCQELQEVDRRC     
26 76-90 CCQELQEVDRRCRCQ +  ++ + 
27 79-93 ELQEVDRRCRCQNLE     
28 82-96 EVDRRCRCQNLEQMV     
29 85-99 RRCRCQNLEQMVRQL ++ +++ + + 
30 88-102 RCQNLEQMVRQLQQQ ++ ++ ++ ++ 
31 91-105 NLEQMVRQLQQQEQI     
32 94-108 QMVRQLQQQEQIKGE ++ ++ ++ +++ 
33 97-111 RQLQQQEQIKGEEVR     
34 100-114 QQQEQIKGEEVRELY     
35 103-117 EQIKGEEVRELYETA     
36 106-120 KGEEVRELYETASEL     
37 109-123 EVRELYETASELPRI     
38 112-126 ELYETASELPRICSI +  +  
39 115-129 ETASELPRICSISPS     
40 118-132 SELPRICSISPSQGC     
41 121-135 PRICSISPSQGCQFQ +++ +++ + + 
42 124-138 CSISPSQGCQFQSSY     
Total cashew positive control +++ +++ +++ +++ 
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Discussion 
In this study we have purified and characterized the three major cashew allergens Ana o 1, 
Ana o 2, and Ana o 3. Our method enables the simultaneous purification of Ana o 1 and Ana 
o 3. 
Using precipitation, ultrafiltration, and gel filtration chromatography, we have isolated three 
cashew allergens with high purity. The purities of the single allergen fractions are 
approximately 96% for Ana o 1, 93% for Ana o 2, and 99% for Ana o 3 as based on SDS-PAGE 
and 88% for Ana o 3 based on high-performance liquid chromatography (HPLC) analysis. The 
only IgE-reactive impurity we observed, as established by Western blotting, was a protein of 
30kDa in the Ana o 1 fraction (Figure 3.2, D1). A substantial difference in IgE-binding to Ana o 
1 is apparent between the two patient groups (blots D1 and D2), which might be explained 
by a population difference of the sera. Group 1 (blot D1) consists of Dutch children, and 
group 2 (blot D2) consists of American adults. Geographical and age differences have been 
described before to explain differences in allergen binding [22, 23]. 
For Ana o 3 we observed only IgE binding to the 10 and 8kDa proteins and not to the 6kDa 
protein. This is consistent with other Western blots performed by us using both various 
patient pools and individual patient sera. Teuber et al., however, did detect IgE binding to 
the 6kDa protein [20]. Our analyses show that the 6kDa protein is the small subunit of Ana o 
3 while both the 10 and 8kDa proteins represent the large subunit. Epitope mapping of Ana 
o 3 by Robotham et al. [15] showed more strongly binding epitopes on the small subunit 
compared to our data. Table 3.4 shows that our patient IgE binds strongest to the peptides 
of the large subunit. One mildly IgE-binding peptide region was identified between the 
presumptive leader sequence15 and the start of the small subunit as determined by 
UPLC/PDA/ESI-MS analysis. It is unknown if this peptide is present in cashew when eaten; 
however, IgE binding to leader peptides that are not attached to the mature allergen has 
been observed before for Ana o [19] and Ana o 2 [11]. 
On Western blot, besides binding of IgE to Ana o 1, Ana o 2, and Ana o 3, several other 
proteins were bound in the total protein extract (Figure 3.2, D1 and D2). These allergens of 
12, 16, 40, 65, 70, and 80kDa have been observed before [20, 24], but have not been 
identified. 
The yield of purification for Ana o 1 is 1%, for Ana o 2 is 34%, and for Ana o 3 is 3%. The low 
yield can be explained by the precipitation steps of the total protein extract where Ana o 1 
and Ana o 3 are discarded along with the undesirable proteins. However, as the protein 
content of cashew is 18.8% [25], the amount of cashew needed is relatively low. No isoform 
selection is expected as inhibition blotting clearly shows complete inhibition of IgE binding to 
Ana o 1 and Ana o 3 in the total protein extract upon inhibition with, respectively, purified 
Ana o 1 or Ana o 3. Besides inhibition of IgE binding to Ana o 1, purified Ana o 1 also 
inhibited binding of IgE to Ana o 3 and partially to Ana o 2. Cross-reactivity between Ana o 1 
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and Ana o 3 was unexpected, although some cross-reactivity between recombinant Ana o 1 
and Ana o 2 has been shown before [11]. Cross-reactivity between 7S globulins, 11S 
globulins, and 2S albumins has been observed before for peanut [26].  
Glycoprotein staining of the cashew protein fractions showed Ana o 1 and an unknown 
protein of 3kDa to be glycosylated. Both Ana o 2 and Ana o 3 are not glycosylated. 
Glycosylation of cashew proteins has been studied once before where only one glycosylated 
protein of ~3kDa was indicated [27]. In their study Sathe et al. used a total protein extract 
that, as can also be observed from our glycoprotein stained gel, possibly did not contain 
enough Ana o 1 to show a clear band in glycoprotein staining. Another explanation could be 
a difference in cashew variety used. 
Under non-reducing denaturing conditions, Ana o 1 is present as both a dimer of 100kDa and 
a single protein of 50kDa. Non-reduced denatured Ana o 2 displays some protein bands that 
are also visible in reducing denaturing SDS-PAGE: the 53kDa full protein and 30 and 
21kDasubunits. Ana o 3 seems to form one complex of ∼12kDa linked by disulfide bridges, 
which was confirmed by LC/ESI-MS. 
Purified Ana o 3 manifested as a triplet of 10, 8, and 6kDa proteins on SDS-PAGE under 
denaturing reducing conditions. Native 2S-albumins are post-translationally processed into 
an N-terminal small subunit of ~5.5kDa and a C-terminal large subunit of ~8.8kDa, held 
together via cysteine linkages [16]. In an attempt to further identify the protein triplet, we 
subjected both native and denatured reduced Ana o 3 to LC-MS analysis. This indicated the 
10 and 8kDa proteins to be the large subunit of 8.2−8.4 and 8.1−8.2kDa, respectively, and 
the 6kDa protein to be the small subunit of 3.7−4.5kDa. Tryptic digestion of Ana o 3 
indicated the small subunit to span amino acids 29−36 until 63−65, including N- and C-
terminal micro-heterogeneity, and the large subunit to span amino acid 69 until 136−137, 
including C-terminal micro-heterogeneity, differing slightly from the proposed amino acid 
stretches proposed by Moreno et al. [16]. The same degree of micro-heterogeneity was 
observed when Ana o 3 was purified in the presence of protease inhibitors, indicating this 
micro-heterogeneity is not an artefact from the method of extraction but is due to 
proteolytic processes, the presence of different precursors, or the shift in cleavage sites in 
the cashew itself [16]. Micro-heterogeneity of 2S albumins has been described before for 
castor bean [28], Brazil nut [29], and sesame [30]. 
This data differs from the data reported by Robotham et al., who described all three protein 
bands to be isoforms of the large subunit of Ana o 3 with very similar N-terminal sequences, 
differing in only 1−2 amino acids out of 10 [15]. An explanation for this discrepancy could lay 
in a difference in cashew variety or storage conditions.  
As food allergy is highly prevalent and the incidence of cashew allergy seems to be rising 
[31], it is relevant to study which proteins are involved. Ana o 1, Ana o 2, and Ana o 3 are the 
three major allergens in cashew. Using pure allergen fractions allows for determining to 
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which specific cashew allergen a patient reacts, and they can be used in cross-reactivity 
studies, where pure allergens can be used for inhibition blotting. Besides, these allergen 
fractions can also be used for analysis of allergen structure, comparing cashew varieties, and 
cashew protein processing stability. 
The advantage of using purified allergens over the use of recombinant allergens is clear for 
Ana o 1 and Ana o 3. Recombinant expression of a glycosylated allergen like Ana o 1 is 
difficult as both prokaryotic (e.g., E. coli) and eukaryotic (e.g., P. Pastoris) expression systems 
may not be capable of reproducing the natural glycation pattern as in cashew [32,33]. 
Considering Ana o 3, recombinant expression will not properly display the micro-
heterogeneity of the native protein; however, recombinant proteins are required to 
compare micro-heterogenic variations of Ana o 3. Besides, other post-translational 
processing modifications such as disulfide bridges (Ana o 2, Ana o 3) might prove more 
difficult in E. coli expression systems [32].  
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Supplementary information 
 
 
 
 
Figure 3.S1 Reducing denaturing SDS-PAGE of ammonium sulphate precipitation. Depicted are (left to 
right): total protein extract from defatted cashew used for purification of Ana o 1 and Ana o 3, 15%, 
30%, 45%, and 52.5% pellet of ammonium sulphate precipitation, final supernatant after 52.5% 
ammonium sulphate precipitation, molecular weight marker. 
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Figure 3.S2 Protein identification, analysis of protein bands from SDS-PAGE indicated in Figure 3.2. 
Results based on MALDI-MS/MS analysis unless stated otherwise. Indicated are the identified protein, 
GenBank number, sequence coverage, Mascot score, and the protein sequence with matched 
peptides underlined. For the proteins identified as Ana o 3 the large subunit (10 and 8kDa protein 
band) or the small subunit (6kDa protein band) as based on Figure 3.5 are indicated in bold. For the 
proteins identified as Ana o 2 the large subunit [11] (30kDa protein band) or the small subunit [11] 
(21kDa protein band) are indicated in bold.  
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Figure 3.S3 Inhibition western blot of Ana o 1 and Ana o 3, using plasma pool of group 2. Molecular 
weight marker followed by 3 lanes containing a total protein extract from defatted cashew used for 
purification of Ana o 1 and Ana o 3. Lane 2 is not inhibited, the plasma used in lane 3 was inhibited 
with 1mg/ml purified Ana o 1, the plasma used in lane 4 is inhibited with 1mg/ml purified Ana o 3. 
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Abstract  
The protein content and allergen composition was studied of cashew nuts from 8 different 
origins (Benin, Brazil, Ghana, India, Ivory Coast, Mozambique, Tanzania, Vietnam), subjected 
to different in-shell heat treatments (steamed, fried, drum-roasted). On 2D electrophoresis, 
9 isoforms of Ana o 1, 29 isoforms of Ana o 2 (11 of the acidic subunit, 18 of the basic 
subunit), and 8 isoforms of the large subunit of Ana o 3 were tentatively identified. Based on 
1D and 2D electrophoresis, no difference in allergen content (Ana o 1, 2, 3) was detected 
between the cashew nuts of different origins (p>0.5), some small but significant differences 
were detected in allergen solubility between differently heated cashew nuts. No major 
differences in N- and C-terminal micro-heterogeneity of Ana o 3 were detected between 
cashew nuts of different origins. Between the different heat treatments, no difference was 
detected in glycation, pepsin digestibility, or IgE binding of the cashew nut proteins. 
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Introduction  
Cashew nuts have been studied regarding their three major allergens [1], Ana o 1 [2], Ana o 
2 [3-5] and Ana o 3 [6], as well as regarding their nutritional content [7], clinical reactivity [8-
11], in vitro digestibility [12, 13], and their detection in food items [14, 15]. However, hardly 
any information is available on potential differences in allergen content between cashew 
nuts of different origins. Only a few studies were found describing a comparison of cashew 
nuts of different origins and varieties; one study counting the amount of chromosomes 
present in cashew nuts of two origins [16] and two other studies reporting no differences in 
protein content in cashew nuts of different varieties or origins [17, 18]. One paper stated in 
their unpublished results not to have detected differences in protein pattern on SDS-PAGE 
between cashew nut protein extracts from Florida and Mumbai, however no results were 
shown [19].  
 
In some nuts and legumes differences in allergen composition were reported for different 
origins. For instance, in Balinese peanuts, very low levels of the 7S globulin Ara h 1 were 
detected compared to other varieties [20]. However, this lower level of Ara h 1 did not result 
in a decrease in immunoreactivity as determined using an RBL (rat basophilic leukemia cell 
line) model [21]. Other, commercial, peanut varieties do not seem to differ in major allergen 
content (Ara h 1, 2, 3 and 6) [22, 23], just as different pistachio nut varieties seem to be 
similar in protein content and IgE binding capacity [24].  
 
With respect to the effects of thermal processing on cashew nuts, most studies have been 
performed on related nuts like pistachio, and legumes like peanut. For example, (steam-) 
roasting of peanut [25] and pistachio [24] decreased protein solubility, with steam-roasting 
of pistachio also inducing a decrease in patient IgE binding and a decrease in pepsin 
digestibility [24]. Using an RBL model, raw hazelnut appeared to be more allergenic than 
roasted hazelnut [26]. Roasting of total peanut protein has been shown to induce increased 
IgE binding in an ELISA assay [27], while no difference between raw and roasted peanut Ara 
h 2 and 6 was detected in an RBL assay [28]. Using purified peanut allergens, roasting of Ara 
h 1 (7S globulin) increased IgE cross-linking of RBL cells, while for Ara h 2/6 (2S albumins) the 
cross-linking capacity was decreased [29]. In a basophil activation test (BAT) model it was 
shown that the effect of thermal processing on peanut differed between peanut varieties 
and patients [30].  
 
The effects of thermal processing on the three major allergens of cashew nuts has been 
studied by Venkatachalam et al. [31], demonstrating the stability of monoclonal antibody 
(mAb)-binding by these allergens. IgE binding of Ana o 1, 2, and 3 was stable (as assessed by 
ELISA, western blot and dot blot) between a pH range of 2 to 12. IgG-binding of Ana o 1 and 
Chapter 4 
78 
2 was heat stable, as only autoclaving, but not microwaving, roasting or y-irradiation, 
resulted in a decrease in mouse mAb binding as shown with western blotting [31]. 
Immunoreactivity of Ana o 3 was decreased by roasting and autoclaving, however this was 
measured by western blot using a mAb that is directed at a conformational epitope [31]. It is 
unclear if these heat treatments affected the multiple linear epitopes of Ana o 3. Roasting of 
cashew nuts was reported to increase the solubility of Ana o 3 [32] while the total cashew 
nut protein solubility decreased [33]. Blanching of the cashew nuts on the other hand, 
causes leaking of all three allergens from the cashew nut into the blanching water [31]. 
However, the effects of frying were not studied by Venkatachalam et al.  
 
In the present study we compared cashews nuts of 8 different origins (Benin, Brazil, Ghana, 
India, Ivory Coast, Mozambique, Tanzania, and Vietnam) to analyze possible differences in 
protein and allergen content. Next, we compared the effect of different heat treatments 
(raw, steaming, frying, and drum roasting) on the protein and allergen content of the cashew 
nuts. We have studied the proteins by DUMAS method, SDS-PAGE, 2D electrophoresis, 
glycoprotein staining, in vitro digestion, and western blotting. Ana o 3 was also analyzed for 
N- and C-terminal micro-heterogeneity using UPLC/PDA/ESI-MS.  
 
The cashew nuts used in this study were heat-treated (steamed, fried, drum-roasted) in the 
shell. Each of these three heat treatments is routinely applied in industry to cashew nuts 
before de-shelling. The effects of such heat treatments on the cashew nut allergens Ana o 1, 
2 and 3, has not been studied before. 
 
Materials and methods  
 
Chemicals 
Urea, thiourea, CHAPS, DTT, SDS, β-mercaptoethanol, NaCl, NH4HCO3, NaHCO3, (NH4)2CO3, 
Tris, glycerol, porcine pepsin, Sigmafast BCIP/NBT and alkaline phosphatase conjugated goat 
anti-rabbit (A3687) were obtained from Sigma-Aldrich, St. Louis, MO. KCl, KH2PO4, 
ammonium sulfate, glycine, Coomassie R-250 and bromophenol blue were purchased from 
Merck, Darmstadt, Germany. 3kDa Amicon centrifugal filter were purchased from Merck 
Millipore, Tullagreen, Ireland. Precision Plus Protein Dual Xtra Standard molecular weight 
marker was purchased from Bio-Rad, Hercules, CA. The 2-D Quant Kit, IPG strips (pH 3-11 
non-linear), IPG buffer (pH 3-11), and iodoacetamide were obtained from GE Healthcare, 
Piscataway, NJ. NuPAGE LDS sample buffer, Mark12 unstained standard molecular weight 
marker, NuPAGE 1mm 4-12% Bis-Tris ZOOM gel, NuPAGE MES SDS running buffer, and 
SYPRO Ruby Protein Gel Stain were purchased from Invitrogen, Carlsbad, CA. CandyCane 
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glycoprotein molecular weight marker, MemCode Reversible Protein Stain Kit, and Pro-Q 
Emerald 300 Glycoprotein gel and blot stain kit were obtained from Thermo Scientific, 
Rockford, IL. Methanol and acetic acid were both purchased from Actu-All, Randmeer, the 
Netherlands. 0.45μm filters were obtained from Minisart, Satorius Stedim, Goettingen, 
Germany. MgCl2(H2O)6 was obtained from Boom BV, Meppel, the Netherlands. Polyclonal 
rabbit anti-human IgE (A0094) was obtained from Dako, Glostrup, Denmark.  
 
Cashew nut samples 
Raw, sundried cashew nuts (Anacardium occidentale) originating from Benin, Brazil, Ghana, 
India, Ivory Coast, Mozambique, Tanzania and Vietnam, were kindly provided by Intersnack 
B.V. (Doetinchem, the Netherlands) as raw cashew nuts in the shell. These raw cashew nuts 
were soaked in water for 8hr at room temperature, after which all floating cashew nuts were 
discarded. Heat-treatments of these raw in-shell cashew nuts were performed by Intersnack 
Nederland B.V.: steaming (20min 100˚C), frying (2min 180˚C), or drum roasting (8min 150˚C). 
Due to limited cashews from Tanzania, no Tanzania steamed sample was available. All heat-
treated cashew nuts were subsequently de-shelled, and incubated for 6hr at 70˚C, after 
which the skin (testa) was removed. For samples that are designated as raw cashew nuts, 
the raw untreated cashew nuts were de-shelled and peeled directly after the 8hr soaking 
step. Shelled cashew nuts were stored at 4˚C, de-shelled and peeled cashew nuts were 
stored at -80˚C.  
 
Protein extraction 
Ten de-shelled and peeled cashew nuts were cut into small pieces, frozen by liquid nitrogen, 
and ground by an analytic mill (IKA A11, Staufen, Germany). Ground cashew nuts were 
stored at -80˚C. Protein was extracted o/n 1:25 w/v in an urea extraction buffer (7M urea, 
2M thiourea, 2% (w/v) CHAPS, 50mM DTT, pH 8.8) at 4˚C while rotating. The samples were 
centrifuged for 20min 4˚C 10.000g and the supernatants were stored at -20˚C.  
 
Protein content 
The protein content in the extracts was determined by the 2-D Quant Kit according to the 
manufacturers’ instructions. The protein content of the ground de-shelled and peeled 
cashew nuts was determined by DUMAS method. In duplicate, 10mg ground cashew nuts 
was analyzed in an N Analyser (Flash EA 1112, Thermo Scientific). A conversion factor of 5.3 
[7] was used to calculate the percentage of protein in the cashew nuts.  
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In vitro gastric digestion 
For a non-denaturing non-reducing protein extract, protein from Vietnam ground cashew 
nut was extracted 1:13 w/v in an ammonium bicarbonate buffer (0.5M NaCl, 0.1M 
NH4HCO3, pH 7.9) for 1hr while shaking at room temperature, followed by centrifugation for 
5min at 10.000g, and 0.45μm filtering. For a denaturing reducing protein extract, protein 
from Vietnam ground cashew nut was extracted 1:13 w/v into the urea extraction buffer 
(7M urea, 2M thiourea, 2% (w/v) CHAPS, 50mM DTT, pH8.8) for 1hr while shaking at room 
temperature, followed by centrifugation for 5min at 10.000g, and 0.45μm filtering. Buffer 
exchange was performed for the urea protein extract by washing the extract five times with 
0.5ml simulated gastric fluid (SGF)[34]: 6.9mM KCl, 0.9mM KH2PO4, 25mM NaHCO3, 
47.2mM NaCl, 0.1mM MgCl2(H2O)6, 0.5mM (NH4)2CO3) in a 3kDa Amicon centrifugal filter. 
To 400μg protein, diluted in 400μl SGF buffer with pH3, 76μg porcine pepsin (equal to 61-
190U) was added. After 1hr incubation at 37˚C while shaking, the reaction was stopped by 
adding LDS sample buffer and β-mercaptoethanol as described below for SDS-PAGE.  
  
SDS-PAGE 
15μg of sample was denatured and reduced (10% β-mercaptoethanol in NuPAGE LDS sample 
buffer, 5min 100˚C) and run on SDS-PAGE as described earlier [1]. The gels were Coomassie 
stained by incubation in fix solution (40% methanol, 10% acetic acid) for 45s 1000W in a 
microwave, followed by 15min incubation at room temperature. Subsequently, the gels 
were stained in 30% methanol, 10% acetic acid, 0.02% w/v Coomassie R-250 for 45s 1000W 
in a microwave, followed by 15min incubation at room temperature. The gels were de-
stained in 8% acetic acid for 45sec 1000W in a microwave followed by shaking o/n at room 
temperature. Imaging and analysis were performed using a Universal Hood III and Image Lab 
4.1 software (both Bio-Rad).  
 
Glycoprotein stain 
Samples were run on SDS-PAGE as described above, alongside a CandyCane glycoprotein 
molecular weight standard. Gels were stained using the Pro-Q Emerald 300 Glycoprotein gel 
and blot stain kit. Imaging and analysis were performed using a Universal Hood III and Image 
Lab 4.1 software.  
  
2D Electrophoresis 
IPG strips (pH 3-11 non-linear) were rehydrated overnight with either 40μg total cashew nut 
protein (urea protein extract), or 5μg purified Ana o 1, 2 or 3 [1] diluted with rehydration 
buffer (5.6M urea, 1.6M thiourea, 20mM DTT, 1.6% w/v chaps, a few grains of bromophenol 
blue, 200x diluted IPG buffer pH 3-11 NL) to a final volume of 125μl. Isoelectric focusing was 
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performed in a protean IEF cell (Bio- Rad): 300V 0.2kvhr linear, 1000V 0.3kVhr rapid, 5000V 
4kVhr rapid, 5000V linear 2kVhr. The focused strips were reduced for 15min in 50mM Tris, 
20mg/ml SDS, 10mg/ml DTT, 30% glycerol and a few grains of bromophenol blue. 
Subsequently, the strips were alkylated for 15min in 50mM Tris, 20mg/ml SDS, 25mg/ml 
iodoacetamide, 30% glycerol and a few grains of bromophenol blue. The strips were run on a 
NuPAGE 1mm 4-12% Bis-Tris ZOOM gel alongside a molecular weight standard (Mark12 
unstained standard). Electrophoresis was performed at 160V for 55min in NuPAGE MES SDS 
running buffer. Gels were stained with SYPRO Ruby Protein Gel Stain according to the 
manufacturers’ instructions.  
For all gels the staining time and light exposure time for the picture were equal.  
 
Western blotting 
Western blotting of 1D and 2D SDS-PAGE was performed as described earlier [1] with the 
addition of a reversible protein stain step (MemCode Reversible Protein Stain Kit) directly 
after the protein transfer. IgE binding to the proteins was visualized by Sigmafast BCIP/NBT 
staining for 6 minutes.  
  
Plasma samples 
Plasma samples were obtained from PlasmaLab International (Everett, WA). Three patients 
with self-reported tree nut or cashew nut allergy and high cashew nut IgE titers were 
selected for western blotting experiments and pooled in equal volumes. Patient 
characteristics are presented in Table 4.1.  
 
Table 4.1 Clinical characteristics of cashew nut and tree nut allergic subjects. IgE levels specific for 
total cashew nut protein and Ana o 1, 2, 3 were measured by Immulite as described by van der Valk et 
al. [53]. Self-reported allergies per patient were provided by PlasmaLab International.  
Patient # 
plasma 
Self-reported allergies  IgE level 
cashew nut 
(kU/l) 
IgE level 
Ana o 1 
(kU/l) 
IgE level 
Ana o 2 
(kU/l) 
IgE level 
Ana o 3 
(kU/l) 
1  Tree nuts, hazelnut, pecan, dust mites, 
grass, insect venom  
19.2 2.5 12.4 12.3 
2  Cashew nut, peanut, walnut, tree 
pollen, cat, dog, horse  
>100 >100 >100 >100 
3  Tree nuts, banana, eggplant 61.7 23.0 58.2 >100 
 
Analysis of Ana o 3 micro-heterogeneity 
Proteins were extracted from raw cashew nuts of eight origins by an ammonium bicarbonate 
buffer (0.1M ammonium bicarbonate, 0.5M NaCl, pH 7.9) 1:5w/v at 4˚C o/n while rotating. 
Proteins in the supernatant (20min, 10.000g, 4˚C) were roughly precipitated by adding 52.5% 
w/w ammonium sulfate and mixing for 2hr while rotating. Subsequently, the samples were 
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centrifuged for 10min, 10.000g at 4˚C. Both native and reduced (1mg protein/ml in 10mM 
DTT, 1% SDS, 5min 100˚C) supernatants containing Ana o 3, were filtered over a 0.5ml 3kDa 
Amicon centrifugal filter and suspended in 200μl eluent A (0.1% trifluoracetic acid and 1% 
acetonitrile). The samples were analyzed by LC/PDA/ESI-MS as described before [1].  
  
Statistical analysis 
One-Way ANOVA analyses were executed with SPSS-22 (LSD). Groups were compared either 
by origin (comparing 8 groups of 4 samples each), or by heat treatment (comparing 4 groups 
of 8 samples each). Background coloring of the gels was subtracted for all analyzed spots. 
Significance levels were set at 0.05%. PCA plot analysis was performed in Canoco 5 version 
5.04. 
  
Results and discussion 
 
Protein content 
The average protein content for all cashew nuts, as measured by DUMAS assay, was 16.8% 
(±1.8%). Averages per country of origin and per heat treatment are presented in Table 4.2. 
On average, the highest protein concentration was measured in cashew nuts from Vietnam, 
and the lowest protein concentration in cashew nuts from India. Table 4.2 also shows the 
significant differences in protein content of cashew nuts of different origins. These 
differences might be related to differences in moisture or fat content of the nuts. Small 
differences in protein content for cashew nuts of different origins have been detected 
before [17]. When comparing the average protein content of raw cashew nuts, we measured 
a lower value (16.9±1.0%) than Rico et al. (18.06 ±0.8% when re-calculated with a conversion 
factor of 5.3) [17]. Variation in moisture content between these two results might explain 
this difference, as we did not dry the nuts before analysis while Rico et al. did.  
In this study, no significant differences were detected in the total protein content of cashew 
nuts subjected to different heat treatments.  
 
1D electrophoresis 
Figure 4.1 shows the electrophoresis profiles of extracted proteins from cashew nuts of 8 
different origins subjected to 4 different heat treatments. The allergens Ana o 1, 2 and 3 are 
indicated in Figure 4.1A. In Table 4.3, the percentages of Ana o 1, 2 and 3 are indicated as a 
percentage of all protein bands on SDS-PAGE from Figure 4.1. The extractable protein 
content of the cashew nuts, visualized on SDS-PAGE, demonstrates the presence of 4.1±0.9% 
Ana o 1, 51.5±4.9% Ana o 2, and 25.4±3.9% Ana o 3 (average of all 31 samples). There were 
no significant differences in allergen content (p>0.5, One-Way ANOVA) for cashew nuts of 
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Table 4.2 Protein content (%) of cashew nuts from different origins and subjected to different heat 
treatments as measured by the DUMAS assay. Average (Avg.) and standard deviation (Stdev.) of 
duplicates are shown. Average compared: protein content of vertically depicted cashew nut origins is 
significantly (p≤0.05, One-Way ANOVA) lower than cashew nuts from Ghana (a), Ivory Coast (b), 
Mozambique (c), Tanzania (d), Vietnam (e). 
 
Raw Steamed Fried 
Drum-
roasted 
Average 
 Avg. Stdev. Avg. Stdev. Avg. Stdev. Avg. Stdev. Avg. Stdev. 
Avg. 
compared 
Benin 17.3 0.2 17.7 0.5 13.7 0.5 16.1 1.6 16.2
 
1.8 c, e 
Brazil 16.1 1.5 16.6 0.2 16.2 0.1 16.2 0.5 16.3 0.3 c, e 
Ghana 17.6 0.4 17.1 1.4 15.1 0.3 17.8 0.5 16.9 1.3 e  
India 16.3 0.6 14.7 0.8 15.8 0.1 14.5 0.6 15.3 0.9 a, b, c, d, e 
Ivory Coast 17.4 0.2 15.7 0.4 16.2 0.3 16.7 0.1 16.5 0.8 c, e 
Mozambique  17.3 1.7 19.4 0.2 16.2 0.1 18.7 0.6 17.9 1.4  
Tanzania 15.8 0.2   17.7 0.1 16.3 0.8 16.6 1.0 c, e 
Vietnam 17.5 0.6 19.2 0.5 18.2 0.4 18.8 0.1 18.4 0.8  
Average 16.9 1.0 17.2 1.7 16.1 1.4 16.9 1.5 16.8 1.8  
 
 
different origins, meaning that Ana o 1, 2 and 3 were present in the same quantities in all 
eight cashew nut origins. In the electrophoresis profile of proteins from cashew nuts 
subjected to different heat treatments however, small but significant differences could be 
detected (One-Way ANOVA). Levels of Ana o 1 were significantly lower in steamed cashew 
nuts compared to raw, fried and drum-roasted cashew nuts (all p=0.00). Also, levels of Ana o 
1 were significantly lower (p=0.02) in fried cashew nuts compared to drum-roasted cashew 
nuts. Levels of Ana o 2 were significantly lower in raw cashew nuts compared to steamed 
(p=0.00), fried (p=0.00) and drum-roasted (p=0.02) cashew nuts. Also levels of Ana o 2 were 
significantly lower in drum-roasted cashew nuts compared to steamed cashew nuts (p=0.02). 
Levels of Ana o 3 were significantly lower in fried cashew nuts compared to raw (p=0.04) and 
drum-roasted (p=0.01) cashew nuts. Table 4.3 also shows the percentage increase or 
decrease in detected allergen in the heat-treated cashew nut compared to the raw cashew 
nut.  
 
Besides these differences in the relative quantities of Ana o 1, 2 and 3 in the protein 
extracts, the presence of >70kDa proteins was clearly lower in the steamed cashew nut 
protein extracts (Figure 4.1). It is expected that the differences in protein composition as 
visualized on SDS-PAGE, result from differences in protein extractability, or from heat-
induced effects on the protein (e.g. aggregation). As seen before, heating causes cashew nut 
[32], peanut [35] and walnut [36] proteins to become insoluble. Prolonged heating (20 and 
especially 24min roasting at 149˚C) can induce a decrease in solubility into a borate buffered 
saline buffer of Ana o 1, 2 and other proteins except Ana o 3 [32, 33]. In accordance with 
these results, in our study, the quantity of Ana o 3 was the highest in the drum-roasted 
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samples. The differences in Ana o 3 solubility upon roasting, are relatively small (3% 
increase) compared to the effects described by Mattison et al. (40% increase) [32]. This can 
be explained by the short heat exposure (roasting 8min 150˚C), and the moderating effect of 
the surrounding shell, of the cashew nuts used in our study. Mattison et al. applied a dark 
roasting heat treatment of 24min at 149˚C to de-shelled cashew nuts.  
 
 
Figure 4.1 SDS-PAGE of urea protein extracts of (A) raw, (B) steamed, (C) fried, (D) drum-roasted 
cashew nuts of 8 origins. All four gels, from left to right: molecular weight standard (in kDa), Benin 
(1), Brazil (2), Ghana (3), India (4), Ivory Coast (5), Mozambique (6), Tanzania (7, not in steamed, gel 
B), Vietnam (8). The position of Ana o 1, 2 and 3 are indicated by arrows in SDS-PAGE A. 
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Table 4.3 Percentage of Ana o 1, 2 and 3 in the urea protein extracts on 1D SDS-PAGE depicted in 
Figure 4.1. Percentages were calculated by Image Lab 4.1. Arrows indicate an increase () or decrease 
() in detected allergen in the heat-treated cashew nut compared to the raw cashew nut. 
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 Raw    
Ana o 1 5.5 4.1 5.2 4.8 4.4 3.7 4.9 4.6 4.6 0.6   
Ana o 2 45.6 48.7 48.2 44.0 45.2 46.6 45.4 47.5 46.4 1.6   
Ana o 3 25.3 27.2 24.2 28.1 27.0 26.4 25.7 26.2 26.3 1.2   
 Steamed    
Ana o 1 3.1 2.9 2.9 2.1 3.7 2.2  2.9 2.8 0.5  39% 
Ana o 2 59.8 54.8 52.5 55.1 53.8 53.6  57.6 55.3 2.5  19% 
Ana o 3 25.8 25.6 27.8 27.1 26.6 25.2  22.3 25.8 1.8  2% 
 Fried    
Ana o 1 4.5 4.0 4.4 3.8 4.4 3.6 4.4 3.9 4.1 0.3  11% 
Ana o 2 48.1 53.2 59.6 62.2 51.5 51.9 51.6 54.4 54.1 4.6  17% 
Ana o 3 28.4 23.2 14.1 15.8 26.1 24.7 23.6 23.1 22.4 4.9  15% 
 Drum-roasted    
Ana o 1 4.9 4.7 5.0 5.5 5.2 4.1 5.0 3.9 4.8 0.5  4% 
Ana o 2 51.6 60.2 48.5 52.0 46.8 51.5 46.2 50.1 50.9 4.4  10% 
Ana o 3 26.0 16.1 29.4 27.9 31.0 27.4 30.1 29.1 27.1 4.7  3% 
 
 
The IgE binding to heat-treated cashew nuts from Vietnam is shown in Figure 4.2. The 
control western blot showed minor non-specific binding of the antibodies to the 21kDa basic 
subunit of Ana o 2 as observed before [1] (data not shown).  
 
 
 
Figure 4.2 Reversible total protein stain on nitrocellulose membrane (A) and western blot (B) of raw 
(1), steamed (2), fried (3) and drum-roasted (4) cashew nut proteins from Vietnam. The molecular 
weight standard (in kDa) is indicated on the left, arrows indicate the cashew nut allergens Ana o 1, 2 
and 3. 
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The western blot in Figure 4.2B shows, based on band intensity calculations of Figure 4.2A 
and B, the same IgE binding to the three known allergens in these four heat-treated cashew 
nut protein extracts. IgE binding to Ana o 1 (50kDa), Ana o 2 (53, 30, 21kDa), and Ana o 3 
(10, 8kDa), as well as IgE binding to 70, 39 and 12kDa protein bands is similar between the 
four heat treatments. For Ana o 3, no IgE binding occurred to the 6kDa small subunit, 
possibly because the strongest IgE-binding epitopes are present in the large subunit for at 
least two out of three plasma samples [1]. IgE binding to the small subunit has been 
detected before [19] and seems to be more variable between persons than IgE binding to 
the large subunit.  
 
 
 
 
 
 
Figure 4.3 Glycoprotein stain of raw (1), steamed (2), fried (3) and 
drum-roasted (4) Benin cashew nut protein extracts. The molecular 
weight standard (in kDa) is indicated on the left of the gels, 
*indicates the position of the 3kDa glycoprotein. 
 
 
Glycoprotein stain 
Heating of nuts can potentially induce differences in glycation [25]. The Maillard reaction is a 
non-enzymatic browning reaction between proteins and non-reducing sugars which occurs 
faster at higher temperatures [37, 38]. Levels of glycated proteins, or Advanced Glycation 
End products, the products of the Maillard reaction, are therefore higher in roasted cashew 
nuts compared to raw cashew nuts [39].  
A glycoprotein stain was performed on 1D SDS-PAGE of cashew nut proteins from the Benin 
origin subjected to four different heat treatments (Figure 4.3). This revealed that in all 
protein extracts only one protein band (3kDa) was clearly glycated/glycosylated, but not Ana 
o 1, 2 or 3. No differences were detected in the protein extracts of differently heat-treated 
cashew nuts. Glycation of heat-treated cashew nut proteins has not been described before, 
but was expected based on peanut studies [25]. Besides, purified cashew nut protein Ana o 
1, when run at high quantity on SDS-PAGE, has shown presence of light 
glycosylation/glycation [1]. The relatively low levels of Ana o 1 in the protein extracts studied 
here, are likely too small to observe the minimal glycosylation/glycation of this protein in a 
total protein extract.  
Based on glycoprotein staining on SDS-PAGE we do not observe differences in glycation 
between proteins due to the heat treatments applied to these cashew nuts. Also no 
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difference in the colour of the cashew nuts was observed after de-shelling and peeling. It is 
likely that the cashew nuts, heat-treated in the shell, were to some extent protected from 
the heat and the Maillard reaction by this shell. Indeed, heating in a shell decreases the level 
of AGEs as shown in peanut [39], an effect that is likely even stronger in cashew nuts as the 
cashew nut shell is rather thick and solid.  
 
2D electrophoresis 
2D electrophoresis of each of the 31 protein extracts was performed to obtain detailed 
information on the presence of possible isoforms of Ana o 1, 2 and 3, and to detect 
differences between the cashew nut origins and heat treatments. The terminology regarding 
isoforms is often inconsistently applied but is used here to refer to different forms of the 
same protein, differing in for example glycosylation or a few amino acids. The presence of 
multiple isoforms might be caused by allelic differences, the occurrence of alternative 
splicing, or the occurrence of different post-translational modifications like glycosylation, 
phosphorylation, deamidation, and N- or C-terminal truncation [40]. Existence of multiple 
isoforms for 7S and 11S globulins as well as for 2S albumins has been documented before in 
peanut [41].  
Based on the 2D electrophoresis and subsequent western blots of purified Ana o 1, 2 and 3 
proteins, and one total protein extract of drum-roasted cashew nuts from Vietnam (Figure 
4.4), the allergens could be tentatively identified on all 2D electrophoresis gels 
(Supplementary information 1). As indicated in Figure 4.5, presumed Ana o 1 isoforms are 
indicated by spot number 1-9, presumed Ana o 2 isoforms are indicated by spot 10-38 with 
the acidic (large) subunit at 33-37kDa (spot 10-20) and the basic (small) subunit at 21-23kDa 
(spot 21-38), and finally presumed Ana o 3 isoforms are indicated by spot number 39-46 at a 
molecular weight of 10 and 8kDa.  
 
When analyzing the results in more detail it appears that purified Ana o 1 (Figure 4.4A) 
consists of four clear protein spots and five less intense protein spots. After western blotting 
(Figure 4.4E), IgE bound to protein spots in the same region on the blot. The individual spots 
can, however, not so clearly be distinguished. Besides IgE binding to these 50kDa protein 
spots, IgE also bound to a few minor protein spots of 30kDa, possibly indicating presence of 
residual Ana o 2 in this purified extract of Ana o 1. For Ana o 1, two isoforms (Ana o 1.0101 
and Ana o 1.0102) are known, differing in length and displaying one amino acid substitution 
[2]. As these two isoforms do not differ in theoretical isoelectric point (5.6, calculated by the 
pI calculator, ExPASy), the differences in isoelectric points of the 9 isoforms of Ana o 1 are 
likely to have been caused by differences in posttranslational modifications of the isoforms.  
Chapter 4 
88 
 
Figure 4.4 Total protein stain (A-D) and western blot (E-H) of 2D electrophoresis of purified Ana o 1 
(A, E), Ana o 2 (B, F), Ana o 3 (C, G), and a total protein extract of Vietnam drum-roasted cashew nuts 
(D, H). The molecular weight standard (in kDa) is indicated on the left of the gels. The 2D 
electrophoresis profile of Ana o 1 and Ana o 3 (dashed box) are enlarged (solid line box) in the corner 
of the gel (A, C) and blot (G). Protein spots and IgE binding spots and regions are indicated by 
numbers corresponding to Figure 4.5. *Indicates IgE binding to proteins of 55kDa. 
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As the isoforms of Ana o 1 have a pI of 5.2-5.8 on 2D electrophoresis, only minor 
(posttranslational) differences are expected between the isoforms. Ana o 1 has 15 predicted 
phosphorylation sites, one N-glycosylation site, and one amidation site [42], which could 
cause such differences in pI between the protein isoforms. On the other hand, also the 
occurrence of additional alleles could explain the different isoforms of Ana o 1 observed 
here. 
For purified Ana o 2 (Figure 4.4B), multiple isoforms were present after 2D electrophoresis; 
11 forms of the 33-37kDa acidic (large) subunit and 18 forms of the 21-23kDa basic (small) 
subunit. The pI range of the acidic subunit isoforms (5.2-6.3) was broader than expected 
(5.7). Such basic shifts on 2D electrophoresis might be caused by dethiomethyl methionine 
modifications [43]. The acidic subunit has 3 predicted acetylation (N-myristolyation) sites, as 
well as 10 phosphorylation sites. However, these posttranslational modifications would 
cause an acidic shift instead of the observed basic shift [44-46]. In contrast, the basic subunit 
of Ana o 2 showed an acidic shift on 2D electrophoresis: the protein spots migrated at a pH 
range of 5.2-9.3 instead of the calculated pI of 8.9. In this basic subunit of Ana o 2, 4 
phosphorylation sites, as well as 1 acetylation (N-myristolyation) site were predicted [42]. 
Both these posttranslational modifications can induce an acidic shift in pI [44-46]. Such an 
acidic shift can be extensive in small basic proteins [46], such as the basic subunit of Ana o 2. 
Also other posttranslational modifications or a combination of different posttranslational 
modifications may have contributed to the large variation in protein isoelectric point. 
Western blotting of this 2D electrophoresis sample (Figure 4.4F) showed binding of IgE to all 
protein spots of the acidic subunit, but not to all protein spots of the basic subunit: IgE of the 
plasma pool used in this study, did not bind to the proteins in spot 21-23, and spot 34-38 
while these proteins were clearly present. Possibly, these isoforms of the Ana o 2 basic 
subunit differ in their amino acid sequence in the epitope region. For different 
recombinantly produced protein isoforms from hazelnut and birch pollen (Cor a 1, Bet v 1), 
patient-specific variation in IgE binding patterns were reported [47, 48]. Perhaps, also in this 
experiment, specificity in IgE binding from different plasma samples, for specific isoforms of 
the protein as represented in spot 21-23, 34, and 35-38, can explain the observations. Since 
multiple epitopes are present on Ana o 2 [3], the difference between the protein isoforms 
might reflect a combination of differences in primary protein structure and variation in 
posttranslational processing. Alternatively, it is also possible that during the purification of 
Ana o 2, non-allergenic proteins of the same molecular weight were co-purified, showing up 
on the 2D electrophoresis gel at spot 21-23 and spot 34-38.  
 
Ana o 3 (Figure 4.4C) appeared as 8 protein spots, 4 of 10kDa and 4 of 8kDa. The small 
subunit of 6kDa could not be detected on either the 2D gel nor on the western blot of 
purified Ana o 3 while being present in the purified extract as visualized on 1D SDS-PAGE [1]. 
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The pI range of the large subunit of Ana o 3 is relatively small: pH 4.4-5.4 and matches with 
the calculated pI of 4.9. Hence, not much posttranslational or sequential diversity within this 
large subunit is likely. Based on the protein sequence, Ana o 3 has 5 potential 
phosphorylation sites, of which three are present in the protein sequence of the large 
subunit [42]. The small subunit of Ana o 3 has a wide diversity in isoelectric points (pI range 
of 6.4-10.1) based on calculation of the differently truncated isoforms [1]. This wide range of 
isoelectric points might cause that this subunit could not be visualized on 2D gel. On western 
blot (Figure 4.4G) only 4 of the 8 protein spots (spot 40, 41, 44, and 45) bound IgE, this might 
be due to a difference in epitopes of the Ana o 3 isoforms, specificity of the plasma samples, 
or impurities in the protein sample.  
 
 
Figure 4.5 Total protein stain of 2D electrophoresis gel of the Ghana raw cashew nut protein extract. 
Indicated are areas and spots with presumed isoforms of Ana o 1, 2 and 3. The molecular weight 
standard (in kDa) is indicated on the left of the gel. 
 
On the 2D electrophoresis gel in Figure 4.4D and western blot in Figure 4.4H, a total protein 
extract of drum-roasted cashew nut proteins from Vietnam is shown. This blot shows the 
same protein spots as the blots of the purified allergens, albeit that no IgE bound to Ana o 3 
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(Figure 4.4H), probably, as too little of this protein was present on this immunoblot and gel 
(Figure 4.4D, H). On 2D electrophoresis gel, drum-roasted cashew nuts from Vietnam have 
relatively low levels of Ana o 3 compared to drum-roasted cashew nuts of other origins, see 
Supplementary information 1D.  
IgE clearly bound the different isoforms of Ana o 1 and Ana o 2. Besides the previously 
mentioned protein spots, IgE also displayed binding to multiple protein spots at ±55kDa 
(Figure 4.4D, H), which is likely the complete Ana o 2 monomer of 53kDa that is lost in the 
purification of Ana o 2 as it is not visible on either 1D [1] or 2D electrophoresis (Figure 4.4B, 
3F).  
When comparing all 31 2D electrophoresis gels to each other (Supplementary information 1) 
all tentatively identified isoforms of Ana o 1, 2 and 3 were present in each of the protein 
extracts, indicating no difference in presence of the isoforms of Ana o 1, 2 or 3 in cashew 
nuts of different origins or after exposure to different heat treatments. The spot intensity 
was calculated for the protein isoforms of Ana o 1, 2 and 3. In line with the results of 1D 
electrophoresis, no significant differences were detected between the different cashew nut 
origins (p>0.5). However, for the different heat treatments the quantities of the three 
allergens did differ; levels of Ana o 1 were significantly lower in steamed cashew nut protein 
extracts compared to fried cashew nut protein extracts (p=0.01). This difference in quantity 
of Ana o 1, that was also detected on 1D electrophoresis (Figure 4.1, Table 4.3), is due to 
differences in color intensity of spot 6-9. Fried cashew nut protein extracts showed higher 
levels of Ana o 2 than raw (p=0.02) and steamed (p=0.04) cashew nut protein extracts on 2D 
electrophoresis. Levels of Ana o 3 were significantly higher in fried cashew nut protein 
extracts compared to raw (p=0.00), steamed (p=0.00), and drum-roasted (p=0.04) cashew 
nut protein extracts. This is opposite of what was determined based on 1D electrophoresis. 
This discrepancy may be explained by the absence of the small subunit in the 2D 
electrophoresis gels while it is present on 1D electrophoresis.  
Cashew nut protein profiles could be clustered per heat treatment and not per origin by 
means of PCA plot (Figure 4.6). Clustering of the groups was caused by the spots of Ana o 2 
for the raw and the drum-roasted cashew nuts, while the combined protein spots of Ana o 1, 
2 and 3 divided the steamed from the fried cashew nut group. Especially the raw cashew nut 
group stands out with minimal overlap from the other heat treatment groups. This PCA plot 
supports the statistical analysis of the 2D SDS-PAGE described above.  
 
The differences in allergen quantity between the differently heated cashew nuts, as 
detected by 2D electrophoresis, can have multiple explanations. As described above, the 
heating steps may have caused changes in protein structure (e.g. aggregation) and protein 
solubility or extractability. Additionally, the tentative identification of the Ana o 1, 2 and 3 
isoforms was based on the 2D electrophoresis of the purified allergens. The purification 
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process could have been selective for certain allergen isoforms or could still contain protein 
impurities that might influence the current protein isoform identifications. However, as the 
2D electrophoresis patterns are highly similar between the purified allergens and the total 
cashew nut protein extracts on both gel and western blot, it is expected that no isoforms 
were missed during protein purification. Still, protein sequencing should confirm these 
tentative protein isoform identifications.  
 
Figure 4.6 PCA plot of spot intensities of Ana o 1, 2 and 3 on all 31 2D electrophoresis gels of cashew 
nut proteins from cashew nuts of diverse origins and subjected to different heat treatments. Raw (R, 
green diamonds), steamed (S, yellow circles), fried (F, red squares) and drum-roasted (D, blue 
triangles) cashew nut samples originating from Benin (Benin), Brazil (Brazi), Ghana (Ghana), India 
(India), Ivory Coast (Ivory), Mozambique (Mozam), Tanzania (Tanza) and Vietnam (Vietn) are shown. 
Grouping per heat treatment (green line raw, yellow line steamed, red line fried blue line drum-
roasted cashew nut) by Canoco5. Arrows correlate to the position of the cashew nut values in the PCA 
plot. The arrows are derived from the data of spot 1-9 (Ana o 1, arrow 1), spot 10-20 (acidic subunit 
of Ana o 2, arrow 2), spot 21-38 (basic subunit of Ana o 2, arrow 5-15), and spot 39-46 (Ana o 3, 
arrow 4). 81.7% of the total variation can be explained by this PCA plot. 
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In vitro gastric digestion 
A protein extract (ammonium bicarbonate extraction buffer, prepared under non-denaturing 
and non-reducing conditions) from cashew nuts from Vietnam was digested by pepsin for 60 
minutes as shown in Figure 4.7A. Before addition of the pepsin (Figure 4.7A, t=0, lane 1-4), 
Ana o 1 (50kDa), Ana o 2 (53, 30, 21kDa) and Ana o 3 (10, 8, 6kDa) were all present in the 
protein extracts. In the higher molecular weight range some differences were detected 
between the four heat treatments of the cashew nut protein extracts (Figure 4.7A lane 1-4). 
Multiple high molecular weight proteins (>60kDa) were present in the raw cashew nut 
protein extract but not in the steamed, fried or drum-roasted cashew nut protein extracts. 
One protein band of 72kDa seems to be absent only in the steamed cashew nut protein 
extract. 
 
These differences in the protein extracts were observed repeatedly for multiple extractions 
and for cashew nuts of different origins. The protein electrophoresis profiles (Figure 4.7A, 
lane 1-4) are different from the 1D electrophoresis results of urea-extracted protein (Figure 
4.1 A-D, lane 8). The increased solubility of the high molecular weight (>60kDa) proteins in 
the urea buffer is probably caused by the higher pH and the denaturing effect of the urea 
buffer [35]. The decreased solubility of high molecular weight proteins after heat treatments 
is similar to what has been observed before in roasted walnuts [36].  
After 60 minutes of pepsin digestion (Figure 4.7A, lane 5-8), protein bands of 35kDa (pepsin), 
10, 8 and 6kDa (molecular weights corresponding to Ana o 3) were visible, as well as a 5kDa 
band that was not detected on SDS-PAGE before digestion. This 5kDa protein likely consists 
of a mixture of peptides from multiple pepsin-digested proteins. Ana o 1 and 2 were 
degraded after 60min incubation with pepsin. This result indicates that Ana o 3 is more 
resistant to pepsin proteolysis than Ana o 1 and 2, as described before by Mattison et al. 
[13]. Also in other nuts and seeds the resistance of 2S albumin proteins to pepsin digestion 
has been shown [49-51]. The heat treatments do not seem to influence the digestibility of 
Ana o 3.  
 
Besides digestion of non-reduced non-denatured heat-treated cashew nut proteins, a small 
experiment was performed digesting urea-extracted cashew nut proteins. These reduced 
denatured proteins were washed in an SGF (simulated gastric fluid) buffer to remove the 
urea and DTT, which interfere with pepsin activity. As shown in Figure 4.7B, Ana o 1 and 2 
were again fully degraded after 60minutes digestion with pepsin, similarly as seen for the 
native protein extracts. In contrast to native Ana o 3, reduced and denatured Ana o 3 was 
largely degraded by pepsin. Only a 7kDa protein remains. As DTT reduces disulfide bridges 
and has been shown to thereby disrupt the alpha helical conformation of Ana o 3 [13] this 
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difference in digestibility between native and reduced Ana o 3 highlights the importance of 
the disulfide bonds and protein conformation in pepsin resistance.  
 
Figure 4.7 Total protein stain on SDS-PAGE of raw (1, 5, 9, 10), steamed (2, 6), fried (3, 7) and drum-
roasted (4, 8) non-reduced (A) and reduced (B) cashew nut proteins from Vietnam before (T=0, lane 1-
4, lane 9) and after (t=60, lane 5-8, lane 10) 60min pepsin digestion. The molecular weight standard 
(in kDa) indicated on the left for SDS-PAGE A and on the right for SDS-PAGE B. [ indicates the high 
molecular weight region (>60kDa) varying between the different heat treatments, * indicates the 
72kDa protein that is absent in the protein extract of steamed Vietnam cashew nuts, arrows indicate 
the cashew nut allergens Ana o 1, 2 and 3. 
 
Micro-heterogeneity of Ana o 3 
No major difference in micro-heterogeneity was detected between the raw cashew nuts of 8 
different origins (Supplementary information 2). As reported earlier [1], Ana o 3 consists of a 
large subunit of 10 and 8kDa, and a small subunit of 6kda when visualized on reducing SDS-
PAGE. The large subunit displays minimal C-terminal micro-heterogeneity while the small 
subunit displays both N- and C-terminal micro-heterogeneity. The highly similar pattern of 
Ana o 3 micro-heterogeneity in cashew nuts of 8 different origins indicates a high degree of 
specificity of this N- and C-terminal micro-heterogeneity. This high degree of similarity in the 
cashew nut genome, post-translational modification process or shift in cleavage site matches 
with the overall high degree of similarity between the different origins of the cashew nuts 
studied here.  
In the present study, we have compared cashew nuts of 8 origins, and subjected (in-shell) to 
three different heat treatments. This is the first study on the electrophoresis profile of 
cashew nuts that have been heat-treated in-shell, a treatment that is always applied 
industrially to cashew nuts prior to de-shelling. A summary of the presented data regarding 
Ana o 1, 2 and 3 is shown in Table 4.4. This table shows the protein characteristics of Ana o 
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1, 2 and 3 after 1D and 2D electrophoresis of protein extracts from cashew nuts from 
different origins and subjected to different heat treatments. Minimal differences (maximum 
3.1%) were detected in total protein content between cashews from different origins. Based 
on 1D and 2D electrophoresis no difference in the Ana o 1, 2 and 3 content of cashew nuts 
from these 8 different origins could be detected. Even a very specific protein characteristic, 
namely the micro-heterogeneity of Ana o 3, was highly similar between the cashew nuts of 
different origins. Cashew nut trees were distributed from Brazil to India and Mozambique in 
the 16th century [52]. In this short time period of 500 years limited to no variation in cashew 
nut allergens has occurred between these populations of cashew nut trees, as based on SDS-
PAGE and 2D electrophoresis. Apparently, possible differences in soil or climate also did not 
strongly affect the quantities of Ana o 1, 2 and 3 in these cashew nuts.  
 
Table 4.4 Overview of protein and isoform characteristics of Ana o 1, 2 and 3 as based on 1D and 2D 
electrophoresis. Significant effects (*p<0.05, One-Way ANOVA) of heat treatments are indicated for 
raw (R), steamed (S), fried (F), and drum-roasted (D) cashew nut protein extracts. The small subunit of 
Ana o 3 is not detectable on 2D electrophoresis gel (-).  
Characteristics Ana o 1 
Ana o 2 Ana o 3 
Acidic 
subunit 
Basic 
subunit 
Large 
subunit 
Small 
subunit 
1
D
 ele
ctro
p
h
o
resis 
Molecular weight, reduced (kDa) 50 30 21 10, 8 6 
Percentage present in urea protein 
extract 
4.1±0.9% 51.5±4.9% 25.4±3.9% 
Present after heat treatment* 
S<R, F, D 
F<D 
R<S, F, D 
D<S 
F<R, D 
Glycated/glycosylated 
Only visible when 
purified [1] 
No No 
Pepsin digestion resistance, 60min, 
400μg native protein + 76μg pepsin 
Degraded Degraded Resistant 
Pepsin digestion resistance, 60min, 
400μg denatured reduced protein 
+ 76μg pepsin 
Degraded Degraded Degraded 
2
D
 ele
ctro
p
h
o
resis 
pI calculated 5.6 5.7 8.9 4.9 6.4-10.1 
pI based on 2D gel electrophoresis 5.2-5.8 
5.2-
6.3 
5.2-9.3 
4.4-
5.4 
- 
Number of isoforms 9 11 18 8 - 
Number of IgE reactive isoforms 9 11 11 4 - 
Present after heat treatment* S<F F>R, S 
F>R, 
S, D 
- 
 
Only small differences were detected between cashew nut proteins of cashew nuts 
subjected to different heat treatments. On both 1D and 2D electrophoresis, the quantity of 
extracted Ana o 1 was lower in steamed cashew nuts compared to fried cashew nuts. The 
quantity of extracted Ana o 3 was, for both 1D and 2D electrophoresis, lower in fried cashew 
nuts compared to raw and drum-roasted cashew nuts. No difference in glycation, 
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digestibility or IgE binding was detected between cashew nuts subjected to different heat 
treatments. As the cashew nuts studied here were heat-treated within the shell, a step that 
occurs prior to the final roasting/frying step, most likely more extreme differences can be 
obtained when focusing on these secondary heat treatment steps as shown by Mattison et 
al. [32]. In further research, cellular studies such as a basophil activation test or RBL cell 
assay might be useful in order to detect possible effects of heat treatments on cashew nut 
proteins on cross-linking of receptor-bound IgE. 
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Supplementary information 
 
 
Figure 4.S1A Total protein stain of 2D electrophoresis of raw cashew nut protein extracts from Benin 
(A), Brazil (B), Ghana (C), India (D), Ivory Coast (E), Mozambique (F), Tanzania (G), Vietnam (H). The 
molecular weight standard (in kDa) is indicated on the left of the gels.  
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Figure 4.S1B Total protein stain of 2D electrophoresis of steamed cashew nut protein extracts from 
Benin (A), Brazil (B), Ghana (C), India (D), Ivory Coast (E), Mozambique (F), Vietnam (H). The molecular 
weight standard (in kDa) is indicated on the left of the gels.   
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Figure 4.S1C Total protein stain of 2D electrophoresis of fried cashew nut protein extracts from Benin 
(A), Brazil (B), Ghana (C), India (D), Ivory Coast (E), Mozambique (F), Tanzania (G), Vietnam (H). The 
molecular weight standard (in kDa) is indicated on the left of the gels.  
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Figure 4.S1D Total protein stain of 2D electrophoresis of drum-roasted cashew nut protein extracts 
from Benin (A), Brazil (B), Ghana (C), India (D), Ivory Coast (E), Mozambique (F), Tanzania (G), 
Vietnam (H). The molecular weight standard (in kDa) is indicated on the left of the gels.  
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Abstract 
This paper describes the recombinant expression of rAna o 1, 2 and 3 by P. pastoris. Like the 
native allergens, rAna o 1 is glycosylated, rAna o 2 and 3 are not. All three recombinant 
proteins are produced as a mixture of complete and truncated or post-translationally 
cleaved polypeptides, of which some N-terminal polypeptides are lost during the purification 
process. Despite the truncation of some of the proteins, all three recombinant allergens 
were IgE reactive as shown by inhibition western blot. 2D electrophoresis showed that rAna 
o 1 and 3 are subjected to only minor posttranslational modifications, while rAna o 2 is more 
extensively modified by P. pastoris.  
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Introduction 
Native, and recombinantly produced allergens have been proven valuable tools in allergy 
diagnostics. The usefulness of pure allergens has been well recognised in studies focussed on 
cross-allergenicity of related allergens [1], patient population characterization via IgE binding 
[2, 3], protein biochemical characterization (glycation [4], heat stability [5], digestibility[6]), 
and the study of (conformational) epitopes [7]. Allergens can either be purified directly from 
the food source or recombinantly produced in expression hosts like bacterial, yeast, insect or 
human cells. Recently, we have described the purification of the three major cashew 
allergens Ana o 1, 2 and 3 [8]. The purity of these allergens was high (96%, 93%, 99% 
respectively as based on SDS-PAGE analysis), however, impurities can contain other allergens 
(e.g. contamination of Ana o 1 with Ana o 2) or other cashew nut proteins. Using a 
recombinant production system this potential contamination is avoided.  
Ana o 1, 2, and 3 have been recombinantly produced in BL21 (DE3) E. coli by Wang and 
Robotham et al. [9-11]. The resulting 55 and 65kDa rAna o 1 (obtained from 2 colonies, 
transformants differing in start site), 52kDa (and 120kDa dimer) rAna o 2, and 14kDa rAna o 
3 were used to identify the native cashew allergens. The choice for recombinant allergen 
production in E. coli is common in the tree nut allergen field. As described by Willison et al. 
[12], most (25/27) tree nut allergens are recombinantly produced by E. coli, while only two 
allergens (Brazil nut Ber e 1, and hazelnut Cor a 8) were produced in Pichia pastoris. 
However, E. coli is known for its inability to perform post-translational modifications like 
disulphide bond formation and glycosylation, except when specific strains are used [13, 14]. 
P. pastoris on the other hand is capable of disulphide bond formation and glycosylation, 
albeit that the glycosylation pattern can differ from that of the native protein [13, 15]. As the 
major allergens from cashew nuts undergo post-translational modifications such as 
glycosylation (Ana o 1 [8]), and disulphide bond formation (Ana o 2 [6], Ana o 3 [8]), we 
chose to produce these three allergens in a P. pastoris expression system.  
In this study we describe the protein characterization of P. pastoris expressed Ana o 1, 2, and 
3. We compare the recombinant allergens to the purified native allergens. The three 
allergens were studied on reducing and non-reducing SDS-PAGE, (inhibition) western blot, 
and by 2D electrophoresis.  
 
Materials and methods  
 
Chemicals 
The AccuPrime pfx polymerase, TOP 10 E. coli cells, pPICzα-A vector, the Fermentas enzymes 
EcoRI, XbaI, Sac I, and T4 DNA ligase, Pichia EasyCompTM kit, Pichia Transformation kit, 
biotin, HisPur Cobalt Spin Columns, MemCodeTM Reversible Protein Stain Kit, anti-c-Myc 
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antibody (R950-25), Mark12TM Unstained Standard, CandyCaneTM glycoprotein molecular 
weight standard, NuPAGE LDS sample buffer, NuPAGE MES SDS running buffer, 10% Bis-Tris 
mini gels, NuPAGE 1mm 4-12% Bis-Tris ZOOM gels, Sypro Ruby Protein Gel Stain, Pro-Q 
Emerald 300 Glycoprotein stain, Pierce™ ECL western blotting substrate were obtained from 
Thermo Scientific, Rockford, IL. The QIAquick PCR purification kit, and the Plasmid Mini and 
Midi kit were purchased from Qiagen, Hilden, Germany. Yeast nitrogen base, potassium 
phosphate, glycerol, sodium phosphate, NaCl, imidazole, β-mercaptoethanol, urea, thiourea, 
DTT, SDS, chaps, Tris, Tween-20, BSA, alkaline phosphatase conjugated goat anti-rabbit 
antibody (A3687), and Sigmafast BCIP/NBT were obtained from Sigma-Aldrich, St. Louis, MO. 
YPD, micro agar, yeast extract, peptone, and sorbitol were obtained from Duchefa 
Biochemie b.v., Haarlem, the Netherlands. The IPG buffer pH 3-11 NL, IPG strips (pH 3-11 
nonlinear), iodoacetamide, and the 2-D Quant Kit were obtained from GE Healthcare, 
Piscataway, NJ. The Precision Plus Protein Dual Xtra Standard and the nitrocellulose 
membrane (0.2μm) were obtained from Bio-Rad, Hercules, CA. Bromophenol blue and 
glycine were purchased from Merck, Darmstadt, Germany. Methanol was purchased from 
Actu-All, Randmeer, the Netherlands, and 30kDa and 3kDa Amicon centrifugal filters were 
obtained from Merck Millipore, Tullagreen, Ireland. Goat anti-mouse HRP (P0447) and 
polyclonal rabbit anti-human IgE (A0094) antibodies were obtained from Dako, Glostrup, 
Denmark.  
 
Gene construction 
The nucleotide sequence of the three allergens were codon optimised for expression in P. 
pastoris and synthesised by BaseClear B.V. (Leiden the Netherlands), based on the 
sequences identified by Wang and Robotham et al.; GenBank number Ana o 1.0101 
AAM73730.2 ; Ana o 2.0101, AAN76862.1; and Ana o 3.0101, AAL91665.1 [9-11]. Start and 
end of the sequences were based on Wang and Robotham et al. [9-11]. For Ana o 1 and 3, 
restriction sites were added, and leader peptides [9-11] were removed by PCR, using the 
primers mentioned below. Ana o 2 cDNA was synthesized without the predicted leader 
sequence. Figure 5.1 and Supplementary information 1 show the synthesised nucleotide 
sequences, the nucleotide sequences obtained by PCR and inserted into a piczα-A vector, 
and the deduced amino acid sequences as expressed by P. pastoris.  
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Figure 5.1. Graphic representation of the Piczα-A vector with inserted DNA, and the recombinant 
proteins as produced and secreted by P. pastoris. 
 
PCR 
For Ana o 1 and 3, synthesised nucleotide sequences were amplified and leader peptides 
were removed by PCR. The following primers were used (Biolegio, Nijmegen, the 
Netherlands): Ana o 1 forward 5’GGGGGAATTCAAGATTGACCCGGAGTTG-3’, Ana o 1 reverse 
5’GGGGTCTAGAAATTCATCAGCACGCC-3’, Ana o 3 forward 
5’GGGGGAATTCTCCATTTACCGAGCCATTG-3’, Ana o 3 reverse 
5’GGGGTCTAGAAAATAAGATGACTGAAACTGACAGC-3’ with EcoRI and XbaI restriction sites 
underlined and GGGG inserted for primer stability. Using an AccuPrime pfx polymerase, 
cDNA was amplified in a Primus 96 plus Thermal Cycler (MWG AG Biotech, Ebersberg, 
Germany), for 2min 95˚C, followed by 30 cycles of 15sec 95˚C, 30sec 57.5˚C, and 2min 68˚C 
for Ana o 1; 2min 95˚C, followed by 5 cycles of 15sec 95˚C, 30sec 56˚C, 1min 68˚C, followed 
by 30 cycles of 15sec 95˚C and 90sec 68˚C for Ana o 3. Amplified cDNA was purified from a 
1% agarose gel by the QIAquick PCR purification kit.  
 
Transformation of Pichia pastoris 
The nucleotide sequence of Ana o 2 was synthesised in a pUC57 vector by BaseClear B.V. and 
by heat-shock inserted into TOP 10 E. coli cells. After overnight growth of the Ana o 2-pUC57 
transformed E. coli, cDNA was isolated using a Plasmid Mini Kit.  
cDNA of Ana o 1, 2 and 3 was cut (EcoRI and XbaI) and ligated (T4 DNA ligase) into a pPICzα-
A vector. TOP 10 E. coli cells were transformed with the plasmid by heat-shock, and zeocin 
resistant transformants were verified by sequencing (BaseClear B.V.). In accordance to the 
protocol of the Pichia EasyCompTM Kit, midiprepped plasmid (Plasmid Midi Kit) was treated 
with restriction enzyme SacI, and, after a heat inactivation step of 20min 65˚C, used for 
transformation into competent P. pastoris cells of strain X33 by use of the EasyCompTM 
Pichia Transformation kit. Transformed cells were plated onto YPDS plates (4% YPD, 2% agar, 
16% sorbitol) containing increasing Zeocin concentrations (100, 250, 500, 750, and 
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1000ug/ml) and three colonies from the 500 and 750ug/ml plates were verified by colony 
PCR.  
 
Expression and purification of recombinant proteins 
The colony expressing most protein out of three colonies was picked for Ana o 1, Ana o 2 
and Ana o 3 and expression was optimized for time and methanol induction. Single colonies 
were grown in 25ml BMGY (BMY (1% yeast extract, 2% peptone, 1.34% yeast nitrogen base, 
4 × 10-5%biotin, 100mM potassium phosphate pH 6) with 1% glycerol) with Zeocin selection, 
at 30˚C for 24hr 230rpm. Subsequently, the cultures were centrifuged (5min 3000g, room 
temperature) and the pellet was re-suspended in 100ml BMMY at an OD600 of 1.0. The 
cultures were grown in BMMY (BMY supplemented with methanol) containing 1% methanol 
for expression during 96hr (rAna o 1, rAna o 2) or 24hr (rAna o 3) at 30˚C 230rpm. During the 
expression period methanol was added to the desirable concentration every 24hr. A control 
colony of empty P. pastoris strain X33 was grown for either 24hr in BMGY+24hr in BMMY or 
24hr in BMGY+96hr in BMMY (the BMMY contained 0.5% methanol as carbon source, higher 
levels than 0.5% was toxic for empty P. pastoris), at 30˚C 230rpm. Supernatant was collected 
by centrifugation at 5000g for 30min at 4˚C, and concentrated in a 50ml 30kDa (rAna o 1, 
rAna o 2) or 3kDa (rAna o 3) Amicon centrifugal filter.  
Recombinantly expressed proteins were purified in 3ml HisPur Cobalt Spin Columns 
according to the manufacturers’ instructions. In short maximally 20mg protein was applied 
onto an equilibrated column (50mM sodium phosphate, 300mM NaCl, 10mM imidazole, pH 
7.4), followed by 30min mixing, washing with equilibration buffer, and elution of the His-
tagged proteins (50mM sodium phosphate, 300mM NaCl, 150mM imidazole, pH 7.4). All 
steps were performed by gravity flow. Eluted His-affinity-purified proteins were 
concentrated in a 0.5ml 3kDa Amicon centrifugal filter.  
 
Protein quantification  
The protein content of the P. pastoris supernatant and the purified recombinant proteins 
was determined by the 2-D Quant Kit according to the manufacturers’ instructions.  
 
1D SDS-PAGE  
Denatured samples containing 5μg protein (10% β-mercaptoethanol in NuPAGE LDS sample 
buffer, 5min 100˚C) were run on SDS-PAGE as described earlier [8]. Mark12TM Unstained 
Standard was used for Sypro Ruby stained gels, CandyCaneTM glycoprotein molecular 
weight standard for Pro-Q Emerald stained gels, and the Precision Plus Protein Dual Xtra 
Standard was used for western blots. Gels were stained o/n using a Sypro Ruby Protein Gel 
Stain for a total protein stain or a Pro-Q Emerald 300 Glycoprotein stain to stain 
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glycoproteins. Imaging and analysis were performed using a Universal Hood III and Image 
Lab 4.1 software (both Bio-Rad).  
Non-Reducing SDS-PAGE was performed as described above, but during the sample 
preparation no β- mercaptoethanol was added.  
 
2D electrophoresis  
IPG strips (pH 3-11 nonlinear) were rehydrated overnight with 8μg protein mixed with 125μl 
rehydration buffer (5.6M urea, 1.6M thiourea, 20mM DTT, 1.6% chaps w/v, a few grains of 
bromophenol blue, and 200x diluted IPG buffer pH 3-11 NL). Isoelectric focussing was 
performed on a protean IEF cell (Bio- Rad): 300V 0.2kvhr linear, 1000V 0.3kVhr rapid, 5000V 
4kVhr rapid, 5000V linear 2kVhr. The focussed strips were reduced for 15min in 50mM Tris, 
20mg/ml SDS, 10mg/ml DTT, 30% glycerol, and a few grains of bromophenol blue. 
Subsequently, the strips were alkylated for 15min in 50mM Tris, 20mg/ml SDS, 25mg/ml 
iodoacetamide, 30% glycerol, and a few grains of bromophenol blue. The strips were run on 
a NuPAGE 1mm 4-12% Bis-Tris ZOOM gel alongside a molecular weight marker (Mark12TM 
Unstained Standard). Electrophoresis was performed at 160V for 55min in NuPAGE MES SDS 
running buffer. Gels were stained o/n with Sypro Ruby Protein Gel Stain according to the 
manufacturers’ instructions.  
 
Western blotting  
Transfer of proteins from 1D and 2D SDS-PAGE gel to a nitrocellulose membrane (0.2μm), 
was performed using a criterion blotter (Bio-Rad) in a cold Tris-glycine buffer (25mM Tris, 
190mM glycine, 0.1% SDS, 20% methanol) for 36min at 70V. Transferred proteins were 
visualised and destained using the MemCodeTM Reversible Protein Stain Kit according to the 
manufacturers’ instructions. Membranes were washed with TBS-T (50mM Tris, 150mM NaCl, 
0.1% Tween-20, pH 7.4), and blocked with 3% BSA in TBS (TBS-T without Tween-20) for 1hr 
at 4 degrees.  
For the c-Myc western blots, after washing with TBST and TBS, the blots were incubated with 
mouse anti-c-Myc antibody, 1:5000 in TBS o/n. Subsequently, the blots were washed with 
TBST and TBS and incubated for 1hr with goat anti-mouse HRP antibody diluted 1:1000 in 
TBS. Next, the blots were washed with TBST and TBS, covered with ECL western blotting 
substrate and images were taken by a Universal Hood III. The antibody control blot was 
performed as described above but with omission of the first antibody, instead incubation 
was performed with TBS.  
For the serum western blots, the blocked membranes were incubated o/n using a serum 
pool diluted 1:5 in TBS, followed by washing in TBST and TBS, and incubating for 1hr using 
polyclonal rabbit anti-human IgE antibody diluted 1:15000. This was followed by washing in 
TBST and TBS and incubating for 1hr using alkaline phosphatase conjugated goat anti-rabbit 
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antibody diluted 1:20.000 in TBS, washing in TBST and TBS, and staining by Sigmafast 
BCIP/NBT for 6min.  
Inhibition western blotting was performed as stated above for serum western blots, 
however, the plasma pool was pre-incubated with 40μg (40μl) His-affinity-purified Ana o 1, 
40μg (100μl) His-affinity-purified Ana o 2, 25μg (50μl) His-affinity-purified Ana o 3, or 40μl 
(equal to the volume of 40μg rAna o 1) His affinity-purified X33 control. Pre-incubation of a 
100μl serum pool with 25-40μg recombinant protein, was performed for 2hr shaking at 
room temperature.  
Analysis of all blots was performed using the Image Lab 4.1 software.  
 
Serum 
The serum pool used for western blotting was composed of 13 sera from cashew-allergic 
patients as diagnosed by a double-blind placebo-controlled food challenge, as described in 
the multicentre prospective study “Improvement of diagnostic methods for allergy 
assessment” with cashew allergy in children as a showcase (trial number NTR3572, medical 
ethical approval number 2012-125, Erasmus Medical Centre Rotterdam) [16]. The plasma 
pool was composed from 3 patients with self-reported cashew nut or tree nut allergy and 
high cashew nut IgE titers. The plasma samples were obtained from PlasmaLab International 
(Everett, WA). Both the serum pool and the plasma pool were obtained by pooling the 
samples in equal volume. For patient characteristics, see Table 5.1.  
 
Protein identification 
Protein identification by MALDI-MS/MS was performed by Alphalyse Denmark as described 
earlier [8].  
 
Table 5.1 Clinical characteristics of the serum and plasma pool used for western blotting. Serum 
samples are from cashew nut allergic subjects diagnosed by double blind placebo controlled food 
challenges [3]. Plasma samples of cashew* and tree nut** allergic subjects obtained from PlasmaLab 
International.  
Serum pool Plasma pool 
patient # sIgE cashew (kU/L) patient # sIgE cashew (kU/L) 
    
1 58.3      1
**
 19.2 
2 100      2
*
 >100 
3 10      3
**
 61.7 
4 32 
 
5 100 
6 32.6 
7 22.5 
8 21.1 
9 11.2 
10 7.9 
11 5.83 
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Results and discussion  
 
Expression and purification of recombinant Ana o 1, 2, 3 
Recombinant Ana o 1, 2 and 3 (rAna o 1, 2, 3) were produced without their leader peptide, 
following the example of Wang and Robotham et al. [9-11]. This was done as previous 
attempts of cloning and protein expression of rAna o 1 and rAna o 3 by P. pastoris failed 
when the leader peptide was present (data not shown). The inability of P. pastoris to 
produce recombinant proteins when the leader peptide is present has been shown before 
[17], and might be explained by hindrance of transcription/translation or instability of the 
protein after production.  
rAna o 1, 2 and 3 were produced in Pichia pastoris and concentrated using a 30kDa (rAna o 
1, 2) or 3kDa (rAna o 3) molecular weight cut-off. The cut-off of 30kDa was chosen for rAna o 
1 and 2 in order to speed up the concentration process and to already remove small proteins 
originating from P. pastoris. The recombinant proteins were purified from the concentrated 
P. pastoris supernatant by His-affinity-purification. The purified proteins were studied on 
reducing and non-reducing SDS-PAGE, (inhibition) western blot, and 2D electrophoresis. The 
expressed proteins will be discussed one by one. An overview of all the results is shown in 
Table 5.2.  
 
Controls 
The P. pastoris control colony, not containing any inserted cashew DNA, was used in order to 
check the purification procedure, and was used as a negative control for the different 
western blots. Figure 5.2A shows the presence of multiple protein bands of 14kDa to 
>200kDa in the P. pastoris supernatant before His-affinity purification. His-affinity 
purification removes all proteins from this extract (lane ctrl). Therefore it is expected that for 
the rAna o 1, 2 and 3 colonies no significant amounts of P. pastoris-specific proteins will 
elute along with the His-tagged rAna o 1, 2 and 3 proteins. As expected [18], the larger 
molecular weight proteins from the P. pastoris supernatant, 50kDa to >180kDa proteins, are 
glycosylated (Figure 5.2B). Figure 5.2C shows no binding of the c-Myc antibody to the control 
samples as no recombinant His- and c-Myc-tagged proteins are produced by this control 
colony. Serum IgE (Figure 5.2D) does bind to a 230kDa P. pastoris protein, however, this only 
occurs in the supernatant and not in the His-affinity purified samples, confirming the 
specificity of the His-affinity purification. As a positive control for the western blots of rAna o 
1, 2 and 3, a total cashew nut protein extract was applied on western blot (Figure 5.2D). In 
this western blot, serum IgE binding to native Ana o 1, 2 and 3 is confirmed: 53kDa 
monomeric Ana o 2, 50kDa Ana o 1, the 20-22kDa basic (small) subunit of Ana o 2, the 33kDa 
acidic (large) subunit of Ana o 2, and the 10 and 8kDa large subunit of Ana o 3 [8]. Finally, in 
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Figure 5.2E an inhibition western blot is shown. A positive total cashew nut protein control is 
included, indicating binding of the plasma IgE to native Ana o 1, 2 and 3. Pre-incubation of 
the plasma IgE with the His-affinity-purified control sample results in a decreased, but not 
completely inhibited, IgE binding to 53kDa Ana o 2 (the complete monomer), 50kDa Ana o 1, 
and a 39kDa protein. No decrease in IgE binding was detected to the acidic and basic 
subunits of Ana o 2 or to Ana o 3. Overall, Figure 5.2 shows by SDS-PAGE and western blot, 
that during the His-affinity purification no significant amount of P. pastoris proteins 
contaminate the His-affinity-purified proteins, and that although some P. pastoris proteins 
(230kDa) bind IgE, these do not contaminate the His-affinity-purified samples.  
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Figure 5.2 Sypro Ruby total protein stain (A), Emerald glycoprotein stain (B), c-Myc western blot (C), 
and serum western blot (D) of 3kDa concentrated P. pastoris supernatant of control colony (P. sup 
ctrl), and His-affinity-purified control (ctrl). Inhibition western blot (F) with IgE binding to a total 
cashew nut protein extract either not inhibited (cashew lane), or inhibited by pre-incubation of the 
plasma pool with an equal volume of His-affinity-purified control as used for inhibition with rAna o 1 
and 2 (Inhibit ctrl lane). The molecular weight in kDa is indicated on the left of the figures, the bold 
numbers on the right of Figure D indicates the protein bands of native Ana o 1, 2 and 3, * in Figure E 
indicates the inhibited proteins.  
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Ana o 1 
Native Ana o 1 is a 7S globulin of 50kDa [8], forming trimers in non-reduced state [19]. 
Recombinantly produced Ana o 1 from E. coli has a molecular weight of 65 and 55kDa, 
depending on the location of the start site [9]. The P. pastoris recombinantly produced Ana o 
1 described in this paper is produced from the same nucleotide sequence as the 65kDa Ana 
o 1 that was expressed in E. coli. When calculated based on the amino acid sequence of the 
expected protein, rAna o 1 is expected to be 62kDa including c- Myc epitope and Histidine 
tag.  
Figure 5.3A shows on reducing SDS-PAGE, that P. pastoris colony rAna o 1 produces a protein 
of 51kDa besides P. pastoris proteins of 14kDa to >200kDa. His-affinity-purified rAna o 1 
contains the same 51kDa protein, as well as several less prevalent proteins of 105 and 
30kDa. MALDI-MS/MS protein identification confirmed the 51kDa protein as Ana o 1, 
matching amino acids from E111 up to the C-terminus, including the Histidine-tag. The 
30kDa protein was also identified as Ana o 1, however, only C-terminal peptides (I202-H537) 
were identified. A 17kDa protein from the P. pastoris supernatant was also identified as Ana 
o 1, however, only N-terminal peptides were identified (Q19-R98). The protein identification 
results are shown in Supplementary information 2. The 51kDa protein was identified as a 
glycoprotein as determined by a glycoprotein stain (Figure 5.3B). Native Ana o 1 is also 
glycosylated [8], however, P. pastoris might glycosylate this protein in a different manner 
[20].  
Non-reduced (Figure 5.3C) rAna o 1 clearly showed higher quantities of the 105kDa protein 
in addition to the 51kDa protein. This 105kDa protein is expected to be a dimeric form of 
rAna o 1, aggregated under non-reducing conditions. Next to these proteins, smaller 
proteins of 25-30kDa are visible, indicating that the 30kDa C-terminal rAna o 1 polypeptide is 
not covalently attached by disulphide bridges, to an N-terminus in non-reducing state.  
On western blot (Figure 5.3D) the anti c-Myc antibody binds to the 105kDa rAna o 1 dimer, 
the 51kDa rAna o 1, and the 30kDa C-terminal rAna o 1, confirming these are either full-
length rAna o 1, or C-terminal rAna o 1. The 17kDa protein does not bind to the anti c-Myc 
antibody, confirming this protein does not contain the C-terminus of rAna o 1.  
On western blot (Figure 5.3E), serum IgE binds to the 51 and 17kDa proteins, confirming the 
immunoreactivity of these proteins. The 105kDa rAna o 1 dimer on the other hand does not 
appear on the serum western blot, likely due to the relatively low abundance of this protein, 
combined with the lower sensitivity of the serum western blot compared to the c-Myc 
western blot. Also the 30kDa C-terminal rAna o 1 is not visible on this serum western blot. 
The relatively weak binding of IgE to the 30kDa C-terminal protein, compared to the stronger 
IgE binding to the 17kDa protein, while both proteins are more or less equally present on 
SDS-PAGE, indicates that, for the sera used, most IgE epitopes are present on the N-terminus 
of rAna o 1.  
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Figure 5.3 Sypro Ruby total protein stain (A), Emerald glycoprotein stain (B), non-reducing Sypro Ruby 
total protein stain (C), c-Myc western blot (D), and serum western blot (E) of 30kDa concentrated P. 
pastoris supernatant of colony rAna o 1 (P. sup rAna o 1), and His-affinity-purified rAna o 1 (rAna o 1). 
Inhibition western blot (F) with IgE binding to a total cashew nut protein extract either not inhibited 
(cashew lane), or inhibited by pre-incubation of the plasma pool with 40μg His-affinity-purified rAna o 
1 (Inhibit rAna o 1 lane). The molecular weight in kDa is indicated on the left of the figures, the bold 
numbers on the right of the figures indicate the protein bands described in Table 5.2, * indicates the 
inhibited protein binding after pre-incubation of the plasma with rAna o 1. 
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As a last experiment the immunoreactivity of rAna o 1 and native Ana o 1 were compared on 
a plasma inhibition western blot, where plasma IgE was inhibited with rAna o 1. Figure 5.3F 
shows that IgE binding to native Ana o 1 (50kDa) is completely inhibited by rAna o 1. This 
inhibition western blot confirms the immunoreactivity of the linear epitopes of rAna o 1, 
matching that of native Ana o 1. 
We have shown that rAna o 1 is glycosylated, and is, on western blot, comparable in 
immunoreactivity to native Ana o 1. However, these results do raise some questions. First of 
all, rAna o 1 is expressed as a 51kDa protein instead of the expected 62kDa. MALDI-MS/MS 
analysis of the 51kDa protein detected mostly C-terminal peptides: all matched peptides  
were found between amino acid E111 and H537, covering 74% of the sequence. Such a 
protein sequence would result in a 48.5kDa protein, very close to the 51kDa detected on 
SDS-PAGE. Protein identification of the 17kDa protein resulted in a matched protein 
sequence (Q19-R98) of only 9.6kDa. Hence, it is likely that not all the peptides were 
identified. This N-terminal 17kDa protein detected in the P. pastoris supernatant might be 
the N-terminus belonging to the C-terminal 51kDa protein. A fraction of these two subunits 
are bound to one another by P. pastoris, as the 17kDa would otherwise be discarded during 
the 30kDa concentration step, as well as during the His-affinity purification of rAna o 1.  
 
It can be seen on reducing SDS-PAGE (Figure 5.3A) and serum western blot (Figure 5.3E), 
that a large amount of the 17kDa protein is lost during purification, indicating that the 
principal fraction of the 51 and 17kDa proteins were not attached to each other during His-
affinity purification. Like other 7S globulins, native Ana o 1 is not processed into subunits, 
but is produced as one 50kDa protein. E. coli-produced Cor a 11, a 7S vicilin from hazelnut 
was produced as one full-length protein [21]. 
 
 At this point it is still unclear where the 30kDa C-terminal polypeptide fits in. Possibly, P. 
pastoris does not only cleave the 62kDa protein into two subunits of 51 and 17kDa, but also 
cleaves the 51kDa C-terminal protein at another site, resulting in a 30 and 25kDa protein. It 
is also possible that these proteins are the product of proteolytic cleavage during the 
production or purification process.  
Overall it can be stated that the production of rAna o 1 in P. pastoris leads to a different 
product, when compared molecularly, as can be obtained from cashew nuts. No comparison 
can be made with the E. coli-produced rAna o 1 as no SDS-PAGE results were shown in the 
paper by Wang et al., only a total cashew nut protein western blot in which the serum was 
pre-incubated (inhibited) with rAna o 1 [9]. Truncated, or proteolytically cleaved expression 
of 7S globulins (E.coli-produced rAha h 1), has been described before [22, 23] and was 
suggested to have been caused by inefficient translation of the protein due to rare codons, 
or due to numerous cysteine residues [23].  
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A graphic representation of the various recombinantly produced protein polypeptides, as 
well as of the native proteins, are presented in Figure 5.6. As based on SDS-PAGE results, in 
P. pastoris, rAna o 1, is produced as a two connected 51 + 17kDa subunits, from which the 
51kDa subunit is partly cleaved into 30 + 25kDa polypeptides. The occurrence of this 7S 
globulin in the form of subunits is different from native Ana o 1. However, despite these 
differences between the cashew native and the P. pastoris recombinant Ana o 1 proteins, IgE 
binding did occur to both proteins. It should be kept in mind that the 17kDa protein did bind 
the serum IgE very strongly, and that a considerable amount of this specific polypeptide is 
lost during either the concentration or the purification step.  
 
Ana o 2  
Ana o 2, the 11S globulin from cashew nut, is a 53kDa protein that is composed of a small 
(basic) subunit of about 21kDa, and a large (acidic) subunit of about 33kDa [8, 10]. In native 
state this protein forms hexameric structures [19]. Cloning of Ana o 2 cDNA into an E. coli 
expression system yielded a 52kDa protein, although no SDS-PAGE data was shown to 
confirm the protein size [10]. Here, recombinant Ana o 2 was produced in a P. pastoris 
expression system.  
In our experiments, the expected molecular weight of the recombinant Ana o 2 protein is 
53kDa, with possible 30 and 24kDa subunits (calculated from [10]). Figure 5.4A shows the 
proteins produced by P. pastoris, and the purified fraction after His-affinity purification. 
Again it can be seen that P. pastoris produced proteins of 14kDa to >200kDa, with the 51-
55kDa protein bands being most pronounced. His-affinity purification selectively purifies 
these 51-53kDa proteins, as well as proteins of 41, 39, 36, and 25-30kDa, from the P. pastoris 
supernatant. The 55, 51, and 36kDa proteins were analysed by MALDI-MS/MS. Both the 55 
and 51kDa proteins were identified as rAna o 2, matching peptides from D171- R416. The 
36kDa protein was also identified as rAna o 2, matching peptides from C45-R416. However, 
this 371 amino acid-long polypeptide sequence would result in a 42kDa protein (C45-R416),  
or a 48kDa protein including the complete N-terminus (C45-H467). As most sequence 
matches were found in the C-terminus of the protein sequence, it is expected that this 
36kDa protein is a C-terminal polypeptide of rAna o 2. 
Native Ana o 2 is not glycosylated as shown by glycoprotein staining [8]. P. pastoris 
recombinant Ana o 2 is also not glycosylated as shown in Figure 5.4B. The glycoprotein stain 
does show presence of 150 and >180kDa glycosylated proteins, in both the P. pastoris 
supernatant and the His-affinity-purified sample. As these proteins are present in low 
quantity on the SDS-PAGE of Figure 5.4A, these proteins must be highly glycosylated to be 
stained so dark in Figure 5.4B. These proteins are likely impurities in the His-affinity-purified 
rAna o 2 sample. The 55, 51, 36, and 25-30kDa proteins are not glycosylated.  
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Figure 5.4 Sypro Ruby total protein stain (A), Emerald glycoprotein stain (B), non-reducing Sypro Ruby 
total protein stain (C), c-Myc western blot (D), and serum western blot (E) of 30kDa concentrated P. 
pastoris supernatant of colony rAna o 2 (P. sup rAna o 2), and His-affinity-purified rAna o 2 (rAna o 2). 
Inhibition western blot (F) with IgE binding to a total cashew nut protein extract either not inhibited  
(cashew lane), or inhibited by pre-incubation of the plasma pool with 40μg His-affinity-purified rAna o 
2 (Inhibit rAna o 2 lane). The molecular weight in kDa is indicated on the left of the figures, the bold 
numbers on the right of the figures indicate the protein bands described in Table 5.2. >180 indicates 
the >180kDa impurities in the His-affinity-purified rAna o 2 sample * indicates the inhibited protein 
binding after pre-incubation of the plasma with rAna o 2. 
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Non-reduced (Figure 5.4C) rAna o 2 shows a higher abundance of a 110kDa protein, which is 
most likely an aggregated form (dimer) of rAna o 2. Beside this possible dimer, the 51-55kDa 
proteins are still clearly visible, as well as proteins of 35-38kDa, 25, 20, and 17kDa.  
 Several western blots were performed with rAna o 2. First of all a western blot using an anti 
c-Myc antibody was done (Figure 5.4D). In both the P. pastoris supernatant and the His-
affinity-purified rAna o 2 sample, the same protein bands are bound by the anti c-Myc 
antibody: 110, 55, 36, 30, 25, 23kDa proteins. Subsequently, a serum western blot (Figure 
5.4E) shows IgE binding to a 230kDa P. pastoris protein, as already shown for the control 
sample of Figure 5.2D. In the His-affinity-purified sample this 230kDa protein is not present 
and therefore does not bind the serum IgE. The serum IgE does bind to the 55 and 51kDa 
rAna o 2 proteins, as well as to the 36, 30, 25 and 23kDa proteins that were also detected on 
the c-Myc western blot. This western blot confirms the IgE reactivity of the recombinantly 
produced Ana o 2.  
Lastly, in Figure 5.4F an inhibition western blot is shown, in which a plasma pool was pre-
incubated with rAna o 2 before western blotting with a total cashew nut protein extract. 
Compared to the non-inhibited cashew nut lane, the rAna o 2-inhibited lane shows strongly 
reduced IgE binding to the 21 and 33kDa Ana o 2 subunits, as well as complete inhibition of 
IgE binding to the 53kDa monomeric Ana o 2. Also decreased IgE binding to a 39kDa protein 
and to Ana o 1 was detected, similar as observed in the control sample of Figure 5.2E, and 
therefore likely caused by the impurities present in the rAna o 2 sample. The inhibition 
western blot indicates that the IgE reactivity of rAna o 2 and native Ana o 2 are highly 
comparable on western blot.  
The characterisation of rAna o 2 from P. pastoris brings about some confusion due to the 
proteins of different polypeptides produced by P. pastoris. First of all it is clear that the 
55kDa protein is the complete rAna o 2 protein. Besides this complete protein several 
truncated rAna o 2 proteins are produced by P. pastoris (Figure 5.6B): 51, 36, 30, 25, and 
23kDa proteins, of which the 36kDa protein was identified as a C-terminal polypeptide of 
rAna o 2. All these proteins contain the C-terminus of rAna o 2, as they are purified via their 
Histidine-tag, and contain the c-Myc epitope as shown by western blotting. In cashew nut, 
the 11S globulin Ana o 2 is produced as a single polypeptide, which is subsequently linked by 
disulphide bridges, and cleaved by asparaginyl endopeptidase [24-26]. The cleavage site of 
this enzyme in native Ana o 2 is after the amino acids D257, N258. In the protein sequence 
of rAna o 2 four sites are present in which an asparagine is preceded by an aspartic acid. 
Possibly, proteolytic enzymes from P. pastoris not only cleave the protein at the designated 
site (N258), but also at these other sites (N24, N214, N344). The C-terminal protein sizes of 
such possibly asparaginyl endopeptidase truncated proteins would be 51, 29, 24 and 14kDa, 
matching with the detected C-terminal polypeptides of 51, 30, and 25/23kDa. Asparaginyl 
endopeptidase cleaves specifically after an asparagine but is not specific towards the amino 
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acid following this asparagine amino acid [27]. Therefore the 36kDa protein might originate 
from a cleavage site at N154 (36kDa C-terminal polypeptide). Similar truncation of a 
recombinantly produced 11S globulin, walnut Jug r 4 in E. coli, has been described before 
[28]. It is clear that the C-terminal polypeptides have not been connected to their N-terminal 
counterpart by disulphide bridges, as occurs in native Ana o 2. This can be concluded as 
these N-terminal polypeptides were not detected on the serum western blot, nor on (non-
reducing) SDS-PAGE. It is unclear why P. pastoris does not connect the N- and C-terminal 
polypeptides, while it is capable of doing so [13, 15].  
All the C-terminal polypeptides are bound by serum IgE on western blot, indicating presence 
of epitopes on these truncated C-terminal rAna o 2 polypeptides. However, only the 55kDa 
protein represents the complete rAna o 2 protein, and as several different N-terminal 
polypeptides are missed during the His-affinity purification of the P. pastoris supernatant, 
the N-terminal epitopes are underrepresented. Next to this, also the conformational folding 
of the proteins is expected to differ from native Ana o 2, thereby possibly affecting the 
conformational epitopes. While native Ana o 2 is composed of two subunits, linked together 
by disulphide bonds [29], a part of the native protein is produced as a 53kDa monomeric 
protein. However, rAna o 2 is produced mostly in monomeric form, and only a part is 
processed into subunits. This difference in subunit structure will change the conformational 
folding of this protein, potentially affecting the conformational epitope present on both 
native and E. coli or P. pastoris recombinantly produced Ana o 2 [30].  
 
Ana o 3  
As shown in Figure 5.5A, the recombinant expression of Ana o 3 in P. pastoris results in the 
production of proteins of 12kDa to >200kDa. Of these proteins, only an 18kDa protein and a 
16kDa protein are purified by His-affinity purification. The expected molecular weight of 
rAna o 3 is 17.3kDa, with possible subunits of 6 and 11kDa (based on [8], and calculated 
from the protein sequence cloned into P. pastoris as described in Supplementary 
information 1). Both the 18kDa protein and the 16kDa protein were identified as Ana o 3 by 
MALDI-MS/MS (A7-R104), see Supplementary information 2.  
The high molecular weight proteins (>50kDa) from P. pastoris are glycosylated (Figure 5.5B). 
The 18 and 16kDa recombinant proteins are not glycosylated. The nucleotide sequence of 
Ana o 3 does contain one putative N-glycosylation motif [8], however, this N-glycosylation 
motif is present in the leader peptide, which is not included in to the recombinant protein. 
Native Ana o 3 is also not glycosylated [8].  
In order to verify the presence of disulphide bridges in the recombinant Ana o 3 protein, a 
non-reducing SDS-PAGE was performed (Figure 5.5C). Native Ana o 3 has a large and a small 
subunit, bound together by disulphide bridges to form a protein of 12.6kDa. The molecular 
weight of recombinant Ana o 3 does not differ between a reducing and non-reducing SDS-
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PAGE, indicating that rAna o 3 is not proteolytically cleaved into a small and a large subunit, 
and that no disulphide bonds are present in rAna o 3.  
Figure 5.5D shows a western blot using a c-Myc antibody, targeting the c-Myc epitope 
located C-terminally in the recombinant proteins. In the P. pastoris supernatant, the c-Myc 
antibody only binds the 18 and 16kDa rAna o 3 proteins, indicating that no recombinant 
proteins containing a c-Myc epitope are discarded during the purification step. In the His-
affinity-purified rAna o 3 sample, the c-Myc antibody does not only bind to the expected 18 
and 16kDa proteins, but also to a 12kDa protein. This 12kDa protein did not appear before 
on SDS-PAGE, however, the c-Myc western blot is more sensitive than SDS-PAGE. It is 
possible this C-terminal protein is produced by P. pastoris at relatively low levels. This 
protein might be produced without (part of) the N-terminus like described for rAna o 2, or it 
might be proteolytically cleaved after production of the complete protein. However, due to 
the low quantity on SDS-PAGE, the 12kDa protein it could not be analysed by MALDI-MS/MS. 
Also the relative amount of this protein, compared to the amount of 18 or 16kDa proteins, 
could not be calculated as it is not visible on SDS-PAGE. Further analysis by mass 
spectrometry could give more information.  
Figure 5.5E shows IgE binding of a serum pool of cashew allergic patients to both the 18 and 
the 16kDa protein of rAna o 3, confirming the immunoreactivity of these recombinant Ana o 
3 proteins. The 12kDa protein that is visible in the c-Myc western blot, is not visible in the 
serum western blot. This protein either does not bind IgE, or is present in too small quantity 
to be visualised on this western blot. Besides binding of IgE to recombinant Ana o 3 in a 
standard serum western blot, also an inhibition western blot was performed. For this 
inhibition western blot, a plasma pool from cashew nut and tree nut allergic patients was 
pre-incubated with His-affinity-purified rAna o 3, in order to analyse if rAna o 3 could bind all 
IgE in this serum pool, and therefore shows the same immunoreactivity on western blot as 
native Ana o 3. Indeed Figure 5.5F shows that, after inhibition, no IgE binds to native Ana o 3 
(10, 8kDa). This indicates that not only does rAna o 3 bind IgE, but also that rAna o 3 
contains the same linear epitopes and has comparable immunoreactivity on western blot as 
native Ana o 3.  
 
It can be concluded that P. pastoris expresses rAna o 3 as 18 and 16kDa proteins (Figure 
5.6C), that can be His-affinity purified, and are, on western blot, immunologically 
comparable to native Ana o 3. It is unclear why rAna o 3 is expressed as both an 18kDa 
protein and as a 16kDa protein. Possibly two different start sites for DNA transcription are 
used by P. pastoris. This has been reported for the expression of the 2S albumin from brazil 
nut, Ber e 1, in P. pastoris [31]. For Ber e 1, approximately 20% of the recombinant protein 
produced was a ±4kDa smaller protein than the expected 14kDa protein [31]. For rAna o 3,  
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Figure 5.5 Sypro Ruby total protein stain (A), Emerald glycoprotein stain (B), non-reducing Sypro Ruby 
total protein stain (C), c-Myc western blot (D), and serum western blot (E) of 3kDa concentrated P. 
pastoris supernatant of colony rAna o 3 (P. sup rAna o 3), and His-affinity-purified rAna o 3 (rAna o 3). 
Inhibition western blot (F) with IgE binding to a total cashew nut protein extract either not inhibited 
(cashew lane), or inhibited by pre-incubation of the plasma pool with 25μg His-affinity-purified rAna o 
3 (Inhibit rAna o 3 lane). The molecular weight in kDa is indicated on the left of the figures, the bold 
numbers on the right of the figures indicate the protein bands described in Table 5.2, * indicates the 
inhibited protein binding after pre-incubation of the plasma with rAna o 3.  
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P. pastoris produces ±15% 18kDa protein and ±85% of the 16kDa protein. Confirmation of a 
difference in start site between the two proteins could be provided by N-terminal 
sequencing of the proteins. No comparison can be made to the E.coli-produced rAna o 3 as 
in this study by Robotham et al. no SDS-PAGE or western blot data are shown besides an 
inhibition western blot [11]. Native Ana o 3 is produced as a large and a small subunit, linked 
together by disulphide bonds [8, 11]. Here, P. pastoris-produces rAna o 3 as the complete 
protein, and as an N-terminally truncated protein. rAna o 3 is apparently not processed into 
subunits as it would be by the cashew tree. Production of a complete 2S albumin, not 
processed into subunits, has been shown before for walnut Jug r 1 and a hazelnut 2S 
albumin, produced in E. coli [32, 33]. It is unclear if E.coli-produced rAna o 3 was cleaved into 
subunits or not [11].  
 
Table 5.2 Overview of protein characteristics of recombinant Ana o 1, 2, and 3 in P. pastoris 
supernatant and His affinity-purified samples. Molecular weight indicated in kDa, - indicates that the 
method was not applied to that sample, (..) indicates the number of spots detected on 2D gel. 
Methods rAna o 1 rAna o 2 rAna o 3 
Supernatant His-purified Supernatant His-purified Supernatant His-
purified 
Calculated 62 53 (30+24kDa subunits) 17 (6+11Da subunits) 
Reducing  
SDS-PAGE 
51,  
14->200 
105, 51, 30 51-53, 
14->200 
51-53, 41, 39, 36, 
25-30 
16, 10,  
14->200 
18, 16 
Glycosylation 50->180 51 50->180 Impurities, not 51-
53 
50->180 No 
bands 
Non-reducing  
SDS-PAGE 
- 105, 51, 25-
30 
- 110, 51-53, 35-38, 
25, 20, 17 
- 16-18 
c-Myc 
western 
51, 30 105, 51, 30 110, 53, 36, 
25, 23 
110, 53, 36, 30, 25, 
23 
18, 16 18, 16, 
12 
Serum 
western 
230, 51, 17 51, 17 230, 53, 51, 
36, 30, 25, 23 
53, 51, 36, 30, 25, 
23 
230, 18, 16 18, 16 
2D gel 
 
- 51 (1), 50 
(3), 30 (5), 
25-30 (5), 17 
(1) 
ND 54 (5), 53 (7), 51 
(7), 50 (4), 39 (2), 
36 (4), 25 (5), 23 
(6), 20 (1), 15 (1), 
13 (1), 7 (1) 
- 18 (2), 
16 (2) 
2D serum 
western 
- 
 
- - 54 (5), 53 (7), 51 
(7), 50 (4), 39 (2), 
36 (4), 25 (5), 24 (4) 
- - 
Protein 
identification 
17 (N-
terminal) 
51, 30 (C-
terminal) 
- 53, 51, 36 (C-
terminal) 
- 18, 16 
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Figure 5.6 Representation of rAna o 1, 2 and 3 as produced by P. pastoris. The top grey bar is the 
native cashew nut protein, the second grey bar is the expected P. pastoris-produced protein with the 
c-Myc and His-tag indicated. The black bars below are the recombinant proteins produced by P. 
pastoris and detected on SDS-PAGE and western blot.  
 
2D electrophoresis 
As 2D electrophoresis of the native cashew nut allergens revealed presence of multiple 
isoforms for both Ana o 1, 2 and 3 (chapter 4 of this thesis), 2D electrophoresis of His-
affinity-purified rAna o 1, 2 and 3 was performed. 2D electrophoresis of rAna o 1 (Figure 
5.7A) shows an abundant spot at 51kDa as well as a few minor spots at 50, 30, 25 and 17kDa. 
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The isoelectric point (pI) of the abundant 51kDa protein spot is 5.4, in line with the expected 
pI of 5.6 [34]. The occurrence of one protein spot for the 51 protein, suggests that P. pastoris 
does not produce many different isoforms of the rAna o 1 protein. The multiple spots for the 
low abundance 30 and 25kDa proteins indicates that these proteins are either different 
forms of incorrectly produced rAna o 1, or that they are post-translationally processed 
forms, which are e.g. glycosylated or phosphorylated.  
rAna o 2 has by far the most complicated spot pattern on 2D electrophoresis of the three 
recombinant proteins, see Figure 5.7B. At a molecular weight of 55kDa 7 spots are present 
(pI 5.4-6.1), 5 spots at 54kDa (pI 5.5-6.0), 7 spots at 51kDa (pI 5.4-6.1), 4 spots at 50kDa (pI 
5.4-5.8), 2 spots at 39kDa (pI 5.0-5.2), 4 pots at 36kDa (pI 5.2-5.4), 5 spots at 25kDa (pI 5.2-
6.1), 6 spots at 23kDa (pI 5.2-6.2), and several separate spots are present at 20 (pI 6.0, 6.2, 
6.8), 15 (pI 4.3), 13 (pI 4.0) and 7kDa (pI 10.5). The spots of 50-54kDa represent most likely 
the same proteins as the 55 and 51kDa bands on SDS-PAGE, differing slightly in 
electrophoresis profile due to the difference in polyacrylamide concentrations between the 
1D and 2D gels. Apparently the full length rAna o 2 protein is subjected to several post-
translational modifications, leading to a change in isoelectric point. On 2D electrophoresis of 
native Ana o 2, 11 spots can be detected for the large acidic subunit (pI 5.4-6.3), and 18 
spots can be detected for the small basic subunit (pI 5.4-9.3, chapter 4 of this thesis). It is 
expected that native Ana o 2 is subjected to several post-translational modifications, and 
this is likely to be the case as well for rAna o 2. However, the pI range of the native protein 
isoforms is much broader (5.4-9.3) compared to the pI range of the most abundant protein 
spots of rAna o 2 (pI 5.0-6.2). This might be related to a difference in protein translation, 
post-translational modifications, or due to the truncation of the recombinant protein. For 
the 2D electrophoresis gel of rAna o 2 also a western blot was performed, in order to 
determine if the isoforms are immuno-reactive (Figure 5.7D). Serum IgE binds to all 
recombinant Ana o 2 protein isoforms mentioned above, except the single protein spots of 
20, 15, 13 and 7kDa, suggesting these single protein spots might be impurities in the His-
affinity-purified protein sample.  
 
Finally, also 2D electrophoresis was performed for rAna o 3. 2D electrophoresis of native Ana 
o 3 shows that the large subunit (10 and 8kDa on reducing SDS-PAGE) has 8 isoforms, 4 of 
10kDa and 4 of 8kDa (Chapter 4 of this thesis). The small subunit of 6kDa was not detected 
on 2D SDS-PAGE. 2D electrophoresis of recombinant Ana o 3 (Figure 5.7C) shows four 
distinct protein spots: two of 18kDa (pI 5.5 and 5.7) and two of 16kDa (pI 5.5 and 5.7). The 
isoelectric points of 5.5 and 5.7 are in line with the expected pI of 5.4 [34]. It is likely that 
rAna o 3 is post-translationally processed by P. pastoris, for example by phosphorylation as 
possible phosphorylation sites are present in the amino acid sequence [35], and P. pastoris is 
capable of phosphorylation [36].  
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Figure 5.7 2D electrophoresis of rAna o 1 (A), rAna o 2 (B), rAna o 3 (C), and a 2D electrophoresis 
western blot of rAna o 2 (D) using a serum pool. The molecular weight in kDa is indicated on the left 
of the figures. 
 
Protein yield 
The protein yield of the three recombinant allergens was calculated as mg His-affinity-
purified protein per litre of P. pastoris supernatant: 10.5mg/L (±1.9mg/L) for rAna o 1, 
4.8mg/L (±3.2mg/L) for rAna o 2 and 11.1mg/L (±7.6mg/L) for rAna o 3. The low protein yield 
of rAna o 2 is probably related to the lower total protein levels present in the P. pastoris 
supernatant of 194.5mg/L (±34.6mg/L) for rAna o 2 compared to 282.5mg/L (±27.6mg/L) for 
Ana o 1 and 267.5mg/L (±34.6mg/L) for rAna o 3. Furthermore, as many truncated C-
terminal rAna o 2 polypeptides were produced by P. pastoris, these proteins lack the N-
terminal α-signal peptide that induces secretion of the recombinant proteins into the P. 
pastoris supernatant. Furthermore, the protein yield might be low as several N-terminal 
polypeptides are discarded during the protein purification step.  
Overall the three recombinant proteins are produced at relatively low quantity when 
compared to the 4- 12g recombinant protein per litre P. pastoris supernatant [15] that P. 
pastoris is capable of. Other tree nut proteins (2S albumin Ber e 1) have been produced at 
200mg/L in E. coli [31].The relatively low yield of all three allergens might be improved by 
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the addition of a Maltose-binding fusion tag to increase protein solubility [12]. Also, the 
recombinant protein production process was optimised for expression time and methanol 
induction, but not for temperature, pH of the growth medium, time of the glycerol growth 
phase, or production system (shake-flask VS bioreactor) [37, 38].  
 
Summary and recommendations  
It can be stated that P. pastoris does produce immunologically reactive cashew nut allergens, 
however, all three proteins are cleaved into polypeptides in a different manner than the 
cashew tree does. As is shown in Figure 5.6A, the primary translation product of rAna o 1 is a 
62kDa protein. The protein is however, produced as, or cleaved into, two polypeptides of 51 
and 17kDa. A small fraction of these two polypeptides are connected by disulphide bridges, 
but most are not. Besides this unexpected cleavage, also the 51kDa protein is for a small 
fraction of the total protein production, cleaved into polypeptides of 21 and 30kDa.  
The production of rAna o 2 is shown in Figure 5.6B. The coding sequence of rAna o 2 
encodes a 53kDa protein, that is potentially split into two subunits of 30 and 24kDa, linked 
via disulphide bridges. However, only a part of the recombinant protein is produced as a 
55kDa protein, which is likely this 53kDa complete protein. rAna o 2 is post-translationally 
cleaved into C-terminal polypeptides of 51, 36, 30, 25 and 23kDa. These C-terminal 
polypeptides are not connected to their N-terminal counterparts, causing these N-terminal 
polypeptides to be discarded during the purification process.  
Last but not least, the peptide structure of rAna o 3 is shown in Figure 5.6C. rAna o 3 
encodes a 17kDa protein, that is potentially split into two subunits of 6 and 11kDa. rAna o 3 
however, is produced as an 18 and 16kDa protein, and minor amount is produced as a 12kDa 
C-terminal polypeptide. It is unclear if the N-terminal polypeptides are attached to their C-
terminal polypeptides, as they are not visible on SDS-PAGE or western blot. However, the N-
terminal polypeptides are theoretically rather small (2-6kDa), and can therefore be difficult 
to detect on SDS-PAGE. It is unclear if there are epitopes present on these N-terminal 
polypeptides.  
Similar truncation or cleavage by P. pastoris as observed here for rAna o 1, 2 and 3, has been 
reported before [22, 23, 28, 31]. It is possible that the polypeptides are formed due to the 
occurrence of different start sites for protein transcription/translation, or due to post 
translational processing. The recombinant allergens are IgE reactive, despite the differences 
between with the native allergens.  
If these P. pastoris-produced recombinant proteins will be used for further experiments, the 
exact transcription/translation start sites or post-translational cleavage sites should be 
studied by N-terminal amino acid sequencing and mass spectrometry. Also, the protein 
production should be optimized. Furthermore a more thorough inhibition blotting 
comparison should be made. Western blotting with native purified protein inhibition should 
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be compared to western blotting with the recombinant proteins. The native and 
recombinant proteins should inhibit IgE binding comparably at similar protein 
concentrations. Also cell experiments could be performed, using for example the rat 
basophil leukemia (RBL) cell line, to compare cross-linking activity of the native proteins to 
the recombinant proteins.  
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Supplementary information 
 
Synthesized Ana o 1 nucleotide sequence: 
CTCGAGAAAAGAGAGGCTGAAGCTGGTCCTCCTACAAAGTTCTCTTTTTCTCTGTTTTTAGTTTCTGTTTTGGTCCTGTGTTT
AGGTTTTGCTTTGGCTAAGATTGACCCGGAGTTGAAACAGTGCAAGCACCAGTGTAAAGTGCAGAGGCAGTATGATGAGC
AACAGAAGGAGCAATGTGTGAAAGAGTGTGAAAAGTACTACAAAGAGAAGAAGGGACGGGAACGAGAGCATGAAGAG
GAAGAAGAGGAATGGGGTACTGGTGGCGTTGATGAACCCAGCACTCATGAGCCAGCTGAAAAGCATCTCTCCCAGTGTAT
GAGACAGTGCGAGAGACAAGAAGGAGGTCAACAAAAGCAATTATGTCGTTTTAGGTGTCAAGAGCGTTATAAGAAAGAG
AGAGGACAACATAATTACAAGAGAGAAGACGATGAAGACGAGGACGAAGATGAAGCCGAGGAGGAAGATGAGAATCCC
TATGTATTCGAGGATGAAGATTTCACCACCAAAGTCAAGACTGAGCAAGGTAAAGTAGTTTTGTTGCCCAAGTTTACTCAA
AAATCGAAGCTTCTTCACGCCCTGGAGAAATACCGTCTAGCCGTTTTGGTTGCAAATCCTCAGGCTTTTGTAGTTCCAAGTC
ACATGGATGCTGACAGTATTTTCTTTGTTTCTTGGGGACGCGGAACTATCACCAAGATCTTAGAGAACAAACGAGAGAGCA
TTAATGTCAGACAGGGAGATATCGTCAGCATTAGTTCTGGTACTCCTTTTTATATCGCCAATAACGATGAAAACGAGAAGC
TTTACCTCGTCCAATTCCTAAGACCTGTAAATTTACCAGGTCATTTCGAAGTGTTTCATGGTCCAGGCGGTGAAAATCCAGA
GTCTTTCTATAGAGCTTTCTCGTGGGAAATATTGGAAGCCGCTCTGAAGACCTCAAAAGACACACTTGAGAAACTTTTCGA
GAAACAGGACCAAGGTACTATCATGAAAGCCTCCAAAGAACAAATTAGAGCTATGTCCAGGAGAGGCGAAGGTCCTAAA
ATTTGGCCATTTACAGAGGAATCAACGGGTTCATTCAAACTGTTCAAAAAGGATCCCTCTCAATCCAATAAATACGGCCAAT
TGTTTGAAGCTGAACGTATTGATTATCCGCCACTTGAAAAGTTGGACATGGTTGTCTCCTATGCGAACATCACCAAGGGAG
GAATGTCTGTTCCTTTCTACAACTCAAGAGCAACGAAAATAGCCATTGTGGTTTCTGGAGAAGGTTGCGTTGAGATAGCAT
GTCCTCATCTATCCTCTTCGAAAAGTTCACACCCAAGTTACAAGAAATTGAGGGCAAGAATTAGAAAGGACACAGTGTTTA
TTGTCCCAGCGGGTCACCCTTTCGCAACTGTTGCTTCAGGAAATGAAAACTTGGAAATCGTGTGCTTTGAAGTAAACGCAG
AAGGCAACATAAGGTACACATTAGCCGGGAAGAAGAACATTATTAAGGTCATGGAGAAGGAAGCTAAAGAGTTGGCATT
CAAGATGGAAGGAGAAGAAGTGGACAAAGTGTTTGGAAAACAAGATGAAGAGTTTTTCTTCCAGGGGCCAGAATGGCGA
AAGGAAAAAGAAGGGCGTGCTGATGAATTTCTAGA 
 
Ana o 1 nucleotide sequence as expressed in P. pastoris:  
ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACAACAGAAGA
TGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATT
TTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGTATCTCTC
GAGAAAAGAGAGGCTGAAGCTGAATTCAAGATTGACCCGGAGTTGAAACAGTGCAAGCACCAGTGTAAAGTGCAGAGG
CAGTATGATGAGCAACAGAAGGAGCAATGTGTGAAAGAGTGTGAAAAGTACTACAAAGAGAAGAAGGGACGGGAACGA
GAGCATGAAGAGGAAGAAGAGGAATGGGGTACTGGTGGCGTTGATGAACCCAGCACTCATGAGCCAGCTGAAAAGCAT
CTCTCCCAGTGTATGAGACAGTGCGAGAGACAAGAAGGAGGTCAACAAAAGCAATTATGTCGTTTTAGGTGTCAAGAGCG
TTATAAGAAAGAGAGAGGACAACATAATTACAAGAGAGAAGACGATGAAGACGAGGACGAAGATGAAGCCGAGGAGGA
AGATGAGAATCCCTATGTATTCGAGGATGAAGATTTCACCACCAAAGTCAAGACTGAGCAAGGTAAAGTAGTTTTGTTGCC
CAAGTTTACTCAAAAATCGAAGCTTCTTCACGCCCTGGAGAAATACCGTCTAGCCGTTTTGGTTGCAAATCCTCAGGCTTTT
GTAGTTCCAAGTCACATGGATGCTGACAGTATTTTCTTTGTTTCTTGGGGACGCGGAACTATCACCAAGATCTTAGAGAAC
AAACGAGAGAGCATTAATGTCAGACAGGGAGATATCGTCAGCATTAGTTCTGGTACTCCTTTTTATATCGCCAATAACGAT
GAAAACGAGAAGCTTTACCTCGTCCAATTCCTAAGACCTGTAAATTTACCAGGTCATTTCGAAGTGTTTCATGGTCCAGGC
GGTGAAAATCCAGAGTCTTTCTATAGAGCTTTCTCGTGGGAAATATTGGAAGCCGCTCTGAAGACCTCAAAAGACACACTT
GAGAAACTTTTCGAGAAACAGGACCAAGGTACTATCATGAAAGCCTCCAAAGAACAAATTAGAGCTATGTCCAGGAGAGG
CGAAGGTCCTAAAATTTGGCCATTTACAGAGGAATCAACGGGTTCATTCAAACTGTTCAAAAAGGATCCCTCTCAATCCAA
TAAATACGGCCAATTGTTTGAAGCTGAACGTATTGATTATCCGCCACTTGAAAAGTTGGACATGGTTGTCTCCTATGCGAA
CATCACCAAGGGAGGAATGTCTGTTCCTTTCTACAACTCAAGAGCAACGAAAATAGCCATTGTGGTTTCTGGAGAAGGTTG
CGTTGAGATAGCATGTCCTCATCTATCCTCTTCGAAAAGTTCACACCCAAGTTACAAGAAATTGAGGGCAAGAATTAGAAA
GGACACAGTGTTTATTGTCCCAGCGGGTCACCCTTTCGCAACTGTTGCTTCAGGAAATGAAAACTTGGAAATCGTGTGCTT
TGAAGTAAACGCAGAAGGCAACATAAGGTACACATTAGCCGGGAAGAAGAACATTATTAAGGTCATGGAGAAGGAAGCT
AAAGAGTTGGCATTCAAGATGGAAGGAGAAGAAGTGGACAAAGTGTTTGGAAAACAAGATGAAGAGTTTTTCTTCCAGG
GGCCAGAATGGCGAAAGGAAAAAGAAGGGCGTGCTGATGAATTTCTAGAACAAAAACTCATCTCAGAAGAGGATCTGAA
TAGCGCCGTCGACCATCATCATCATCATCAT 
 
Ana o 1 amino acid sequence as obtained from P. pastoris: 62.1kDa 
EFKIDPELKQCKHQCKVQRQYDEQQKEQCVKECEKYYKEKKGREREHEEEEEEWGTGGVDEPSTHEPAEKHLSQCMRQCERQ
EGGQQKQLCRFRCQERYKKERGQHNYKREDDEDEDEDEAEEEDENPYVFEDEDFTTKVKTEQGKVVLLPKFTQKSKLLHALEKY
RLAVLVANPQAFVVPSHMDADSIFFVSWGRGTITKILENKRESINVRQGDIVSISSGTPFYIANNDENEKLYLVQFLRPVNLPGHF
EVFHGPGGENPESFYRAFSWEILEAALKTSKDTLEKLFEKQDQGTIMKASKEQIRAMSRRGEGPKIWPFTEESTGSFKLFKKDPS
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QSNKYGQLFEAERIDYPPLEKLDMVVSYANITKGGMSVPFYNSRATKIAIVVSGEGCVEIACPHLSSSKSSHPSYKKLRARIRKDTV
FIVPAGHPFATVASGNENLEIVCFEVNAEGNIRYTLAGKKNIIKVMEKEAKELAFKMEGEEVDKVFGKQDEEFFFQGPEWRKEKE
GRADEFLEQKLISEEDLNSAVDHHHHHH 
 
Synthesized Ana o 2 nucleotide sequence: 
GAATTCCGTCAGGAATGGCAACAACAAGATGAGTGCCAAATCGATAGGCTGGATGCCTTGGAACCCGATAACCGAGTTG
AGTATGAAGCCGGTACGGTTGAAGCCTGGGACCCTAACCATGAGCAATTCCGATGTGCTGGTGTTGCATTGGTTAGGCAT
ACCATACAACCTAATGGCCTGTTGTTGCCTCAATATTCTAATGCTCCTCAATTGATTTACGTTGTCCAGGGTGAGGGTATGA
CAGGTATTTCATATCCAGGATGTCCAGAAACTTACCAAGCACCCCAACAGGGAAGACAGCAGGGACAGTCTGGTAGATTC
CAGGACCGGCATCAAAAGATCCGAAGATTTAGACGAGGCGATATTATCGCAATCCCCGCCGGAGTAGCACACTGGTGTTA
CAACGAGGGCAATTCCCCGGTCGTCACTGTTACTCTTCTGGACGTCTCAAACTCGCAAAATCAGCTTGATAGGACGCCTAG
AAAATTTCATCTGGCTGGTAACCCTAAAGATGTATTTCAGCAACAGCAACAACACCAATCCAGAGGGAGAAACCTTTTTTCT
GGTTTTGATACAGAGTTATTGGCTGAGGCTTTCCAAGTGGACGAACGTCTGATAAAGCAGTTGAAAAGCGAGGACAACAG
GGGTGGAATTGTTAAGGTTAAGGATGACGAACTTAGAGTGATCAGACCATCAAGATCCCAATCCGAGCGTGGAAGTGAA
AGTGAAGAGGAAAGTGAGGATGAAAAAAGAAGATGGGGACAACGTGACAATGGGATTGAAGAAACCATTTGCACTATG
AGATTAAAAGAGAATATCAATGATCCTGCTCGCGCTGACATTTACACCCCAGAAGTTGGTCGTCTTACTACATTAAACTCCC
TCAACCTCCCAATTTTGAAATGGCTTCAACTCAGTGTTGAAAAGGGTGTGCTATACAAAAATGCTCTAGTCCTGCCACACTG
GAACTTGAACTCGCATTCCATAATATATGGATGTAAGGGTAAAGGTCAGGTTCAAGTAGTAGACAACTTCGGCAACAGAG
TGTTCGACGGCGAAGTCAGAGAGGGACAGATGTTGGTCGTGCCACAAAACTTTGCAGTAGTTAAGCGTGCAAGAGAGGA
AAGATTCGAATGGATTTCTTTCAAGACCAATGATCGGGCCATGACTTCTCCGTTAGCTGGACGCACCTCTGTTTTAGGTGG
GATGCCAGAGGAAGTGTTAGCCAATGCGTTCCAGATCTCAAGAGAAGATGCTAGGAAGATCAAGTTTAATAATCAGCAGA
CAACTTTGACATCTGGAGAGTCAAGCCACCATATGAGGGATGATGCTGGTCTAGA 
 
Ana o 2 nucleotide sequence as expressed in P. pastoris:  
ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACAACAGAAGA
TGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATT
TTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGTATCTCTC
GAGAAAAGAGAGGCTGAAGCTGAATTCCGTCAGGAATGGCAACAACAAGATGAGTGCCAAATCGATAGGCTGGATGCCT
TGGAACCCGATAACCGAGTTGAGTATGAAGCCGGTACGGTTGAAGCCTGGGACCCTAACCATGAGCAATTCCGATGTGCT
GGTGTTGCATTGGTTAGGCATACCATACAACCTAATGGCCTGTTGTTGCCTCAATATTCTAATGCTCCTCAATTGATTTACGT
TGTCCAGGGTGAGGGTATGACAGGTATTTCATATCCAGGATGTCCAGAAACTTACCAAGCACCCCAACAGGGAAGACAGC
AGGGACAGTCTGGTAGATTCCAGGACCGGCATCAAAAGATCCGAAGATTTAGACGAGGCGATATTATCGCAATCCCCGCC
GGAGTAGCACACTGGTGTTACAACGAGGGCAATTCCCCGGTCGTCACTGTTACTCTTCTGGACGTCTCAAACTCGCAAAAT
CAGCTTGATAGGACGCCTAGAAAATTTCATCTGGCTGGTAACCCTAAAGATGTATTTCAGCAACAGCAACAACACCAATCC
AGAGGGAGAAACCTTTTTTCTGGTTTTGATACAGAGTTATTGGCTGAGGCTTTCCAAGTGGACGAACGTCTGATAAAGCAG
TTGAAAAGCGAGGACAACAGGGGTGGAATTGTTAAGGTTAAGGATGACGAACTTAGAGTGATCAGACCATCAAGATCCC
AATCCGAGCGTGGAAGTGAAAGTGAAGAGGAAAGTGAGGATGAAAAAAGAAGATGGGGACAACGTGACAATGGGATT
GAAGAAACCATTTGCACTATGAGATTAAAAGAGAATATCAATGATCCTGCTCGCGCTGACATTTACACCCCAGAAGTTGGT
CGTCTTACTACATTAAACTCCCTCAACCTCCCAATTTTGAAATGGCTTCAACTCAGTGTTGAAAAGGGTGTGCTATACAAAA
ATGCTCTAGTCCTGCCACACTGGAACTTGAACTCGCATTCCATAATATATGGATGTAAGGGTAAAGGTCAGGTTCAAGTAG
TAGACAACTTCGGCAACAGAGTGTTCGACGGCGAAGTCAGAGAGGGACAGATGTTGGTCGTGCCACAAAACTTTGCAGTA
GTTAAGCGTGCAAGAGAGGAAAGATTCGAATGGATTTCTTTCAAGACCAATGATCGGGCCATGACTTCTCCGTTAGCTGG
ACGCACCTCTGTTTTAGGTGGGATGCCAGAGGAAGTGTTAGCCAATGCGTTCCAGATCTCAAGAGAAGATGCTAGGAAGA
TCAAGTTTAATAATCAGCAGACAACTTTGACATCTGGAGAGTCAAGCCACCATATGAGGGATGATGCTGGTCTAGAACAA
AAACTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGACCATCATCATCATCATCAT 
 
Ana o 2 amino acid sequence as obtained from P. pastoris: 53.3kDa 
EFRQEWQQQDECQIDRLDALEPDNRVEYEAGTVEAWDPNHEQFRCAGVALVRHTIQPNGLLLPQYSNAPQLIYVVQGEGMT
GISYPGCPETYQAPQQGRQQGQSGRFQDRHQKIRRFRRGDIIAIPAGVAHWCYNEGNSPVVTVTLLDVSNSQNQLDRTPRKF
HLAGNPKDVFQQQQQHQSRGRNLFSGFDTELLAEAFQVDERLIKQLKSEDNRGGIVKVKDDELRVIRPSRSQSERGSESEEESE
DEKRRWGQRDNGIEETICTMRLKENINDPARADIYTPEVGRLTTLNSLNLPILKWLQLSVEKGVLYKNALVLPHWNLNSHSIIYG
CKGKGQVQVVDNFGNRVFDGEVREGQMLVVPQNFAVVKRAREERFEWISFKTNDRAMTSPLAGRTSVLGGMPEEVLANAF
QISREDARKIKFNNQQTTLTSGESSHHMRDDAGLEQKLISEEDLNSAVDHHHHHH 
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Synthesized Ana o 3 nucleotide sequence:  
CTCGAGAAAAGAGAGGCTGAAGCTGCAAAGTTCTTACTCCTCCTATCTGCCTTCGCAGTCCTCCTCCTGGTGGCTAACGCC
GAATTCTCCATTTACCGAGCCATTGTGGAGGTTGAAGAAGACTCGGGCCGTGAGCAGAGTTGCCAACGGCAGTTCGAAGA
GCAGCAGCGATTCCGGAACTGTCAAAGGTACGTGAAGCAGGAGGTCCAGAGGGGAGGACGCTATAACCAGAGACAAGA
AAGCTTGAGGGAATGCTGCCAGGAGTTGCAGGAAGTAGACAGAAGGTGCCGCTGCCAGAACCTAGAGCAAATGGTGAG
GCAGCTGCAGCAACAGGAACAAATAAAGGGTGAGGAGGTTCGGGAACTTTATGAAACAGCCAGTGAATTGCCTCGCATTT
GCAGTATTTCACCCAGCCAGGGCTGTCAGTTTCAGTCATCTTATTTTCTAGA 
 
Ana o 3 nucleotide sequence as expressed in P. pastoris: 
ATGAGATTTCCTTCAATTTTTACTGCTGTTTTATTCGCAGCATCCTCCGCATTAGCTGCTCCAGTCAACACTACAACAGAAGA
TGAAACGGCACAAATTCCGGCTGAAGCTGTCATCGGTTACTCAGATTTAGAAGGGGATTTCGATGTTGCTGTTTTGCCATT
TTCCAACAGCACAAATAACGGGTTATTGTTTATAAATACTACTATTGCCAGCATTGCTGCTAAAGAAGAAGGGGTATCTCTC
GAGAAAAGAGAGGCTGAAGCTGAATTCTCCATTTACCGAGCCATTGTGGAGGTTGAAGAAGACTCGGGCCGTGAGCAGA
GTTGCCAACGGCAGTTCGAAGAGCAGCAGCGATTCCGGAACTGTCAAAGGTACGTGAAGCAGGAGGTCCAGAGGGGAG
GACGCTATAACCAGAGACAAGAAAGCTTGAGGGAATGCTGCCAGGAGTTGCAGGAAGTAGACAGAAGGTGCCGCTGCCA
GAACCTAGAGCAAATGGTGAGGCAGCTGCAGCAACAGGAACAAATAAAGGGTGAGGAGGTTCGGGAACTTTATGAAAC
AGCCAGTGAATTGCCTCGCATTTGCAGTATTTCACCCAGCCAGGGCTGTCAGTTTCAGTCATCTTATTTTCTAGAACAAAAA
CTCATCTCAGAAGAGGATCTGAATAGCGCCGTCGACCATCATCATCATCATCAT 
 
Ana o 3 amino acid sequence as obtained from P. pastoris: 17.3kDa 
EFSIYRAIVEVEEDSGREQSCQRQFEEQQRFRNCQRYVKQEVQRGGRYNQRQESLRECCQELQEVDRRCRCQNLEQMVRQLQ
QQEQIKGEEVRELYETASELPRICSISPSQGCQFQSSYFLEQKLISEEDLNSAVDHHHHHH 
 
Figure 5.S1 Nucleotide and protein sequences of rAna o 1, rAna o 2 and rAna o 3. Restriction sites are 
indicated in bold, leader peptides are double struck through, a-factor signal sequence and kex2 signal 
cleavage sequence are single struck through, c-Myc epitope and His-tag are underlined. 
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rAna o 1: 51kDa protein band, 58% sequence coverage, Mascot score 855. Amino acid E111 
and H537 are indicated in bold. 
EFKIDPELKQCKHQCKVQRQYDEQQKEQCVKECEKYYKEKKGREREHEEEEEEWGTGGVDEPSTHEPAEKHLSQCMRQCERQ
EGGQQKQLCRFRCQERYKKERGQHNYKREDDEDEDEDEAEEEDENPYVFEDEDFTTKVKTEQGKVVLLPKFTQKSKLLHALEKY
RLAVLVANPQAFVVPSHMDADSIFFVSWGRGTITKILENKRESINVRQGDIVSISSGTPFYIANNDENEKLYLVQFLRPVNLPGHF
EVFHGPGGENPESFYRAFSWEILEAALKTSKDTLEKLFEKQDQGTIMKASKEQIRAMSRRGEGPKIWPFTEESTGSFKLFKKDPS
QSNKYGQLFEAERIDYPPLEKLDMVVSYANITKGGMSVPFYNSRATKIAIVVSGEGCVEIACPHLSSSKSSHPSYKKLRARIRKDTV
FIVPAGHPFATVASGNENLEIVCFEVNAEGNIRYTLAGKKNIIKVMEKEAKELAFKMEGEEVDKVFGKQDEEFFFQGPEWRKEKE
GRADEFLEQKLISEEDLNSAVDHHHHHH 
 
rAna o 1 30kDa protein band, 30% sequence coverage, Mascot score 636. Amino acid I202 
and H537 are indicated in bold. 
EFKIDPELKQCKHQCKVQRQYDEQQKEQCVKECEKYYKEKKGREREHEEEEEEWGTGGVDEPSTHEPAEKHLSQCMRQCERQ
EGGQQKQLCRFRCQERYKKERGQHNYKREDDEDEDEDEAEEEDENPYVFEDEDFTTKVKTEQGKVVLLPKFTQKSKLLHALEKY
RLAVLVANPQAFVVPSHMDADSIFFVSWGRGTITKILENKRESINVRQGDIVSISSGTPFYIANNDENEKLYLVQFLRPVNLPGHF
EVFHGPGGENPESFYRAFSWEILEAALKTSKDTLEKLFEKQDQGTIMKASKEQIRAMSRRGEGPKIWPFTEESTGSFKLFKKDPS
QSNKYGQLFEAERIDYPPLEKLDMVVSYANITKGGMSVPFYNSRATKIAIVVSGEGCVEIACPHLSSSKSSHPSYKKLRARIRKDTV
FIVPAGHPFATVASGNENLEIVCFEVNAEGNIRYTLAGKKNIIKVMEKEAKELAFKMEGEEVDKVFGKQDEEFFFQGPEWRKEKE
GRADEFLEQKLISEEDLNSAVDHHHHHH 
 
rAna o 1 17kDa protein band, 13% sequence coverage, Mascot score 113. Amino acid Q19 
and R98 are indicated in bold. 
EFKIDPELKQCKHQCKVQRQYDEQQKEQCVKECEKYYKEKKGREREHEEEEEEWGTGGVDEPSTHEPAEKHLSQCMRQCERQ
EGGQQKQLCRFRCQERYKKERGQHNYKREDDEDEDEDEAEEEDENPYVFEDEDFTTKVKTEQGKVVLLPKFTQKSKLLHALEKY
RLAVLVANPQAFVVPSHMDADSIFFVSWGRGTITKILENKRESINVRQGDIVSISSGTPFYIANNDENEKLYLVQFLRPVNLPGHF
EVFHGPGGENPESFYRAFSWEILEAALKTSKDTLEKLFEKQDQGTIMKASKEQIRAMSRRGEGPKIWPFTEESTGSFKLFKKDPS
QSNKYGQLFEAERIDYPPLEKLDMVVSYANITKGGMSVPFYNSRATKIAIVVSGEGCVEIACPHLSSSKSSHPSYKKLRARIRKDTV
FIVPAGHPFATVASGNENLEIVCFEVNAEGNIRYTLAGKKNIIKVMEKEAKELAFKMEGEEVDKVFGKQDEEFFFQGPEWRKEKE
GRADEFLEQKLISEEDLNSAVDHHHHHH 
 
 
rAna o 2: 53kDa protein band, 24% sequence coverage, Mascot score 241. Amino acid D171 
and R416 are indicated in bold. 
EFRQEWQQQDECQIDRLDALEPDNRVEYEAGTVEAWDPNHEQFRCAGVALVRHTIQPNGLLLPQYSNAPQLIYVVQGEGMT
GISYPGCPETYQAPQQGRQQGQSGRFQDRHQKIRRFRRGDIIAIPAGVAHWCYNEGNSPVVTVTLLDVSNSQNQLDRTPRKF
HLAGNPKDVFQQQQQHQSRGRNLFSGFDTELLAEAFQVDERLIKQLKSEDNRGGIVKVKDDELRVIRPSRSQSERGSESEEESE
DEKRRWGQRDNGIEETICTMRLKENINDPARADIYTPEVGRLTTLNSLNLPILKWLQLSVEKGVLYKNALVLPHWNLNSHSIIYG
CKGKGQVQVVDNFGNRVFDGEVREGQMLVVPQNFAVVKRAREERFEWISFKTNDRAMTSPLAGRTSVLGGMPEEVLANAF
QISREDARKIKFNNQQTTLTSGESSHHMRDDAGLEQKLISEEDLNSAVDHHHHHH 
 
rAna o 2: 51kDa protein band, 32% sequence coverage, Mascot score 263. Amino acid D171 
and R416 are indicated in bold. 
EFRQEWQQQDECQIDRLDALEPDNRVEYEAGTVEAWDPNHEQFRCAGVALVRHTIQPNGLLLPQYSNAPQLIYVVQGEGMT
GISYPGCPETYQAPQQGRQQGQSGRFQDRHQKIRRFRRGDIIAIPAGVAHWCYNEGNSPVVTVTLLDVSNSQNQLDRTPRKF
HLAGNPKDVFQQQQQHQSRGRNLFSGFDTELLAEAFQVDERLIKQLKSEDNRGGIVKVKDDELRVIRPSRSQSERGSESEEESE
DEKRRWGQRDNGIEETICTMRLKENINDPARADIYTPEVGRLTTLNSLNLPILKWLQLSVEKGVLYKNALVLPHWNLNSHSIIYG
CKGKGQVQVVDNFGNRVFDGEVREGQMLVVPQNFAVVKRAREERFEWISFKTNDRAMTSPLAGRTSVLGGMPEEVLANAF
QISREDARKIKFNNQQTTLTSGESSHHMRDDAGLEQKLISEEDLNSAVDHHHHHH 
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rAna o 2: 36kDa protein band, 45% sequence coverage, Mascot score 423. Amino acid C45 
and R416 are indicated in bold. 
EFRQEWQQQDECQIDRLDALEPDNRVEYEAGTVEAWDPNHEQFRCAGVALVRHTIQPNGLLLPQYSNAPQLIYVVQGEGMT
GISYPGCPETYQAPQQGRQQGQSGRFQDRHQKIRRFRRGDIIAIPAGVAHWCYNEGNSPVVTVTLLDVSNSQNQLDRTPRKF
HLAGNPKDVFQQQQQHQSRGRNLFSGFDTELLAEAFQVDERLIKQLKSEDNRGGIVKVKDDELRVIRPSRSQSERGSESEEESE
DEKRRWGQRDNGIEETICTMRLKENINDPARADIYTPEVGRLTTLNSLNLPILKWLQLSVEKGVLYKNALVLPHWNLNSHSIIYG
CKGKGQVQVVDNFGNRVFDGEVREGQMLVVPQNFAVVKRAREERFEWISFKTNDRAMTSPLAGRTSVLGGMPEEVLANAF
QISREDARKIKFNNQQTTLTSGESSHHMRDDAGLEQKLISEEDLNSAVDHHHHHH 
 
 
rAna o 3: 18kDa protein band, 69% sequence coverage, Mascot score 452. Amino acid A7 
and R104 are indicated in bold. 
EFSIYRAIVEVEEDSGREQSCQRQFEEQQRFRNCQRYVKQEVQRGGRYNQRQESLRECCQELQEVDRRCRCQNLEQMVRQLQ
QQEQIKGEEVRELYETASELPRICSISPSQGCQFQSSYFLEQKLISEEDLNSAVDHHHHHH 
 
rAna o 3: 16Da protein band, 69% sequence coverage, Mascot score 513. Amino acid A7 and 
R104 are indicated in bold. 
EFSIYRAIVEVEEDSGREQSCQRQFEEQQRFRNCQRYVKQEVQRGGRYNQRQESLRECCQELQEVDRRCRCQNLEQMVRQLQ
QQEQIKGEEVRELYETASELPRICSISPSQGCQFQSSYFLEQKLISEEDLNSAVDHHHHHH 
 
Figure 5.S2 Protein identification of P. pastoris recombinantly produced proteins, matched peptides 
are underlined. 
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This thesis focussed on the cashew nut (Anacardium occidentale) allergens, Ana o 1, Ana o 2 
and Ana o 3. This research was carried out within a larger project, the IDEAL project 
(Improvement of Diagnostic mEthods for ALlergy assessment, cashew allergy in children as a 
showcase), a collaborative project integrating molecular and clinical aspects of cashew nut 
allergy. While this thesis is focussed mostly on cashew nut allergen characterisation, the 
clinical research in Rotterdam, Delft and Groningen focused on the diagnosis of cashew nut 
allergy in children using double blind placebo controlled food challenges (DBPCFC), skin prick 
tests (SPT), serum IgE (sIgE) measurements, and quality of life assessments in cashew nut 
sensitized children. Merging different disciplines in this way, led to a collaboration in which 
molecular and clinical data could be used to deepen our understanding of this type of 
allergy, and thoroughly characterised allergen samples could be biologically characterised 
making use of sera of patients included in this study. This collaboration led to new insights 
into cashew nut allergy.  
 
Cashew nut allergy 
In the IDEAL project, the cashew nut proteins were not only studied at laboratory scale, as 
will be discussed later in this chapter, the cashew nut proteins were also studied regarding 
their clinical profile [1-4]. The study was initiated because at the children’s hospital 
“Kinderhaven”, in Rotterdam, a high number of children were reported having possible 
cashew nut allergy (290 children). Of these 290 children, 90 were tested by SPT, of which 69 
(73%) were sensitized to cashew nuts. In the IDEAL study, cashew nut sensitized children 
were diagnosed for cashew nut allergy by a double blind placebo controlled food challenge 
(DBPCFC) [1]. In 137 (76.5%) of the 179 tested children, an IgE mediated cashew nut allergy 
could be confirmed by a positive DBPCFC. Symptoms experienced during these positive 
challenges were gastro-intestinal (64% oral allergy symptoms, 72% nausea/stomach 
pain/vomiting/diarrhoea), symptoms of the skin (21% urticarial, 28% redness and itchiness, 
27% angioedema), 19% symptoms of the eye, 15% symptoms of the upper airways, and 7% 
symptoms of the lower airways. No cardiovascular symptoms were observed [1]. The 
remarkably low dose of cashew nut protein required for the induction of an allergic reaction 
was already specified by Blom et al. (7.4mg cashew nut causing an allergic reaction in 5% of 
the allergic population) [5] and by Davoren et al. (anaphylaxis after contact via skin or oral 
mucosa) [6]. This was confirmed by the study of van der Valk et al., as 17% of the children 
experienced anaphylaxis upon ingestion of only 1mg cashew nut protein [1]. This lowest 
observed adverse effect level (LOAEL) of cashew nut protein is comparable to the LOAEL of 
peanut protein. Ingestion of 100μg peanut protein can already result in subjective symptoms 
in peanut allergic patients. Objective symptoms have been observed from 5mg peanut 
protein onwards [7].  
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The age of the cashew nut allergic patients studied here was between 2 and 17 years old, 
with an average of 9 years old [1]. It is known that food allergy is more prevalent in children 
than in adults [8]. This might be caused by the low gastric acid and pepsin secretion early in 
life [9, 10], the overall immaturity of the gastro-intestinal tract in new-borns [11], and 
possible sensitization to allergens via the umbilical cord during pregnancy [12], or via breast 
milk [13]. Of the cashew nut sensitized children, 38% reported not having consumed cashew 
nut [2]. Sensitization in-utero, or via the breast milk, might explain this phenomenon. Of 
course it is also possible that children or their parents are unaware of previous consumption 
of, or skin contact with, (traces of) cashew nuts.  
 
Based on the review presented in Chapter 2, intestinal exposure to soluble monomeric Ana 
o 1, 2, and 3 should induce tolerance. However, in cashew nut also trimeric (Ana o 1) and 
hexameric (Ana o 2) allergens are present, which have a higher probability of transport by 
M-cells, inducing a local immune response.  
 
No improvement in quality of life was gained by the patients participating in the IDEAL study 
after the food challenge or diagnosis (either positive or negative) [4]. This was explained by 
the relative ease of avoiding cashew nuts in the diet, which is not as burdensome as avoiding 
for example dairy- or egg-based products [4]. A negative food challenge also did not often 
result in the introduction of cashew nuts into the diet on regular basis. Only 43% of the 
negatively diagnosed children successfully introduced cashew nuts into their diet [3].  
 
Allergy diagnostics 
At the moment, the golden standard of food allergy diagnostics is the DBPCFC [14]. 
However, a DBPCFC is costly and time consuming, as well as invasive for the patients. Other 
diagnostic tools are the patient history, SPT, mediator release assays, specific IgE 
measurements, and elimination diets [15]. Many of these tests require well-characterised 
allergen extracts or purified allergens. In component resolved diagnostics (CRD), purified 
natural or recombinant allergens are used for serologic patient characterisation; enhancing 
the knowledge regarding clinical diagnostics and possible cross-reactivity towards other 
allergens, and allowing the classification of patients into different clinical phenotypes [16, 
17]. In the IDEAL study the clinical centres have performed the DBPCFC, while we have 
purified native allergens and produced recombinant allergens for specific IgE measurements. 
This was done in order to possibly add more diagnostic tools for the diagnosis of cashew nut 
allergy, and to avoid the invasive and costly DBPCFC wherever possible.  
 
The purification process for native Ana o 1, 2 and 3, has been described in Chapter 3. The 
purified allergens have subsequently been applied for clinical diagnostics: serum IgE 
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measurements of Ana o 1, 2 and 3 [2]. Cashew allergic children had (median values) sIgE 
levels of 2.0, 6.3, and 13.0 kU/l for Ana o 1, 2 and 3 respectively. Sensitized, but not allergic, 
children had median sIgE levels of 0.2, 1.2, and 0.6 kU/l for Ana o 1, 2 and 3 respectively [2]. 
The serum levels of Ana o 1, 2 and 3 could better distinct between allergic and sensitized-
only patients, than sIgE or SPT of total cashew nut protein. However, based on allergen 
specific sIgE levels, no distinction could be made between mild and severe allergic reactions 
[2].  
Based on the sIgE data, a predictive model was developed by van der Valk et al. that should 
help to decide whether or not a DBPCFC is required for the diagnosis of a patient [25]. This 
model includes gender, SPT results, and Ana o 3 sIgE levels. 
 
Besides the use of native purified allergens, also recombinant allergens can be used in sIgE 
testing. As mentioned in Chapter 1, recombinant protein production can give higher yields, is 
easier to standardise, and the produced allergen will not be contaminated with the presence 
of other allergens. Purification of allergens directly from the food, as the allergens described 
in Chapter 3, yields allergens with correct post-translational modifications, and the 
possibility to purify multiple isoforms at once. In Chapter 5 we described the recombinant 
production of Ana o 1, 2 and 3 in a yeast (P. pastoris) system, and compared them to the 
native allergens. As described in Chapter 5, P. pastoris-produced Ana o 1, 2 and 3 were IgE 
reactive, but differed from the native allergens. Like the native allergen, rAna o 1 was 
glycosylated, but it was cleaved into two subunits that were mostly not bound to one 
another, and therefore significant amounts of the N-terminal rAna o 1 polypeptide was lost 
during purification. Ana o 2 was cleaved into at least 5 subunits, probably by endo 
peptidases that should cleave Ana o 2 only once to obtain the acidic and basic subunit. Also 
for Ana o 2 the N-terminal polypeptides were removed during purification as they were not 
bound to their C-terminal counterparts. Finally, Ana o 3 was also produced differently than it 
should have been, with the production of two proteins of which one misses its N-terminal 
polypeptide. Furthermore, Ana o 3 was not cleaved into two subunits as occurs in the 
cashew nut. All in all the recombinantly-produced cashew nut allergens either need to be 
further studied to better understand why the proteins were produced as they were, or 
cloning and production of these allergens should be done again. However, it is difficult to 
decide whether or not our recombinant allergens are exceptional, or if such differences 
between native and recombinant allergens occur more often. For example the E.coli-
produced allergens from Wang and Robotham et al. [18-20] were never shown on SDS-
PAGE, so if truncation or endopeptidase cleavage of the proteins has occurred remains 
unclear to the reader. Furthermore, papers that do note such discrepancies between native 
and recombinant allergens [21-24], only mention such observations briefly, and do not relate 
to the effect this might have on subsequent applications of such a recombinant allergen.  
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The cashew nut allergens 
Ana o 1, 2 and 3 are the only characterised allergens from cashew nut so far. These three 
major allergens have been studied regarding their nucleotide sequence [18-20], 
electrophoretic profile on 1D [18-20, 26], state of glycosylation [26], heat and pepsin/trypsin 
digestibility [27-29], the identification of linear [18-20] and conformational epitopes (Ana o 2 
only) [30, 31], and they have been recombinantly expressed in E.coli [18-20]. In this thesis 
we have characterised purified native allergens further by 2D-electrophoresis (Chapter 4) 
and have expressed recombinant proteins also in the P. pastoris expression system (Chapter 
5). The protein characteristics of these three allergens are summarized in Table 6.1.  
 
As this thesis focusses mostly on the allergens Ana o 1, 2 and 3, a visual representation is 
provided in Figure 6.1. This Figure shows an SDS-PAGE of a total cashew nut protein extract 
and the purified allergens Ana o 1, 2 and 3 which are described in Chapter 3 of this thesis. 
Ana o 1 is a 50kDa vicilin (7S globulin), Ana o 2 is a 53kDa 11S globulin with acidic (30kDa) 
and basic (21kDa) subunits, Ana o 3 is a 2S albumin with large subunits of 8.1-8.4kDa 
(molecular weight on SDS-PAGE 10 and 8kDa) and a small subunit of 3.7-4.5kDa (molecular 
weight on SDS-PAGE 6kDa). A 53kDa band is indicated containing Ana o 2 protein [26]. 
 
 
 
 
 
 
Figure 6.1 SDS-PAGE of a total cashew nut protein 
extract, purified Ana o 1, purified Ana o 2, and 
purified Ana o 3. The molecular weights are 
indicated on the left. In the figure Ana o 1 is 
indicated (1, 50kDa), Ana o 2 acidic subunit (2A, 
±30kDa), Ana o 2 basic subunit (2B, ±21kDa), Ana o 
3 large subunits (3L, 10 and 8kDa), Ana o 3 small 
subunit (3S, 6kDa). *indicates a 53kDa protein band 
containing Ana o 2.  
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Table 6.1 Protein characteristics of cashew nut allergens Ana o 1, Ana o 2 and Ana o 3. Data obtained 
from Chapter 3 [26], Chapter 4 [27], and Chapter 5 [32] from this thesis, and from literature. 
Protein characteristics Ana o 1 Ana o 2 Ana o 3 
General protein 
characteristics 
Genbank number Ana o 1.0101 
AAM73730.2,  
Ana o 1.0102 
AAM73729.1 
AAN76862.1 AAL91665.1 
Protein family Vicilin, 7S globulin 
[20] 
Legumin, 11S 
globulin [19] 
2S albumin [18] 
Known by other names - Cashew major 
protein [29], 
Anacardein [31] 
- 
Leader peptide  Yes, M3-A28 [20] Yes, L1-A14 [19] Yes, M1-A20 [18] 
Recombinant 
expression E.coli 
Yes [20] Yes [19] Yes [18] 
Recombinant 
expression P. pastoris 
Yes [32] Yes [32] Yes [32] 
Protocol for 
purification available 
Yes [26] Yes [26] Yes [26, 33, 34]  
1D electrophoresis Molecular weight 
reduced 
50kDa [20, 26] 21, 30kDa [19, 26, 
30]  
10, 8, 6kDa [18, 26] 
Molecular weight 
native 
50kDa [20, 26] 53kDa [19, 26, 30] 12.6kDa [18] 
Subunits on SDS-PAGE No [20, 26] Yes, 30kDa acidic 
subunit, 21kDa 
basic subunit [19, 
26, 30] 
Yes, 8-10kDa large 
subunit, 6kDa small 
subunit [26] 
Quaternary structure Homo-trimer, 
150kDa [35] 
Homo-hexamer, 
±360kDa [35] 
Homo-monomer, 
12.6kDa [35] 
Disulphide bridges No Yes, 1 [33, 35] Yes, 4 [35, 36] 
Predicted N-
glycosylation 
Yes, N391 [26] No [26] Yes, N19 [26] 
Glycosylation (native) Yes [26] No [26] No [26] 
Mass spectrometry  N-terminal micro-
heterogeneity 
Unknown, not 
expected 
Unknown, not 
expected 
Yes, large and small 
subunit [26] 
C-terminal micro-
heterogeneity 
Unknown, not 
expected 
Unknown, not 
expected 
Yes, small subunit 
[26] 
Size of subunits No subunits Not done Large subunit 8.1-
8.4kDa, small 
subunit 3.7-4.5kDa 
[26] 
2D electrophoresis 
 
Isoelectric point 
calculated 
5.6 [27] 5.7 (acidic 
subunit), 8.9 
(basic subunit) 
[27] 
4.9 (large subunit) 
6.4-10.1 (small 
subunit) [27] 
Isoelectric point  5.4-5.8 [27] 5.4-6.3 (acidic 
subunit), 5.4-9.3 
(basic subunit) 
[27] 
4.4-5.4 (large 
subunit), small 
subunit not visible 
[27] 
Number of isoforms 
(spots) 
9 [27] 11 (acidic subunit) 
18 (basic subunit) 
[27] 
8 (large subunit) 
[27] 
Stability Pepsin digestibility 
(400μg protein, 126U 
Degraded [27] Degraded [27] Resistant [27],  
degraded after 
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pepsin, 60min) 60min when 
reduced [27] 
Trypsin digestibility 
(25μg protein, 20U 
trypsin, 5min) 
Degraded [33] Resistant [33] Resistant [33] 
Pepsin (25μg protein, 
0.8U pepsin, 30min) + 
trypsin (2U trypsin, 
30min) 
Degraded [33] Degraded [33] Partially degraded 
[33] 
Heat stability in-shell: 
steaming, frying, drum 
roasting 
Decreased 
solubility after 
steaming [27] 
Increased 
solubility after 
frying [27] 
Decreased solubility 
after frying [27] 
Heat stability de-
shelled: roasting 
Decreased 
solubility [28] 
Decreased 
solubility [28] 
Increased solubility 
[28] 
Heat stability de-
shelled: Blanching, γ -
irradiation, 
microwaving, dry 
roasting 
No effect on 
linear epitopes 
(antibody binding) 
[29] 
No effect on 
linear epitopes 
(antibody binding) 
[29] 
Decreased IgG 
binding to a 
conformational 
epitope [29] 
Heat stability: 
autoclaving 
Decreased mAb 
binding to linear 
epitopes [29] 
Decreased mAb 
binding to linear 
epitopes [29] 
Decreased IgG 
binding to a 
conformational 
epitope [29] 
pH stability Stable except pH 
1, 13 [29] 
Stable except pH 
1, 13 [29] 
Stable except pH 1, 
12, 13 [29] 
Difference 
between multiple 
cashew nut origins 
1D electrophoresis No significant 
differences [27] 
No significant 
differences [27] 
No significant 
differences [27] 
2D electrophoresis No significant 
differences [27] 
No significant 
differences [27] 
No significant 
differences [27] 
IgE binding 
characteristics  
Number of linear 
epitopes 
11 [20] 22 [19] 16 [18], 12 [26] 
Conformational 
epitopes 
Unknown 1 [30, 31] Unknown 
IgE reactive isoforms 
2D electrophoresis 
9/9 [27] 11/11 (acidic 
subunit) 
11/18 (basic 
subunit) [27] 
4/8 [27] 
Clinical 
characteristics 
sIgE cashew nut 
allergic children 
2.0 kU/l [2] 6.3 kU/l [2] 13.0 kU/l [2] 
sIgE cashew nut 
sensitized children (not 
allergic) 
0.2 kU/l [2] 1.2 kU/l [2] 0.6 kU/l [2] 
Predictive value for 
cashew nut allergy 
Predictive [2] Predictive [2] Predictive [2, 37, 38] 
Cross-reactivity Homology to other 
proteins 
80% identical to 
Pis v 3 [39], 
27% identical to 
Ara h 1 [20] 
48% identical to 
Pis v 2 [40], 
43% identical to 
Ara h 3, 42% 
identical to Ara h 
4 [19] 
64% identical to Pis 
v 1 [40] 
 
In vitro cross-reactivity Pis v 3 [39] Pis v 2 [40] Pis v 1 [40] 
Clinical cross-reactivity Pistachio [38-43], mango [44-46]  
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The development of allergies towards cashew nut proteins is not unexpected since vicilin 
proteins (Ana o 1), 11S globulins (Ana o 2), and 2S albumins (Ana o 3) have been identified as 
allergens in a multitude of plants, including most tree nuts. Vicilin proteins, like Ana o 1, 
have been identified in, among others, chickpea (Cic a 1), coconut (Coc n 1), hazelnut (Cor a 
11), lentil (Len c 1), peanut (Ara h 1), pea (Pis s 1, Pis s 2), pecan (Car i 2), pistachio (Pis v 3), 
sesame (Ses i 3), soy (Gly m 5), and walnut (Jug r 2) [48]. 11S Globulins, such as Ana o 2, have 
been identified in almond (Pru du 6), Brazil nut (Ber e 2), chickpea (Cic a 6), coconut (Coc n 
4), hazelnut (Cor a 9), kiwi (Act d 12), peanut (Ara h 3, Ara h 4), pecan (Car i 4), pistachio (Pis 
v 2, Pis v 5), sesame (Ses i 6, Ses i 7), soy (Gly m 6), walnut (Jug r 4), and white mustard (Sin a 
2) [48]. 2S Albumins, like Ana o 3, have been identified in Brazil nut (Ber e 1), butternut (Jug 
ca 1), castor bean (Ric c 1, Ric c 3), hazelnut (Cor a 14), kiwi (Act d 13), oriental mustard (Bra j 
1), peanut (Ara h 2, Ara h 6, Ara h 7), pecan (Car i 1), pistachio (Pis v 1), rapeseed (Bra n 1), 
sesame (Ses i 1, Ses i 2), soy (Gly m 8), walnut (Jug n 1, Jug r 1), and white mustard (Sin a 1) 
[48]. Not only do these three allergens have much in common with other allergenic proteins, 
but also many other common characteristics of allergenic proteins can be noticed for these 
three allergens (see Table 6.2):  
1. First of all, a crucial requirement for proteins to act as allergens is to contain at least 
two IgE-binding epitopes. Without these two epitopes, the required cross-linking of 
two IgE molecules cannot occur, and no allergic reaction will take place. Ana o 1 
contains 11 linear epitopes [20], Ana o 2 contains 22 linear epitopes [19], as well as at 
least one conformational epitope [30, 31], and Ana o 3 contains at least 12 [26] or 16 
[18] epitopes. The difference in number of epitopes detected in our study (12 
epitopes, Chapter 3) and in the paper of Robotham et al. (16 epitopes [18]) might 
have been caused by the different patient serum used (derived from American adults 
with self-reported cashew nut allergy), different method of peptide production, 
different manner of IgE detection on blot, or it could be caused by a difference in cut-
off point of positive IgE binding. In our study, not only did we detect 9 epitopes 
within the large and small subunit of Ana o 3, we also detected 3 mildly IgE-reactive 
epitopes in the leader peptide of Ana o 3. This leader peptide was not included in the 
epitope analysis of Robotham et al. A leader peptide (signal peptide) directs the 
transport of the protein towards the endoplasmic reticulum, and is cleaved from the 
pre-protein, after which the leader peptide is expected to be degraded [49]. As it is 
not certain that all leader peptides of Ana o 3 are degraded in the edible nut, we 
choose to take along the leader peptide in our epitope analysis.  
2. Secondly, Ana o 1, 2 and 3 all three function as seed storage proteins. In general, 
allergens are not enzymatic or structural proteins that are metabolically required in 
the plant [50].  
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3. Next, most allergens have a molecular mass between 10 and 60kDa [51, 52], a 
molecular weight range that includes Ana o 1 (50kDa), 2 (53kDa) and 3 (12.6kDa).  
4. Also, high abundance of a protein (>1% of the total protein content [53] is an often 
occurring characteristic of allergenic proteins that is also observed for Ana o 1 (±4%), 
Ana o 2 (±52%), and Ana o 3 (±25%) (Chapter 4). It is likely that this high abundance 
increases the likelihood of (part of) the protein surviving the digestive tract, and 
coming into contact with the immune system, possibly setting off a sensitization 
reaction.  
5. Besides the high abundance of allergenic proteins within the total protein content, 
also the total protein content is often relatively high (>20%) in allergenic foods [54]. 
Many allergenic foods with a protein content <30% often have high levels of fat, 
while non-allergenic foods with a protein content <30% often have high levels of 
carbohydrates. The food matrix might interfere with the digestion process by 
competition (protein) [55], and by protecting the proteins inside lipid structures [56]. 
Cashew nuts have both a high protein content (±16.8%) (Chapter 4), and a high lipid 
content (±50%) [57-60].  
6. This before-mentioned characteristic (high protein content) is also related with 
higher levels of glycation (Maillard reaction) [61]. Roasting of cashew nuts increases 
the presence of advanced glycation end products (AGEs) from 6730kU/100g to 
9807kU/100g cashew nuts. The formation of AGEs is stronger during high heat low 
moisture processing steps (dry roasting, frying), compared to heating steps in the 
presence of water (e.g. steaming, boiling) [61]. In Chapter 3 we described that, of the 
cashew nut allergens, only Ana o 1 is glycosylated. Upon heating, no glycation of the 
cashew nut proteins was observed in our study (Chapter 4), however, the heating 
was applied to cashew nuts within the shell, shielding the nuts from the heat. Indeed, 
upon removal of the shell, there was no difference in colour between raw and heated 
(20min 100˚C steamed, 2min 180˚C fried, 8min 150˚C drum roasted) cashew nuts 
[27]. In the raw, as well in as the heated cashew nuts, a strongly glycated 3kDa 
cashew nut protein was detected [26, 62]. This 3kDa protein has not been recognised 
as an allergen by western blotting, possibly this 3kDa protein is too small to contain 
multiple epitopes [56]. Glycation may also influence a proteins’ allergenicity. Huby et 
al. stated that many allergens are glycosylated [63]. The effect of glycation on the 
allergenic reaction is not yet fully determined. For example, in peanut, glycation of 
raw Ara h 1 (7S vicilin) did not alter its’ immunoreactivity (reverse EAST inhibition 
assay) [64], while glycation of Ara h 2 and Ara h 6 (2S albumins) reduced IgE binding 
(ELISA) [65], glycated rAra h 2 increased IgE binding (ELISA, EAST assay) [66], and 
glycation of a total peanut protein extract increased IgE binding (western blot) [67].  
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7. A second to last characteristic that is often observed in protein allergens, is stability 
of their immunological properties to (in vitro) digestion [56, 68, 69]. For example 
peanut allergens have been shown to be still immunologically active after gastric 
digestion [70]. However, resistance to digestibility does not always provide a clear 
distinction between allergenic and non-allergenic proteins [71], and results can differ 
between studies [72]. Overall, 2S albumins (Brazil nut, mustard, soy, sunflower seed) 
seem to be consistently stable against pepsin digestion [72]. In Chapter 4, we 
reported that, of the three allergens, the 2S albumin Ana o 3 is most resistant to 
pepsin digestion. After 60min of pepsin digestion, using physiologically relevant 
levels of pepsin [56], Ana o 3 was still detectable on SDS-PAGE, while Ana o 1 and 2 
were not. No difference in pepsin digestibility was observed between proteins 
obtained from cashew nuts that had been exposed to different heat treatments in-
shell. When the cashew nut proteins were reduced by urea and DTT before pepsin 
digestion, disrupting the disulphide bridges and thereby the protein conformation, 
Ana o 3 was more easily digested. With this experiment the critical role of the 
disulphide bridges for digestion stability is demonstrated.  
Mattison et al. [33], also observed a higher pepsin digestion stability of Ana o 3 
compared to Ana o 1 and 2. In their study mass spectrometric analysis revealed the 
presence of 5-15kDa polypeptides from both Ana o 2 and Ana o 3 after pepsin 
digestion [33]. As we have not performed such an analysis on our digested proteins, 
we cannot confirm if protein fragments of Ana o 2 were obscured by the protein 
bands of Ana o 3. However, it should be noted that Mattison et al. used about ten 
times less pepsin in this analysis. Also, we did not observe protein bands above 
12kDa (Chapter 4), and in our data the protein pattern on SDS-PAGE in the 6- 10kDa 
range of the digested proteins, is identical to the non-digested protein pattern of Ana 
o 3 in this same 6-10kDa range. Mattison et al. also studied cashew nut protein 
digestion, using both pepsin and trypsin, each for 30 minutes [33]. Only 10kDa 
proteins were visible after this digestion step, containing mostly Ana o 3 and minor 
amounts of Ana o 2 polypeptides [33].  
It is important to realise that a protein that is more easily digested, is expected to be 
less allergenic as the chance of sensitization is less than for digestion-stable proteins. 
Once a person is allergic, however, the allergic reaction often occurs quickly after 
consumption of the allergen [73], before the proteins reach the digestive enzymes. 
For peanut it was shown that uptake of immune-reactive peanut polypeptides, 
occurred already 10 minutes after ingestion of the peanuts [74]. The absorption of 
immune-reactive peanut polypeptides seemed to already start in the mouth, no 
swallowing of the peanuts seems necessary [74].  
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8. Lastly, stability of their immunological properties upon (heat-) processing, is a 
frequently observed characteristic of allergenic proteins [70]. As summarized by 
Rahaman et al. [75], processing may enhance, reduce, or have no effect on protein 
allergenicity [75]. Processing-induced modifications, such as unfolding, aggregation, 
glycosylation, and enzymatic hydrolysis, can lead to the disruption and the exposure 
of linear and conformational epitopes [75]. For example, roasting of peanut can 
increase IgE binding (ELISA) to the total protein [76]. Roasting of purified Ara h 1 (7s 
globulin) did not change its IgE binding capacity (EAST assay) [64], while boiling 
purified Ara h 1 induced the formation of large aggregates and decreased its IgE 
binding capacity (EAST assay, histamine release by RBL cells) [64]. For cashew nut 
proteins, dark roasting strongly increased the solubility of Ana o 3, and decreased the 
solubility of Ana o 1 and 2 as shown on SDS-PAGE and confirmed by ELISA (human 
IgE, polyclonal rabbit anti-cashew) [28]. Blanching, γ -irradiation, microwaving, and 
dry roasting did not affect Ana o 1 and 2 binding by a mAb [29]. IgG binding to Ana o 
1 and 2 was however affected after 20-30minutes autoclaving, and after incubation 
at pH 1 and 13. IgG binding of the mAb to Ana o 3 was reduced after blanching, 
roasting, and autoclaving [29]. However, the specific mAb used in that study targets a 
conformational epitope of Ana o 3, so no conclusion can be drawn on the effect of 
these heat treatments on the linear epitopes of Ana o 3. When studying the effect of 
blanching on the protein composition of food items, it should be kept in mind that 
proteins can leak into the boiling water. In Figure 6.2, both a raw and a blanched 
(10min 100˚C) cashew nut protein extract, as well as the concentrated blanching 
water are presented. Multiple cashew nut proteins elute into the cooking water (lane 
blanching water), but as Ana o 2 is the most prevalent protein, this is also the most 
prevalent protein in the cooking water. About 0.2% of the proteins eluted from the 
cooking water in this experiment. Venkatachalam et al. indicated that Ana o 1, 2 and 
3 all elute into the cooking water (western blotting, mAb) [29]. Elution of allergens 
into the cooking water has also been described for peanut [77].  
Cashew nuts always undergo multiple heating steps before they are ready for 
consumption. As described in Chapter 1, the nut is first heated within its shell, and a 
second heat treatment is later applied to the de-shelled cashew nuts [78]. In Chapter 
4 we have described the effect of this first (in-shell) heat treatment on the cashew 
nut proteins. Only small differences in protein composition (1D and 2D 
electrophoresis) were detected between cashews subjected, in-shell, to steaming, 
frying, and drum roasting. For example the quantity of extracted Ana o 1 was lower in 
steamed cashew nuts than in fried cashew nuts, the quantity of extracted Ana o 2 
was higher in fried cashew nuts than in raw cashew nuts, and the quantity of Ana o 3 
was lower in fried cashew nuts than in raw or drum roasted cashew nuts [27]. No 
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difference in IgE binding was noted between the differently heat-treated cashew 
nuts. The higher level of soluble Ana o 3 in the drum roasted cashews was seen 
before [28], however, the increase observed by Mattison et al. was much higher (40% 
[28]) compared to our results (3%). This difference can be explained by the shorter 
roasting time applied in our study, and by the moderating effect of the thick cashew 
nut shell in our study, as we applied 8min 150˚C to in-shell cashew nuts [27], and 
Mattison et al. applied 24min 149˚C to de-shelled cashew nuts [28]. 
 
 Table 6.2 Allergenic characteristics of Ana o 1, Ana o 2, and Ana o 3. Data obtained from literature, 
and from Chapter 3 [26] and Chapter 4 [27] from this thesis. Symbols indicate high (),intermediate 
(±), and no () correlation with allergenicity. 
Characteristic Ana o 1 Ana o 2 Ana o 3 
Homology to other 
allergens 
80% identical to 
Pis v 3 [39], 
27% identical to 
Ara h 1 [20] 
 48% identical to Pis v 
2 [40], 
43% identical to Ara h 
3, 42$ identical to Ara 
h 4 [19] 
 64% identical to Pis v 
1 [40] 
 
 
Multiple epitopes 11 linear [20]  22 linear [19] 
1 conformational [30, 
31] 
 12-16 linear [18, 26]  
No daily used protein 7S globulin, seed 
storage protein 
 7S globulin, seed 
storage protein  
 2S albumin, seed 
storage protein  
 
Protein 10-60kDa 50kDa [20, 26]  53kDa (30+21kDa 
subunits) [19, 26] 
 12.6kDa [18, 26]  
High abundance specific 
protein (>1%) 
4% [27]  52% [27]  25% [27]  
High total protein levels, 
high fat levels 
±16.8% protein 
[27], ±50% lipid 
[57-60] 
 ±16.8% protein [27], 
±50% lipid [57-60] 
 ±16.8% protein [27], 
±50% lipid [57-60] 
 
Glycation Yes [26]  No [26]  No [26]  
Digestion stability Low [27, 33]  Middle [27, 33] ± High [27, 33]  
In-shell processing 
stability (steam, fry, drum 
roast)  
Only minor 
effects on protein 
solubility [27] 
 Only minor effects on 
protein solubility [27] 
 Only minor effects on 
protein solubility [27] 
 
De-shelled processing 
stability (Blanching, γ -
irradiation, microwaving, 
dry roasting) 
No effect on 
linear epitopes 
(antibody 
binding) [29] 
 No effect on linear 
epitopes (antibody 
binding) [29] 
 Decreased IgG binding 
to a conformational 
epitope [29] 
± 
De-shelled processing 
stability (autoclaving, pH 1 
or 13) 
Decreased mAb 
binding to linear 
epitopes [29] 
 Decreased mAb 
binding to linear 
epitopes [29] 
 Decreased IgG binding 
to a conformational 
epitope [29] 
± 
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Figure 6.2 Total protein extract of raw and blanched (10min 
100˚C) acetone-defatted cashew nuts (0.1 M ammonium 
bicarbonate, 0.5M NaCl, 1:5 w/v o/n), 15µg protein loading. 
Blanching water is 20 times concentrated by evaporation. The 
molecular weights are indicated on the left. 
 
 
 
 
Taken together, Ana o 1, 2 and 3 are important and highly stable cashew nut allergens. In 
Chapter 4 we have proven that cashew nuts, derived from different origins, all contain Ana o 
1, 2 and 3 in similar quantities (as judged from 1D and 2D electrophoresis). Also, no 
differences were observed in the allergenic isoforms present in the cashew nuts of different 
origins, as determined by 2D electrophoresis [27]. These results indicate that for the 
available literature on cashew nuts, each study using different cashew nuts, these 
parameters are not likely to explain differences in characteristics of cashew nut allergens 
between different studies.  
 
Both the cDNA sequences for the recombinant production of Ana o 1, 2 and 3, as well as the 
molecular weight of the three allergens were based on publications by the group of dr 
Kenneth Roux (Florida State University). However, some conflicting results between our 
results and their publications were obtained and described here:  
First of all, Ana o 1 is labelled as a major allergen as IgE from 50% (10/20) of a group of 
cashew allergic patients bound recombinant Ana o 1 [20]. In our studies, we have not 
performed dot blotting or western blotting experiments with purified or recombinant Ana o 
1 with single sera. We have always used serum pools in order to minimize the amount of 
serum needed for the experiments. The patients in this study were children, and therefore 
limited amount of blood was drawn at the medical centres. When pooling sera, specific IgE is 
diluted resulting in a less strong IgE binding pattern, but high levels of specific IgE from one 
person can skew the IgE binding pattern from the pool towards a single allergen. In our study 
we have had difficulties with some serum pools to detect IgE binding to Ana o 1, while IgE 
binding to Ana o 2 and Ana o 3, both also major allergens [18, 19] was almost always 
detected. A difference in population or age of the patients might explain these differences in 
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IgE binding patterns [79, 80]. Furthermore, the IgE levels of the cashew allergic children 
(positive DBPCFC) to Ana o 1 are lower (2.0 kU/l) than the IgE levels to Ana o 2 (6.3 kU/l) and 
Ana o 3 (13.0 kU/l) [2]. Possibly the pooling of the sera, combined with the low quantity of 
Ana o 1 in the protein extracts (4% Chapter 4), lead to the occasional difficulty in detecting 
Ana o 1 on western blot.  
Secondly, in Chapter 3, we have tentatively identified a 53kDa protein from reducing SDS-
PAGE as the monomeric form of Ana o 2. Under non-reducing conditions, more of this 53kDa 
protein is detected on SDS-PAGE. However, it was expected that reduced Ana o 2 would only 
be present in the form of acidic and basic subunits, and not as a 53kDa primary translation 
product. Wang et al. also detected Ana o 2 in this 53kDa protein band, as inhibition western 
blotting, using E.coli-expressed rAna o 2 as inhibitor, decreased IgE binding to this 53kDa 
protein [19]. Possibly not enough β-mercaptoethanol was added to reduce Ana o 2 fully. On 
the other hand, since as much as 10% β-mercaptoethanol is added to reduce the proteins, 
and as purified Ana o 2 does not display this 53kDa protein band, it is not expected that this 
is the reason. Most likely not all Ana o 2 is cleaved into subunits during the formation of this 
protein. This also implies that this 53kDa monomeric Ana o 2 is not present in the purified 
Ana o 2 since it is not detected on SDS-PAGE.  
Thirdly, the study of Ana o 3 resulted in some results that conflicted with data from 
literature. The first puzzle that needed to be solved was the molecular weight of Ana o 3. 
Ana o 3 is reported as a 12.6kDa protein [18], while on reducing SDS-PAGE Ana o 3 is 
detected as three protein bands of 10, 8 and 6kDa (Figure 6.1). A 2S albumin is usually 
synthesized as a precursor polypeptide, which is subsequently cleaved into a large (8-10kDa) 
and a small subunit (3-4kDa) [36]. We were curious what subunits of Ana o 3 are present at 
what molecular weight on SDS-PAGE, since 8 and 4kDa subunits were expected, while 10, 8 
and 6kDa subunits were detected. Furthermore, Robotham et al. reported that all three 
protein bands were large subunit polypeptides of Ana o 3, as all three had a similar N-
terminal amino acid sequence. The small subunit was not mentioned in this study. As 
described in Chapter 3, we detected polypeptides of the large subunit in the 10 and 8kDa 
protein bands, while small subunit polypeptides were detected in the 6kDa protein band. 
Furthermore, N- and C-terminal micro-heterogeneity (terminal clipping) was detected in the 
small subunit of Ana o 3, only minimal C-terminal micro-heterogeneity was detected in the 
large subunit. These results are in contrast with the data from Robotham et al. as they 
observed large subunit N-terminal amino acids in the 6kDa protein band. As the three 
protein bands are very close together on SDS-PAGE, it might be that proteins from the 8kDa 
protein band, but not the 6kDa protein band was analysed by Robotham et al. No N-terminal 
clipping was reported by Robotham et al., matching our results that no N-terminal clipping 
occurs in the large subunit.  
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For major fish allergen parvalbumin it was suggested, based on protein sequence 
comparisons and an allergen database, that protein sequence micro-heterogeneity is related 
to increased protein isoform allergenicity [81]. Of course, micro-heterogeneity might also 
reduce IgE binding [82], for example when occurring in the epitopes of the allergen. As 
reported in Chapter 4, the N- and C-terminal micro-heterogeneity of Ana o 3 in cashew nuts 
from 8 different origins was highly similar. Therefore no difference in allergenicity is 
expected between Ana o 3 proteins from different origins. Also it should be noted that most 
micro-heterogeneity for Ana o 3 was detected in the N-terminus of the small subunit. We 
have not detected any epitopes in that region (Chapter 3), but Robotham et al. [18] did.  
The second puzzle concerning Ana o 3, concerns the IgE binding to the small subunit (6kDa 
protein band) of Ana o 3. Despite the presence of 3 (Chapter 3) to 7 [18] epitopes on the 
small subunit of Ana o 3, no IgE binding was observed in any of the multiple western blots 
we have performed. In literature, only Teuber et al. depicts a western blot showing clear IgE 
binding to all three protein bands of Ana o 3 [83]. This difference in IgE binding can be 
explained by a difference in serum used on the western blot, our study population 
apparently binds stronger to the large subunit of Ana o 3 than to the small subunit.  
 
In Chapter 4, we have reported that Ana o 1, Ana o 2, and Ana o 3, all contain multiple 
isoforms. Based on 2D electrophoresis and western blot of both the purified allergens and a 
total cashew nut protein extract, the isoforms of Ana o 1, 2 and 3 were tentatively identified. 
We detected 9 isoforms of Ana o 1, 29 isoforms of Ana o 2 (11 isoforms of the acidic subunit, 
18 spots of the basic subunit), and 8 isoforms of Ana o 3 (4 isoforms of the 10kDa large 
subunit, 4 isoforms of the 8kDa large subunit, the small subunit was not observed on 2D 
electrophoresis). Occurrence of these different isoforms is expected to be due to post-
translational modifications such as phosphorylation, glycosylation (Ana o 1), acetylation, etc. 
Upon western blotting IgE was bound by all isoforms of Ana o 1, all isoforms of the large 
subunit of Ana o 2, 11 out of 18 isoforms of the small subunit of Ana o 2, and 4 out of the 8 
isoforms of the large subunit of Ana o 3. The absence of IgE binding to some of the isoforms 
of Ana o 2 and 3 might be patient-specific as only one plasma pool was used for these 
western blots, but it is also possible that the epitopes of these specific isoforms are different 
from the other isoforms. A last reason for the lack of IgE binding to some of the allergen 
isoforms is that these might be different proteins, which were not detected on 1D SDS-PAGE 
because of the similarity in molecular weight with the purified allergen. Future experiments 
should include protein sequencing experiments in order to confirm the identity of these 
tentatively identified allergen isoforms.  
 
The allergens Ana o 1, 2 and 3 were purified in Chapter 3. The purity of these samples was 
96% for Ana o 1, 93% for Ana o 2, and 99% for Ana o 3, as based on SDS-PAGE analysis, and 
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88% for Ana o 3 as based on HPLC analysis. Based on 2D electrophoresis and 2D western 
blot, Ana o 1 seems indeed of high purity; all 50kDa protein spots bound IgE, indicating, but 
not yet confirming, all protein spots are isoforms of Ana o 1. A minor impurity of 30kDa was 
detected both on 1D (Chapter 3) and 2D electrophoresis (Chapter 4). This impurity is most 
likely the acidic subunit of Ana o 2 as it is bound by IgE upon western blotting. On inhibition 
western blot (total cashew nut protein western blot with plasma pre-incubated with purified 
Ana o 1), IgE binding to Ana o 1, but also partially to Ana o 2 and 3, was inhibited by purified 
Ana o 1. The impurity of Ana o 2 in the purified Ana o 1 extract explains the inhibition of IgE 
binding to Ana o 2. The impurity might be only a small percentage, but for inhibition a large 
quantity of protein was used (1mg/ml). Next, the inhibition of Ana o 3 can be caused by 
possible cross-reactivity between 7S globulins and 2S albumins [84].  
The purity of Ana o 2 is high based on 1D SDS-PAGE (93%), however, it should be noted that 
the 53kDa monomeric Ana o 2 is not detected in the purified protein sample (Chapter 3, 4). 
Furthermore, western blotting of a 2D electrophoresis gel of purified Ana o 2 indicates that 
not all protein spots bind IgE (Chapter 4). These non-IgE reactive proteins could be Ana o 2 
with modifications in the epitope region, otherwise these proteins might be impurities with 
the same molecular weight as Ana o 2. The purity of this sample should be confirmed by 
HPLC analysis, and protein identification analysis should be performed on the 2D 
electrophoresis protein spots.  
The highest purity was observed for Ana o 3 (99%). On 1D SDS-PAGE no impurities were 
observed, while on 2D electrophoresis not every protein spot was bound by IgE. Again, as for 
Ana o 2, either these protein spots are isoforms of Ana o 3 with a difference in the epitopes, 
or these protein spots are impurities of the same molecular weight as Ana o 3.  
 
Besides the known allergens Ana o 1, 2 and 3, it is highly likely that also other allergens are 
present in cashew nuts. In peanut for example, 11 allergens have been detected: 7S vicilin 
Ara h 1, 11S globulin Ara h 3 and 4, 2S albumin Ara h 2, 6, and 7, profilin Ara h 5, 
pathogenesis related (PR) Ara h 8, nonspecific lipid transfer protein (nsLTP) Ara h 9, and 
oleosin Ara h 10 and 11 [85]. In tree nuts, such as almond, chestnut, hazelnut, and walnut 
also similar allergens (nsLTP, oleosin, profilin, PR) have been identified [86, 87]. On our 
western blots (Chapter 3, 4) several IgE-binding protein bands are observed that are not Ana 
o 1, 2 or 3: E.g. 80, 60, 40, 17, and 13kDa protein bands. Based on the protein size 
comparison with the peanut allergens, the 13kDa cashew nut protein might be a profilin, and 
the 17kDa protein could be a PR protein. The nsLTP proteins have a similar molecular weight 
as Ana o 3 (7-9kDa [35]), which makes the identification of this protein difficult. The 60kDa 
IgE-binding cashew nut protein is of comparable molecular weight as Ara h 1 (7S vicilin) and 
Ara h 3 and 4 (11S globulins). Oleosins are fat-soluble proteins, and as cashew nuts are often 
defatted prior to protein extraction, such proteins are likely not to be detected on western 
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blot. Also in the experiments in this thesis the cashew nuts were defatted prior to protein 
extraction, therefore it is expected that no oleosins were present on SDS-PAGE or western 
blot. It is highly recommended that further protein identification studies should be 
performed concerning these unknown allergens from cashew nut.  
 
Co-sensitization 
Of the children that participated in the IDEAL study, 50% reported having experienced an 
allergic reaction towards pistachio, 7% to mango, 22% to hazelnut, and 34% to peanut, after 
consumption of these foods. Based on serum IgE (sIgE) measurements in all cashew nut sIgE-
sensitized children, 98% children were co-sensitized to pistachio, 21% to mango, 69% to 
hazelnut, and 62% to peanut. Co-sensitization of children when measured by skin prick test 
(SPT) in cashew nut sensitized children (positive cashew nut SPT), resulted in 92% co-
sensitization to pistachio, 19% to mango, 44% to hazelnut, and 59% to peanut [1]. As can be 
observed from Figure 6.3, mango (Mangifera indica, fruit) and pistachio (Pistacia vera, 
nut/seed) belong, together with cashew nut (Anacardium occidentale), sumac (Rhus coriaria, 
spice), and pink pepper (Schinus molle and Schinis terebinthifolius, berry used as spice), to 
the Anacardiaceae family. Besides the Anacardiaceae family, also other tree nuts beside 
cashew nut and pistachio are indicated in this figure. Peanut is not included in this figure as 
it is not a tree nut.  
 
Table 6.3 Allergens known from cashew nut, pistachio, mango and pink pepper. Allergen with 
molecular weight in native (N) or reduced (R) state. Besides these allergens the protein sequence of 
several other proteins, e.g. rubisco and energy metabolism related proteins, are known for all four 
mentioned foods (NCBI, protein index).  
 
7S 
globulin 
11S 
globulin 
2S 
albumin 
Profillin Chitinase Other 
Cashew Ana o 1 
(N+R 
50kDa) 
[20, 26] 
Ana o 2  
(N 53kDa, 
R 
21,30kDa) 
[19, 26, 
33]  
Ana o 3  
(N 13kDa, 
 R 10, 8, 
6kDa) [26, 
96] 
     
Pistachio Pis v 3  
(R 
45kDa) 
[39] 
Pis v 2 
(R 32kDa) 
[40] 
Pis v 5 (R 
36kDa) 
[48] 
Pis v 1  
(R 7kDa) 
[40] 
  Pis v 4  
(R 26kDa, 
manganese 
superoxide 
dismutase,[48, 
97]) 
  
Mango    Man i 
3.01,  
Man i 
3.02 
[48] 
Unnamed 
chitinase 
(R 46kDa) 
[48, 98]  
Unnamed Bet v 
1-like protein  
(R 14kDa) [48] 
Man i 1 
(R 
40kDa)  
[48, 99] 
Man i 2 
(R 
30kDa)  
[48, 99] 
Pink 
pepper 
Unknown 
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Because of the high co-sensitization rate of cashew nut allergic patients to pistachio and 
hazelnut that was observed in the children in our study, we initiated a sub-study into co-
sensitization towards multiple tree nuts and Anacardiaceae family members: cashew nut, 
mango, pink pepper, pistachio, sumac, pine nut, Brazil nut, chestnut, hazelnut, pecan, 
walnut, macadamia, and almond.  
 
The chance of having an allergy to more than one tree nut is considerable: 35-37% based on 
clinical history [88, 89], or 14% (2/14) based on food challenges [90]. Allergic cross-reactivity 
between cashew nut and pistachio has been well-described [41-43, 91], and avoidance of 
both nuts is advised when diagnosed with cashew nut allergy [92]. More specifically, the 
cashew nut allergen Ana o 1 and the pistachio allergen Pis v 3, both vicilin proteins, display 
substantial cross-reactivity [39]. Considering cross-reactivity within the Anacardiaceae 
family, less research has been done compared to tree nut cross-reactivity. A few cases have 
been reported where mango allergic individuals were also allergic to pistachio [93], cashew 
[94], or cashew apple [95]. Other studies on cross-reactivity between cashew and other 
members of the Anacardiaceae family, such as pink pepper or sumac, could not be found. An 
overview of all allergens described from cashew, pistachio and mango is presented in Table 
6.3. 
 
For this cross-allergenicity study, protein was extracted from raw nuts and fruits (cashew 
nut, mango, pink pepper, pistachio, sumac, pine nut, Brazil nut, chestnut, hazelnut, pecan, 
walnut, macadamia, almond) into an urea buffer (8M Urea, 20mM Sodium Phosphate pH7, 
1mM NaCl), and into a tris buffer (20mM Tris pH7.6, 150mM NaCl, 1mM EDTA). The tris and 
urea protein extracts were mixed 1:1 based on equal protein concentrations. Dot blots were 
spotted in duplicate with 250ng protein from the mixed tris/urea protein extracts. The sera 
of 57 IDEAL-study patients were studied on dot blot. Of these 57 patients, 14 tested negative 
for cashew nut allergy in the DBPCFC [1], 41 tested positive, and 2 were undecided. Based on 
the dot blots, the 57 patients could be categorized into four groups:  
 Group 1, Anacardiaceae sensitized: positive for cashew nut, positive for at least one 
other member of the Anacardiaceae family, positive for up to one tree nut outside 
the Anacardiaceae family; 7 patients (7/7 positive DBPCFC): serum pool 1.  
 Group 2, cashew nut sensitized: positive for cashew nut, not positive for other 
members of the Anacardiaceae family, positive for up to two tree nuts outside the 
Anacardiaceae family; 18 patients (14/18 positive DBPCFC).  
 Group 3, Anacardiaceae and tree nut sensitized: positive for cashew nut, positive for 
at least one other members of the Anacardiaceae family, positive for more than two 
tree nuts outside the Anacardiaceae family; 11 patients (8/11 positive DBPCFC): 
serum pool 3.  
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 Group 4, not cashew nut sensitized: not positive for cashew nut; 21 patients (12/21 
DBPCFC positive, 2/21 undecided DBPCFC).  
 
In group 4, false negative results were obtained in 12 out of 20 patients that did not show 
IgE binding to cashew nut proteins on dot blot but are allergic to cashew nuts as diagnosed 
by DBPCFC. These results might be caused by the use of raw cashew nuts for the dot blots, 
while in the DBPCFC roasted cashew nuts were incorporated into muffins. Furthermore 
these muffins contained sugar and were heated, quite likely causing Maillard reactions, 
possibly forming glycated cashew nut proteins, which may increase allergic reactivity [66, 
67]. Also it is possible that during the protein extraction certain allergens, such as fat soluble 
oleosins, are missed, and are therefore not present on dot blot while having been present in 
the muffin. Lastly, the possibility was considered that these patients experienced mainly oral 
or abdominal complaints during the DBPCFC. Experience of mostly oral complaints could be 
an indication that these patients responded to unstable proteins, which were denatured by 
the low pH of the stomach, and which were then possibly also denatured by the high levels 
of urea in one of the extraction buffers. Experience of mostly abdominal complaints could be 
an indication that these patients responded to epitopes which are hidden inside the 
proteins, exposed only after the denaturing effect of the stomach, which might not occur in 
the protein extraction buffer for the dot blot. However, no significant difference was 
detected in the occurrence of oral or abdominal complaints (nausea, vomiting, and 
diarrhoea) between the patients with false negative dot blot results and the patients 
responding positive on both dot bot and DBPCFC. The false positive results obtained in this 
experiment (7/36 patients) are expected to be due to the presence of IgE in sensitized, but 
not allergic, individuals.  
 
Western blotting (Figure 6.4) was performed on cashew nut, pistachio, mango, pink pepper, 
and sumac proteins, using two serum pools; serum pool 1 (patient group 1, Anacardiaceae 
sensitized) and serum pool 2 (patient group 3, Anacardiaceae and tree nut sensitized). 
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Figure 6.4 SDS-PAGE (A) and western blot (B, C) of cashew (1), pistachio (2), mango (3), pink pepper 
(4), and sumac (5) proteins. For western blot B serum pool 1 was used, for western blot C serum pool 
3 was used. The protein bands are indicated on the left in the five lanes of SDS-PAGE and western 
blot.  
 
The IgE of the two groups of cashew-sensitized patients bound the cashew nut, pistachio, 
mango, pink pepper and sumac proteins in a distinct pattern. IgE from serum pool 1 binds 
larger molecular weight proteins (>50kDa), while the IgE from serum pool 3 binds more to 
proteins in the 15-50kDa range. Both serum pools bind equally to the small molecular weight 
proteins of 8-10kDa (presumed 2S albumins; Ana o 3 and Pis v 1). The proteins from sumac 
did not separate well on SDS-PAGE. It is unsure if the lack of IgE binding to sumac (Figure 6.4, 
B and C, lane 5) on western blot is caused by the lack of sumac protein-specific IgE or by the 
lack of proper separation of the sumac proteins.  
 
Based on Table 6.3, some of the protein bands, detected on SDS-PAGE and western blot, 
were tentatively named. Lane 1, cashew nut, shows IgE binding to Ana o 2 (protein band 2 
the 53kDa monomeric protein, protein band 4-5 the basic and acidic subunits) and Ana o 3 
(8kDa, band 6 the large subunit). Lane 2, pistachio, shows IgE binding to 7S globulin Pis v 3 
(41kDa, band 9), 11S globulin Pis v 5 (34kDa, band 10), 11S globulin Pis v 2 (32kDa, band 11), 
Pis v 4 (26kDa, band 13), and 2S albumin Pis v 1 (9kDa, band 16). IgE binding to mango 
proteins, lane 3, occurred to Man i 1 (42kDa, band 17), and Man I 2 (33kDa, band 19). As no 
allergenic proteins are known from pink pepper, no bands could be identified from western 
blot, however, the molecular weight of band 22 and band 28 could possibly indicate these to 
be a 11S globulin (52kDa, band 22) and a 2S albumin (8kDa, band 28). The occurence of seed 
storage proteins such as 11S and 2S albumins in the pink pepper berry is possible as these 
seed storage proteins are recognised as allergens in various plants such as tomato, kiwi, soy, 
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lupine, rapeseed, and chickpea [48]. It is likely that the high levels of co-sensitization 
between cashew nut and pistachio, observed in the children participating in the IDEAL study, 
is due to the presence of 7S, 11S and 2S albumins in both nuts. Whether or not pink pepper 
should also be avoided by these children is not yet fully determined. First SPT and sIgE 
measurements, and possibly DBPCFC tests should be performed to confirm our results in 
vivo.  
The presence of IgE against mango proteins in the serum of cashew nut allergic children is 
interesting, however the question does remain how clinically relevant these allergens are, as 
serum IgE levels and skin prick test results for mango were significantly lower than for 
cashew in both patient groups (p <0.05, ANOVA, LSD, SPSS-22). Besides, in a sub-group of 
the IDEAL patient population (11 children), no children reacted positive during an open food 
challenge with mango, 17 other children indicated to be able to eat mango at home without 
any allergic reaction. Of these 28 children, 12 were sensitized to mango as determined by 
sIgE levels and SPT.  
 
The observed difference in IgE-protein binding profile might indicate a possible difference in 
primary food allergen (e.g. cashew or pistachio), or a possible difference in primal allergen 
family (e.g. 2S albumin or 11S globulin). In our study no difference in severity of the allergic 
reaction towards cashew nut was noted between the two groups. These data should be 
extended with mass spectrometric protein identification methods to better understand the 
difference in IgE binding patters between patient groups, and the western blots should be 
repeated with either more patient serum pools or, preferably, unpooled sera.  
Subdivision of patients into groups based on sensitization profile, might, in the future, lead 
to a better distinction between patients with different co-sensitization and co-allergenicity 
profiles. The need for more invasive and costly diagnostic methods such as the DBPCFC 
might decrease when co-allergenicity profiles can be predicted based on serum IgE profile 
(by western blot or sIgE measurement).  
 
Future directions 
In the IDEAL study both the clinical as well as the molecular characteristics of cashew nut 
allergy was studied. Based on the DBPCFC, SPT results, and the sIgE measurements (using 
our purified cashew nut allergens), a predictive model was established by van der Valk et al. 
[25]. This model provides an indication whether or not a person should be diagnosed by 
DBPCFC, or that sIgE and SPT measurements alone can be used for the diagnosis. Perhaps in 
a later stage other determinants, such as a mediator release assay, can be incorporated into 
this model. The addition of a mediator release assay might discriminate better between the 
levels of severity of the allergy. However, first experiments should be performed using 
various patient sera to see if the level of cell degranulation (using e.g. RBL or LAD2 cells) 
General discussion 
163 
correlates with the severity of the patients’ allergy. It might also be useful to measure sIgE of 
the separate pistachio allergens of all cashew nut allergic patients. This might give more 
information regarding cross-allergenicity between the separate allergens of cashew nut and 
pistachio. As described in this chapter, different co-sensitization profiles towards cashew, 
pistachio, pink pepper and mango, were observed for different patient groups. Possibly 
these sensitization profiles can be linked to true co-allergenicity between cashew nut and 
other nuts. If such a diagnostic profile can be developed, better advice might be provided 
concerning the avoidance of certain foods in the diet. However the DBPCFC will still need to 
be used as the golden standard for allergy diagnostics.  
The current study used cashew nut allergy as a showcase allergy. The results from this study 
might also be used as a basis for other food allergens. A model, similar to the model 
produced by van de Valk et al. was described in 2012 by Klemans et al.for peanut allergy 
[100]. It can be envisioned that such a model might also be prepared for other tree nuts such 
as pistachio, hazelnut, etc. For such a model again DBPCFC, SPT and sIgE measurements to 
specific allergens should be performed. sIgE measurements might be performed with native 
purified allergens as was done in this study, or with recombinantly produced allergens.  
 
The patients in this study were children of 2 to 17 years old. Tree nut allergy is less prevalent 
among adults than among children [101]. It is unclear if the same sIgE levels to Ana o 1, 2 
and 3 can be expected in adults as all studies have been performed in children [1, 37, 38] 
Furthermore it is unknown if the same co-sensitization and co-allergenicity can be expected 
in this different age group. Additionally it is unknown if the same patient characteristics such 
as sIgE levels are similar in children from a different geographic location.  
Regarding the cashew nut allergens Ana o 1, 2 and 3 several opportunities for more research 
remain. First of all two isoforms of Ana o 1 and one isoform of both Ana o 2 and Ana o 3 
have been identified, while for the same types of allergens in peanut multiple isoforms have 
been detected [48], therefore it can be expected that also multiple isoforms can still be 
detected in cashew nut, especially when keeping in mind the 2D electrophoresis results 
described in Chapter 4. Furthermore it highly likely that beside Ana o 1, 2 and 3, also other 
allergens (e.g. Ana o 4, 5, 6), such as profilins, pathogenesis related proteins, and oleosins 
are present in the cashew nut. Further identification of the allergens in cashew nuts would 
improve the possibilities of diagnostic measurements in cashew nut sensitized and allergic 
patients.  
 
Several attempts have been made to decrease the allergenicity of cashew nuts [102, 103]. 
This is a difficult tasks for multiple reasons: first of all, as described in Chapter 4, no 
difference in soluble allergen content was detected between cashew nuts of 8 different 
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origins. Besides, since Ana o 1, 2 and 3 are present at high levels in the cashew nut, it would 
be difficult to remove them while maintaining viable and tasty cashew nuts. 
The in-shell heat treatments described in Chapter 4 indicated that no large effect on allergen 
solubility occurs in the pre-treatment of cashew nuts prior to the removal of the shell. Heat 
treatments performed after removal of the shell, showed that dark roasting decreased the 
solubility of Ana o 1 and 2 [28], and that autoclaving can decrease monoclonal antibody 
binding to linear epitopes of Ana o 1 and 2 [29]. Treatment of cashew nut protein extracts 
with sodium oleate and sodium sulphite could also reduce IgE binding to the cashew nut 
allergens [102, 103]. However it is questionable how tasty such autoclaved or dark roasted 
cashew nuts are, or what the effect is of sodium oleate or sodium sulphite on whole cashew 
nuts. It might, however, be relevant to study the combined effect of pre-shelling heat 
treatments with subsequent roasting steps under conditions generally applied to cashew 
nuts meant for consumption.  
 
Conclusions 
In this thesis we have characterised the cashew nut allergens Ana o 1, 2 and 3, both as native 
purified proteins (Chapter 3), but also as the P. pastoris recombinantly produced proteins 
(Chapter 5). Furthermore we have compared the cashew nut allergens from cashew nuts of 
different origins (Chapter 4), and subjected to different heat treatments in-shell (Chapter 4). 
Furthermore, we have provided a background on the cashew nut proteins (Chapter 1), 
cashew nut allergy (Chapter 1), and the pathway of (allergenic) protein transport in 
sensitized and non-sensitized persons (Chapter 2).  
The results from this thesis have already been applied to expand the clinical patient 
characterisation with measurements of IgE levels to purified cashew nut allergens. These 
results have subsequently been used in a predictive model that can be used to evaluate the 
need for DBPCFC in children with possible cashew nut allergy. This model, when confirmed 
to work in other (geographic) patient populations, might be used to avoid unnecessary food 
provocations, and perhaps similar models should be composed for other food allergens or 
patient populations. In this thesis the current knowledge regarding the cashew nut allergens 
has been expanded with purification protocols and protocols for the recombinant 
purification of the allergens from P. pastoris, identification of N- and C-terminal micro-
heterogeneity of native Ana o 3, 2D electrophoretic profiles for Ana o 1, 2 and 3, and 
information regarding the presence of the three allergens in multiple cashew nut origins. 
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Cashew nut allergy can be a severe food allergy of which the prevalence appears to be 
increasing. The aim of this thesis was a comprehensive molecular and serological 
characterisation of the cashew nut allergens Ana o 1, 2 and 3 for improved diagnosis and 
characterisation of patient populations.   
 
Chapter 1 in this thesis provides background information on cashew nuts, allergy, the 
allergens Ana o 1, 2 and 3, the effect of heat treatments on cashew nut proteins, the 
digestibility of cashew nut proteins, cross-reactivity between cashew nut proteins and other 
tree nuts, and the detection of cashew nut in food products. Subsequently, in Chapter 2, a 
review is presented on the topic of epithelial protein and allergen transport. This review 
describes multiple pathways of intestinal protein transport, sums up existing experimental 
data concerning protein and peptide transport, and presents different methods to study this. 
Interestingly, the pathway of (allergenic) protein transport can differ between sensitized and 
non-sensitized persons. In sensitized persons, protein transport occurs transcellularly via 
enterocytes, and paracellularly with the involvement of mast cells, while in non-sensitized 
persons microfold cells and enterocytes are considered most important.  
In the next three chapters, cashew nut allergens were studied. Cashew nut allergy and 
cashew nut allergens were chosen because of a high number of undiagnosed cashew nut 
allergic children reported at the children’s hospital “Kinderhaven”, in Rotterdam, an 
outpatient clinic that is involved in this study. Chapter 3 describes a protocol for the 
purification of Ana o 1, 2 and 3 from cashew nuts. Ana o 1 and 3 were purified by protein 
extraction, salt precipitation and filtering over a 30kDa molecular weight membrane. Ana o 2 
was purified by protein extraction followed by gel filtration chromatography. These purified 
proteins were characterised by SDS-PAGE, western blot, glycoprotein stain, and protein 
identification. In this chapter also more in-depth analysis was performed on the N- and C-
termini of the large and small subunits of Ana o 3. These N- and C-termini of Ana o 3, as well 
as the SDS-PAGE protein profiles were compared between cashew nuts of different origins in 
Chapter 4. In this chapter also the effects of different heat treatments on the 
electrophoretic behaviour of cashew nut allergens from various origins were studied, using 
both 1D and 2D electrophoresis. In these data no significant differences were detected 
between the electrophoresis patterns of Ana o 1, 2 or 3 in the various origins of cashew nuts. 
Some small but significant differences in Ana o 1, 2 and 3 content, however, were detected 
between the differently heated cashew nuts. No major differences in N- and C-terminal 
micro-heterogeneity were detected between cashew nuts of different origins.   
Next, in Chapter 5, the cashew nut allergens Ana o 1, 2 and 3 were produced as recombinant 
proteins using a yeast (P. pastoris) production system. This procedure was used as 
recombinant allergens often produce higher yields of higher purity compared to native 
purified allergens. The recombinant proteins were compared to the native cashew nut 
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proteins for their glycosylation pattern, IgE binding capacity, and 2D electrophoresis profile. 
In Chapter 6, the major findings of this thesis are discussed. An overview of the protein 
characteristics (e.g. 1D and 2D electrophoresis profile, glycosylation, IgE binding, pepsin-
digestibility) was provided, as well as a discussion on the clinical benefits that can be derived 
from the results obtained in this thesis. Also some additional results are presented, studying 
the serologic cross-reactivity between cashew nuts and other tree nuts and Anacardiaceae 
nuts and fruits. 
 
This thesis provides an in-depth study regarding the protein characteristics of the cashew 
nut allergens Ana o 1, 2 and 3. Using the allergens that were purified in this thesis project, 
the serum IgE levels of Ana o 1, 2 and 3 could be measured in cashew nut-allergic children. 
The allergens were also recombinantly produced to obtain higher quantity of allergens for 
regular use in diagnostics of cashew nut allergy. The results from this thesis can potentially 
expand clinical patient characterisation with measurements of IgE levels to purified and 
recombinantly produced major cashew nut allergens. These results might have applications 
for other food allergens or patient populations. 
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